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 ABSTRACT 
High training loads or prolonged bouts of acute exercise can increase susceptibility to 
opportunistic infections. Such infections, although generally medically innocuous, can have 
profound negative implications for athletic performance. This thesis presents a series of 
studies investigating which factors influence infection risk in athletes, as well as exploring 
potential strategies to maintain immunocompetence during heavy training. 
In Chapters 2 and 3, a large cohort of elite winter endurance athletes were followed over a 
number of years to determine patterns and frequency of illness in this population, and to 
identify training- and competition-related predictors of infection. Incidence rates and 
seasonal patterns of illness were found to be broadly similar to elite athletes from summer 
sports, and to the general population. Competition, air travel, greater day-to-day fluctuations 
in training load and lower performance level were significant predictors of illness.  
When high training loads are combined with insufficient recovery, athletes may become 
overreached or overtrained. Previous studies suggest that increasing carbohydrate intake can 
be an effective means of preventing overreaching during periods of intense training. In 
Chapter 4 we therefore investigated the efficacy of carbohydrate supplementation in 
reducing immune disturbances and symptoms of overreaching. The lower carbohydrate 
does (20 g/h during exercise) was found to be equally effective in preserving immunity and 
power output as the higher dose (60 g/h), with modest immune and performance changes 
observed in both groups following eight days of intensified training.    
Many athletes fail to ingest sufficient fluid to maintain euhydration during exercise. 
However, Chapter 5 found that moderate hypohydration, elicited by a 24 h period of fluid 
restriction, had little effect on immune responses to prolonged exercise.  
 Altitude training is an important component of the training process of most of today’s elite 
endurance athletes. Chapters 6 and 7 explored the effects of acute and prolonged hypoxic 
training on immunity. Despite a somewhat augmented stress hormone response to exercise 
in hypoxia, altitude training was found to have little negative effect on host defence, 
providing relative exercise intensity at altitude and sea-level was matched.  
Key words: immunity; URS; overreaching; hydration; carbohydrate; altitude; cytokines; 
IgA; performance. 
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CHAPTER 1: GENERAL INTRODUCTION 
There is a general consensus that moderate levels of physical activity are beneficial for 
multiple aspects of health, including immune function (Nieman and Pedersen, 1999, Klentrou 
et al., 2002). However, high training loads or prolonged, intense bouts of acute exercise may 
actually increase susceptibility to opportunistic infections, particularly of the upper-
respiratory tract (Nieman, 1994, Moreira et al., 2009).  As such, the relationship between 
infection susceptibility and exercise load has often been described as a J-shaped curve, 
although this is not always supported in the literature (Fondell et al., 2011; Malm, 2006).  
Whatever the influence on immunity, reaching an international level in any sport invevitably 
requires a huge amount of dedicated training. For elite endurance athletes, high training loads 
are therefore inevitable. Depending on the sport, these athletes typically train between 500 
hours (e.g. long distance running) (Billat et al., 2001, Billat et al., 2003) to in excess of 1000 
hours per year (e.g. rowing, cycling, triathlon) (Fiskerstrand and Seiler, 2004, Neal et al., 
2011, Zapico et al., 2007).  
With medals often being decided by seconds or fractions of seconds, even minor infections 
generally considered medically innocuous can meaningfully and deleteriously impact on 
performance, and on an athlete’s career. This is compounded by the fact that the risk of such 
infections is typically highest during important periods of heavy training and competition 
(Hellard et al., 2015, Nieman et al., 1990).   
1.1 INFECTION INCIDENCE IN ATHLETES 
Upper respiratory infection (URI) is the most common medical complaint affecting athletes 
(Fricker et al., 2005, Reeser et al., 2003). Anecdotally, athletes and coaches report that elite 
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and highly trained endurance athletes experience a greater number of URIs than the general 
population, but there is currently little empirical evidence in the scientific literature to support 
this theory. Indeed, studies suggest that there is little difference in overall infection rates 
between athletes and the general population (Fricker et al., 2000, Hellard et al., 2015, Monto, 
2002; Fondell et al., 2011), but that  URI episodes in athletes typically cluster around 
competitions and intensified training periods rather than following normal seasonal trends 
(Walsh et al., 2011b). Most likely, athletes are not at substantially higher risk of infection 
compared to the general population, other than during the periods they are competing or 
undertaking particularly high training loads (Pyne and Gleeson, 1998). Malm (2006) 
suggested that the relationship between training load and infection susceptibility is more akin 
to an S-shape than a J-shape, proposing that, although high training loads typically suppress 
immunity, in order to be a successful elite athlete an individual must have an immune system 
able to withstand infections, even during severe physiological and psychological stress.  
A number of studies have investigated sex-differences in infection susceptibility. In the 
general population, males appear to be somewhat more prone to respiratory infections 
(Falagas et al., 2007) likely due to a combination of anatomic, lifestyle, behavioural, and 
socioeconomic differences between males and females, and to the immunomodulatory effects 
of sex hormones (Verthelyi, 2001). Oestrogens generally enhance the immune response, 
while androgens suppress both cellular and humoral immunity. However, a number of recent 
studies on athletes have found that female athletes actually experience a higher frequency of 
URI than their male counterparts. Reports on medical services provided during recent 
summer and winter Olympic Games all indicate that female athletes may be more susceptible 
to this type of infection (Engebretsen et al., 2010, Engebretsen et al., 2013, Soligard et al., 
2015). He et al. (2014) found no sex-differences in the incidence of URI, but the duration of 
symptoms was significantly longer for females. Increased URI incidence and/or severity in 
10 
 
female athletes might be explained by lower secretion rates of salivary amylase, lactoferrin 
and lysozyme (He et al., 2014) and salivary secretory immunoglobulin-A (S-IgA) (Evans et 
al., 2000). 
Since studies on URI in athletes commonly report short duration of symptoms (1-3 days) it 
may be that many of these events are due to viral reactivation rather than a primary infection 
(Gleeson et al., 2002, Walsh et al., 2011b). Ekblom and colleagues (2006) found that only 
athletes who had recently experienced an infectious episode were at increased risk of illness 
following a race, suggesting that post-race increases in URI may be related to performing 
strenuous exercise too soon following a previous infection. It is also likely that a number of 
reported URI events are due to non-infectious causes of inflammation. Indeed, Spence et al. 
(2007) found that viral or bacterial pathogens were isolated in fewer than 30% of URI cases 
reported by competitive triathletes suggesting that, in a large number of cases, respiratory 
symptoms reported by athletes may be due to non-infectious causes. In general, it would 
appear that approximately one third of URIs reported by athletes are due to infection, one 
third are due to a non-infectious medical cause, and one third have an unknown aetiology 
(e.g. physical/mechanical damage such as drying of airways, or migration to airways of 
inflammatory cytokines produced as a result of muscle damage) (Cox et al., 2008, Walsh et 
al., 2011b). Irrespective of whether or not they are due to infection, symptomatic URI are 
associated with reduced athletic performance (Pyne et al., 2001). However, since 
differentiating between infection and other inflammatory stimuli which mimic URI is clearly 
problematic, the term upper-respiratory symptoms (URS) will be used in the place of URI for 
the remainder of this thesis.  
The following sections introduce some of the key factors that might influence immune 
function and infection risk in athletic populations.  
11 
 
1.2 INFLUENCE OF TRAINING & COMPETITION ON IMMUNITY 
1.2.1 Acute endurance exercise 
Various aspects of host defence appear to be negatively affected during the hours 
immediately following an acute bout of prolonged exercise. This results in what has been 
termed an “open window” for infection, lasting from 3 to 72 hours post exercise depending 
on the marker measured (Nieman and Pedersen, 1999). Almost certainly, this 
immunosuppression is multifactorial in origin, since changes in a large number of immune 
variables are observed.  
1.2.1.1 Leukocyte number 
Prolonged exercise is associated with a pronounced leukocytosis that persists for several 
hours post-exercise, the magnitude of which is dependent on both the intensity and duration 
of the exercise (Nieman et al., 1993, Robson et al., 1999). This is principally driven by an 
increase in circulating neutrophils, while monocyte and lymphocyte numbers increase to a 
lesser extent. However, during the recovery period following exercise, the number of 
lymphocytes falls below baseline, primarily due to a reduction in NK cells and type 1 (pro-
inflammatory) T cells in the circulation (Gleeson and Bishop, 2005). This biphasic response 
appears to be due to the initial actions of elevated plasma catecholamines and shear stress 
which cause demargination of cells into the circulation (Shephard, 2003), followed by the 
more delayed action of elevated plasma cortisol causing an exodus of lymphocytes from the 
bloodstream during recovery from exercise (Walsh et al., 2011b). The reduction in the 
number of circulating lymphocytes during recovery is transient, typically lasting no more 
than a few hours, and likely represents a temporary redistribution of cells to reservoir sites.  
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1.2.1.2 Leukocyte function 
In addition to changes in the absolute and relative number of leukocytes in the circulation, the 
ability of some cell types to mount an appropriate response to an immune challenge appears 
to be compromised following prolonged exercise. Nieman et al. (1995) investigated the effect 
of 2.5 hours of intensive running on lymphocyte number and function. Serum cortisol was 
elevated post-exercise, while the mitogen-induced lymphocyte proliferative response was 
decreased relative to controls for more than 3 h post-exercise. A number of studies have also 
reported reductions in mitogen-stimulated T cell production of TNF-α, IFN-γ, IL-2 and IL-1β 
following prolonged exercise (Starkie et al., 2001, Lancaster et al., 2005b, Lancaster et al., 
2004, Lewicki et al., 1988, Baum et al., 1997), resulting in a shift in the type 1/type 2 T 
lymphocyte cytokine balance toward a more type 2 (anti-inflammatory) response. Since 
reductions in T cell function, and particularly type 1 responses, are associated with increased 
susceptibility to viral infections (Fabbri et al., 2003), this may be a mechanism through which 
acute, prolonged exercise increases the risk of URS. However, changes in in vitro mitogen-
stimulated T cell proliferation and cytokine production should be interpreted with caution, 
since results may be confounded by a number of factors. Differences in the number of 
responder cells in blood samples collected before and after exercise, increased cell apoptosis 
in cell culture (Green and Rowbottom, 2003) and differences in immune responses to 
powerful T cell mitogens as opposed to specific antigens (Bishop et al., 2005) may all 
influence total cytokine production and proliferative responses.  
NK cell cytotoxic capacity is augmented during exercise and reduced post-exercise, primarily 
due to changes in absolute numbers of NK cells. However, intense, prolonged exercise also 
appears to result in reduced cytotoxic capacity per cell (Gleeson and Bishop, 2005). 
Similarly, there is a reduction in neutrophil phagocytic function and degranulation in 
response to bacterial challenge which persists for several hours post-exercise (Robson et al., 
13 
 
1999, Peake, 2002, Muns, 1994, Bishop et al., 2001b, Bishop et al., 2001a). Although the 
number of monocytes in the circulation increases following exercise, toll-like receptor 
expression decreases (Simpson et al., 2009, Lancaster et al., 2005a). During exercise there is 
a preferential mobilization of CD14+CD16+ pro-inflammatory monocytes, but the number of 
these is subsequently reduced in the circulation during recovery (Simpson et al., 2009) which 
might explain the concurrent reduction observed for monocyte production of TNF-α and IL-6 
in response to LPS-stimulation (Starkie et al., 2005, Smits et al., 1998, Kvernmo et al., 1992). 
A single bout of prolonged exercise also significantly reduces both the induction and 
elicitation of in vivo T-cell-mediated immunity to a novel antigen (diphenylcyclopropenone), 
as measured via experimental contact-hypersensitivity (Harper Smith et al., 2011, Davison et 
al., 2015), which may be indicative of increased infection susceptibility.  
1.2.1.3 Mucosal immunity 
Studies on the effect of acute endurance exercise on mucosal immunity have yielded 
somewhat inconsistent results. Generally, it would appear that S-IgA secretion is reduced or 
unchanged following exercise of moderate intensity (Laing et al., 2005b, Walsh et al., 2002) 
and increased following high-intensity exercise (Blannin et al., 1998). Saliva flow rate is 
reduced following strenuous exercise (Blannin et al., 1998), but this is typically compensated 
for, at least to some degree, by increases in S-IgA concentration. A smaller number of studies 
have explored changes in other salivary anti-microbial proteins, and the available data 
indicate that concentrations and secretion rates of salivary lactoferrin, lysozyme LL-37 and α-
amylase all increase following exercise (Killer et al., 2015, Kunz et al., 2015, West et al., 
2010, Gillum et al., 2015). Changes in mucosal immunity with acute exercise are likely 
linked to the effect of sympathetic nervous system activation on transcytosis and exocytosis 
of salivary proteins (Walsh et al., 2011b), likely explaining why these responses are 
dependent on exercise intensity.  
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1.2.2 Endurance training  
In addition to transient changes in immune variables following an acute bout of exercise, 
chronic exercise training appears to result in more prolonged changes to some aspects of 
immune function. Although this remains somewhat contested, a number of studies have 
observed that athletes with higher training loads experience a greater rate of URS, and high 
running mileage appears to be positively related to URS risk (Nieman et al., 1990, Heath et 
al., 1991), as does training volume in triathletes (Spence et al., 2007).  
1.2.2.1 Leukocyte number 
Regular endurance training does not appear to notably alter resting blood leukocyte counts, 
providing blood samples are collected when athletes are fully recovered from (i.e. at least 24 
hours after) the previous exercise bout (Walsh et al., 2011b).   
1.2.2.2 Leukocyte function 
Gleeson et al. (2011a) found that athletes with a high training load (≥11 h moderate- high 
intensity training  per week) experienced more than twice as many URS episodes and had 
approximately threefold higher resting IL-2, IL-4, and IL-10 production by antigen- 
stimulated  whole blood culture  than  athletes with a low (3–6 h  per  week) training volume. 
An elevated anti-inflammatory cytokine response to immune challenge could be one 
mechanism through which heavy training loads might increase susceptibility to infection. 
Increased antigen-stimulated IL-10 production, in particular, appears to be a risk factor for 
URS (Gleeson et al., 2012). Although also released by monocytes, IL-10 is primarily 
produced by lymphocytes and, in particular, regulatory T (Treg) cells. Endurance trained 
athletes with a high training load have a significantly higher Treg percentage of total 
lymphocytes and antigen-stimulated IL-10 production compared to sedentary individuals 
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(Handzlik et al., 2013). Other aspects of leukocyte function do not appear to differ markedly 
between endurance athletes and the general population (Walsh et al., 2011b).  
1.2.2.3 Mucosal immunity 
A number of studies have investigated differences in markers of mucosal immunity between 
athletes and non-athletes, as well as investigating longitudinal changes in salivary 
antimicrobial proteins (AMPs) following heavy periods of training. Salivary levels of both S-
IgA and lactoferrin have been found to be lower in elite endurance athletes compared to age-
matched controls (West et al., 2010, Tomasi et al., 1982a). Gleeson et al. (1999) found that 
salivary S-IgA levels in swimmers were 4.1% lower for each additional month of training, 
and that S-IgA levels were inversely correlated with the number of infections in both elite 
swimmers and moderately exercising controls. Similarly, Neville et al. (2008) found that, 
although S-IgA was highly variable both within and between athletes, a decline in an 
individual's relative S-IgA was predictive of URS risk. An S-IgA concentration less than 40% 
of an individual’s mean healthy value was associated with a one in two chance of contracting 
a URS within three weeks. Indeed, S-IgA secretion has been suggested to be one of the most 
useful clinical biomarkers to predict URS incidence in athletes (Fahlman and Engels, 2005) 
and is the only immune marker to date to show a strong and consistent relationship with URS 
risk. The underlying mechanism for depressed S-IgA secretion following training may be 
related to altered hypothalamic-pituitary-adrenal axis activity inhibiting S-IgA synthesis 
and/or transcytosis (Walsh et al., 2011b).  
1.2.3 Intensified training & overreaching  
As well as differences in habitual training, studies indicate that short-term increases in 
training load can influence infection risk. Overload is a key training principle used by athletes 
and coaches in order to improve physical performance, and periods of intensified training are 
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commonly incorporated over the course of a training season. The aim of such periods, 
although initially resulting in acute fatigue and a short-term decrement in performance, is to 
achieve an eventual supercompensation in performance capacity following tapering/recovery 
(Mujika et al., 1995). However, when excessive physical overload is combined with 
insufficient recovery and/or other life stressors such as lack of sleep, emotional or 
psychological stress, inadequate diet/energy intake, or environmental stress (heat, cold, 
altitude etc.), the total load placed on the athlete may become too great and lead to a state of 
overreaching or overtraining. Overreaching (OR) is defined as an accumulation of training 
and/or non-training stress resulting in a short-term decline in performance capacity, from 
which recovery may take from several days to several weeks (Meeusen et al., 2013). This can 
be further differentiated into Functional OR (where recovery takes from two days up to one 
week, and which can be incorporated into a training programme to facilitate long-term 
performance development) or Non-functional OR (where recovery can take several weeks) 
(Figure 1.1). Overtraining (OT) is defined as an accumulation of training and/or non-training 
stress resulting in a long-term decline in performance capacity, from which recovery can take 
several months. Hence, the main distinguishing difference between OT and OR is the time 
required to restore performance capacity. Functional OR, where performance recovers within 
a few days, may be considered a routine aspect of an athlete’s training. An athlete suffering 
from OT, however, may take up to several years to recover.   
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Figure 1.1 The overtraining continuum. Brackets indicate typical timescales required 
for recovery (adapted from (Meeusen et al., 2013)) 
Because a certain level of functional OR is required in order to improve athletic performance, 
athletes and coaches continually tread a fine line between insufficient training stimulus and 
excessive overload. As a result, imbalances between training and recovery, particularly in the 
presence of other life stressors, lead to a relatively high incidence of non-functional OR/OT 
amongst elite athletes, with the career prevalence reported to be 50% or higher (Morgan et 
al., 1987, Matos et al., 2011). 
Much anecdotal evidence suggests that athletes suffering from non-functional OR or OT 
experience increased URS incidence and symptom duration/severity. Indeed, an increased 
susceptibility to infection is one of the most common symptoms of OT (McKenzie, 1999). As 
well as transient changes associated with a single bout of strenuous and/or prolonged 
exercise, studies suggest that periods of particularly intense training may lead to a more 
chronic immune dysfunction in OR or OT athletes, and could explain a concurrent increase in 
URS susceptibility. Immune disturbances associated with intensified training include reduced 
salivary S-IgA levels (Gleeson et al., 1995, Mackinnon and Hooper, 1994), reduced numbers 
of NK cells (Gleeson et al., 1995, Meyer et al., 2004) and absolute numbers of CD3+ and 
CD4+ cells (Baj et al., 1994a), decreased exercise-induced mobilization of leukocytes 
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(Lancaster et al., 2004, Witard et al., 2012) impaired neutrophil function (oxidative burst and 
degranulation) (Baj et al., 1994a, Robson-Ansley et al., 2007), reduced Glutamine/Glutamate 
ratio (Halson et al., 2003, Rowbottom et al., 1995, Coutts et al., 2007, Parrybillings et al., 
1992), and elevated plasma levels of IL-6 and CK at rest (Robson-Ansley et al., 2007). In 
addition, some studies suggest an impaired capacity of immune cells to produce cytokines in 
response to an immune challenge following a period of IT (Baj et al., 1994a, Lancaster et al., 
2004, Morgado et al., 2012).  
Hormonal changes appear to play a key role in the pathogenesis of OT (Urhausen et al., 
1995), and many of the changes in immune variables in response to intensified training have 
been attributed to the immunomodulatory influence of exercise-induced elevations in 
circulating stress hormones, and to changes in the sensitivity of the Hypothalamic-Pituitary-
Adrenal axis (Meeusen et al., 2013). A glucocorticoid released from the adrenal cortex in 
response to stress, cortisol has immunosuppressive and anti-inflammatory effects (Auphan et 
al., 1995), acting to mediate the recovery from immune activation early in the stress response, 
thus preventing an “overshoot” of the immune reaction (Sorrells and Sapolsky, 2007). 
Cortisol acts to suppress the production of pro-inflammatory cytokines (Petrovsky et al., 
1998), as well as up-regulate the expression of certain anti-inflammatory cytokines (Elenkov 
and Chrousos, 2002), thus functioning as a negative feedback mechanism and protecting 
against excessive inflammation. The Testosterone:cortisol ratio has been stipulated as a 
useful diagnostic tool for OT, with some studies reporting an increase in resting plasma 
cortisol concentration, often alongside a concurrent decrease in testosterone, following 
intensified training (Slivka et al., 2010, Coutts et al., 2007), suggesting a shift towards a more 
catabolic state. However, it would appear that a decrease in this ratio in actual fact only 
indicates the physiological stress of the training and cannot distinguish between normal and 
OR/OT athletes (Meeusen et al., 2013) and several other studies have found no change in 
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plasma cortisol concentrations at rest following a short-term period of IT (Urhausen et al., 
1998, Mackinnon et al., 1997, Hooper et al., 1993). However, there is some evidence 
available that OR athletes have a diminished rise in cortisol with acute exercise (Snyder et al., 
1995, Lancaster et al., 2004, Urhausen et al., 1998, Witard et al., 2012, Verde et al., 1992). 
This appears to be due, at least in part, to diminished adrenal responsiveness to 
adrenocorticotropic hormone (ACTH) (Lehmann et al., 1998).  
1.3 INFLUENCE OF NUTRITIONAL STATUS ON IMMUNITY 
1.3.1 Macronutrient intake  
It is well known that malnutrition impairs immune function (Calder and Jackson, 2000) but 
studies suggest that endurance athletes frequently undertake periods of training during which 
energy intake is not sufficient to match energy expenditure (Edwards et al., 1993, 
Venkatraman and Pendergast, 2002). Overall energy balance is clearly an important factor in 
maintaining immunocompetence in athletes, but equally important is that this energy is 
provided in the form of a well-balanced diet,  in order to avoid deficiencies in those nutrients 
that play a central part in immune cell triggering, interaction, differentiation and functional 
expression (Gleeson et al., 2004). 
1.3.1.1 Protein 
Not surprisingly, since the immune system relies on fast cell replication and generation of 
proteins such as cytokines and immunoglobulins, inadequate protein intake is associated with 
impaired host defence – particularly T-lymphocyte function - and increased infection 
susceptibility (Gleeson et al., 2004, Bishop et al., 1999). Although protein intake in athletes 
generally appears to be sufficient (van Erp-Baart et al., 1989, Venkatraman and Pendergast, 
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2002), some athletes may be at risk of protein deficiency, particularly during periods of heavy 
training and/or weight loss.  
Glutamine is the most abundant, nonessential amino acid in human muscle and plasma, and is 
an important fuel for a number of immune cells, particularly lymphocytes and macrophages 
(Venkatraman and Pendergast, 2002, Walsh et al., 1998). Prolonged exercise is associated 
with reduced plasma glutamine (Castell and Newsholme, 1997, Gleeson et al., 1998), and it 
has been suggested that oral glutamine supplementation may ameliorate some aspects of the 
post-exercise immunosuppression and reduce infection risk (Castell and Newsholme, 1997). 
However, although an attractive hypothesis, the majority of studies do not support that 
reduced plasma glutamine meaningfully contributes to exercise-induced immunosuppression 
(Rohde et al., 1998, Gleeson, 2008, Walsh et al., 2000).  
1.3.1.2 Carbohydrate (CHO)  
A number of studies have explored the impact of dietary CHO or acute CHO supplementation 
during exercise on immune responses to physical activity. Consuming a high CHO diet for 2-
3 days has been associated with an attenuated rise in plasma cortisol during exercise, better 
maintained plasma glutamine concentration post-exercise, and smaller exercise-induced 
perturbations in the number of circulating leukocytes, neutrophils and lymphocytes during the 
post-exercise period (Gleeson et al., 1998, Mitchell et al., 1998, Bishop et al., 2001b). A high 
CHO diet has also been found to have a favourable effect on post-exercise S-IgA levels in 
competitive endurance athletes (Costa et al., 2005) as well as ameliorating exercise-induced 
increases in plasma cytokines (Bishop et al., 2001c). However, it does not appear to better 
maintain lymphocyte proliferative responses (Mitchell et al., 1998) or neutrophil 
degranulation (Bishop et al., 2001b).  
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Of studies investigating the effects of acute CHO supplementation during exercise on 
immune function, the vast majority have reported an attenuated cortisol response due to better 
maintenance of plasma glucose (Gunzer et al., 2012, Davison et al., 2015). However, data on 
whether this translates into better maintained immune function are somewhat inconsistent. 
CHO supplementation has been consistently found to attenuate the exercise-induced increase 
in circulating leukocytes, neutrophils and monocytes (Nieman et al., 2006b, Davison et al., 
2015) and diminish post-exercise reductions in LPS-stimulated neutrophil degranulation 
(Bishop et al., 2003) but does not appear to ameliorate exercise-induced changes in NK cell 
activity (Nieman et al., 1997b), mitogen-stimulated cytokine production (Henson et al., 
2004), granulocyte and monocyte phagocytosis or oxidative burst (Nieman et al., 1997a), in 
vivo cell-mediated immunity (Davison et al., 2015), or S-IgA (Henson et al., 1998b, Li and 
Gleeson, 2005). Henson et al. (1998) found that CHO supplementation before, during, and 
after 2.5 hours of intensive running had a significant effect in maintaining lymphocyte 
proliferative responses, although subsequent studies have not been able to replicate this 
(Henson et al., 2004). Nieman et al. (2003) found that ingestion of a 6% CHO beverage 
during prolonged, strenuous running attenuated the exercise-induced increase in plasma IL-6, 
IL-10, and IL-1ra in overnight fasted marathon runners, while Peake and colleagues (Peake et 
al., 2008) found no effect of CHO supplementation on either plasma cytokines or neutrophil 
degranulation responses to cycling when exercise was performed 2 h after a meal. Hence, it 
appears that the efficacy of acute CHO supplementation in alleviating exercise-associated 
immune disturbances depends not only on the immune marker measured, but also on the 
exercise intensity/duration and the pre-exercise CHO status of participants. It is also worth 
noting that CHO ingestion markedly improves endurance exercise performance. As a result, 
studies investigating immune responses to an exercise bout of fixed duration and intensity 
with and without CHO may not reflect the real-world situation in which an athlete will likely 
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be capable of exercising harder and/or for longer when ingesting CHO. Indeed, when 
exercise is performed to exhaustion, CHO ingestion increases time to fatigue but appears to 
have little effect on immunity (Bishop et al., 2001a). As well as supplementation strategies 
during exercise, some studies have found that CHO feeding, with or without additional 
protein, immediately after a bout of prolonged exercise may be effective in improving 
bacterially stimulated neutrophil degranulation (Costa et al., 2011) and salivary lysozyme 
(Costa et al., 2012) during the recovery period.  
As well as potentially alleviating some of the immunological disturbances associated with 
acute exercise, studies suggest that energy, and specifically CHO, intake may play a role in 
the prevention of OR and OT. Achten et al. (2004) found that an increase in dietary CHO 
from 5.4 to 8.5 g/kg bm/day better maintained physical performance and mood state in 
runners undergoing a period of intensified training, reducing the symptoms of OR. Similarly, 
Halson and colleagues (2004) found that CHO supplementation during an intensified training 
period alleviated the performance decrement and symptoms of OR in cyclists. Costa et al. 
(2005) found that consumption of a high CHO diet (12 g/kg bm/day) during a period of 
intensified training had a favourable effect on markers of immunity, attenuating cortisol 
release and increasing salivary S-IgA concentration.  
The mechanism through which increased CHO intake tempers immune disturbances 
associated with acute, prolonged exercise and intensified training may be via an attenuation 
of the stress response to exercise. During exercise, plasma cortisol concentration has been 
found to be inversely related to plasma glucose availability (Tsintzas et al., 1996), with 
hypoglycaemia stimulating an increase in cortisol release (Gleeson et al., 1998). Maintaining 
plasma glucose also provides a direct energy substrate for immune cells, which have very 
high metabolic rates (Gunzer et al., 2012).  
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It is, however, worth noting that the majority of studies that have investigated the influence of 
CHO supplementation on immune responses to exercise and training have studied responses 
to very high doses (e.g. 1L of 6% CHO per hour of exercise) in fasted participants. As such, 
these studies may do not always reflect typical real-world practices of athletes.  
1.3.1.4 Fat 
To date, relatively little is known about the role of dietary fat in modifying the immune 
response to exercise. Pedersen et al. (2000) found that that ingestion of a fat-rich diet during 
training was detrimental to the immune system, specifically NK-cell activity, compared to a 
CHO-rich diet. However, it is not clear whether this negative effect is due to excess fat intake 
or inadequate CHO intake. On the other hand, diets very low in fat may also compromise 
immunity in athletes, likely primarily due to negative energy balance (Venkatraman et al., 
2001).  
1.3.2 Micronutrient intake 
A growing body of literature suggests that vitamin D status is an important predictor of 
infection risk in athletes. Although some foods contain vitamin, the principle natural source is 
dermal synthesis from cholesterol, with this being dependent on sunlight (specifically UVB) 
exposure. As such, vitamin D levels vare typically lower during winter and early spring 
(Klingberg et al., 2015).  He et al. (2013) found that athletes deficient in vitamin D (plasma 
25(OH)D < 30 nmol/L) reported increased frequency, duration and severity of URS 
compared to athletes with optimal vitamin D status (>120 nmol/L). Vitamin D deficiency was 
also associated with lower S-IgA secretion rate and diminished pro-inflammatory cytokine 
production by monocytes and lymphocytes. In a subsequent study, the authors found that two 
weeks of daily vitamin D supplementation (5000 IU/day) had a beneficial effect in up-
regulating the expression of both S-IgA and cathelicidin in athletes during a winter training 
24 
 
period, suggesting that this might improve resistance to respiratory infections (He et al., 
2015). 
Some studies also suggest that megadoses of vitamin C may be effective in reducing infection 
risk in athletes. Peters et al. (1993) found that ingesting 600 mg of vitamin C for 3 weeks 
prior to an ultramarathon significantly reduced the incidence of post-race URS. However, the 
effects of vitamin C supplementation on exercise-induced immune perturbations and 
infection incidence in athletes are inconsistent, and a number of other studies have found no 
positive effect (Nieman et al., 2002). 
There is little evidence that supplementation with other vitamins and minerals is effective in 
maintaining immunocompetence in athletes who consume an otherwise balanced diet (Walsh 
et al., 2011a), and overconsumption of certain vitamins, notably vitamin E and vitamin A, 
may in fact impair immunity (Gleeson et al., 2004). It is also possible to question to what 
extent it is desirable to block the immune and inflammatory responses and oxidative stress 
associated with prolonged exercise, since doing so may interfere with signalling mechanisms 
for endurance adaptation (Gomez-Cabrera et al., 2008, Walsh et al., 2011a). 
1.4 INFLUENCE OF HYDRATION STATUS ON IMMUNITY 
Athletes frequently commence training or competition in a mildly or moderately 
hypohydrated state (Da Silva et al., 2012, Fernando Aragon-Vargas et al., 2009, Volpe et al., 
2009, Maughan et al., 2005) and typically fail to ingest sufficient fluid to offset sweat loss 
during exercise (Da Silva et al., 2012, Maughan et al., 2005, Maughan et al., 2004, Beis et al., 
2012). Compared with exercise in a euhydrated state, hypohydration results in an augmented 
stress response and, thus, potentially greater disturbances to immune function. Maresh et al. 
(2006) found that athletes hypohydrated to ∼5% body mass loss had significantly higher 
plasma cortisol concentrations both before and after acute submaximal exercise. Similarly, 
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Bishop and colleagues (2004) found that fluid ingestion during prolonged exercise attenuated 
the cortisol response, although there was no effect on the neutrophil response. Mitchell et al. 
(2002), on the other hand, found that although hypohydration resulted in elevated plasma 
cortisol when exercise was performed  in the heat, there was no effect of hydration status on 
cortisol concentration,  total or  differential leukocyte numbers,  or lymphocyte function 
when exercising in temperate ambient conditions. As well as possibly attenuating the stress 
response to exercise, regular fluid intake appears to maintain saliva flow rate (Bishop et al., 
2000, Fortes et al., 2012) and secretion rates of salivary lysozyme and α-amylase during 
prolonged exercise, although it does not appear to significantly alter S-IgA secretion rate 
(Fortes et al., 2012). As such, undertaking exercise in a hypohydrated state, within the range 
applicable to athletes, appears to have some implications for mucosal immunity. However, 
despite some studies reporting an augmented cortisol response, there is to date little evidence 
that systemic immunity is significantly affected, although a number of markers have not yet 
been investigated.   
1.5 INFLUENCE OF ENVIRONMENTAL FACTORS ON IMMUNITY 
In addition to high training loads, endurance athletes are commonly exposed to 
environmental stressors, such as hypoxia and extremes of temperature, which may impact on 
physiological and metabolic function, and compound exercise and training-induced immune 
disturbances.  
1.5.1 Altitude 
Hypoxic training is routinely used by competitive endurance athletes, both to improve 
exercise performance at sea level (Levine and StrayGundersen, 1997, Stray-Gundersen et al., 
2001) and to acclimatise prior to competition at altitude (Fulco et al., 2000). However, there 
26 
 
is some evidence that athletes experience an increased incidence of opportunistic infectious 
illness during and/or immediately following a period of altitude training (Bailey et al., 1998). 
Exercise in hypoxic conditions typically causes greater physiological stress than exercise at 
sea level (Bailey and Davies, 1997). Taking into account this augmented stress response to 
exercise, coupled with reports of increased resting levels of adrenaline, cortisol and IL-6 at 
high altitude (Mazzeo, 2005), it is not altogether surprising that both acute and chronic 
hypoxic training have been found to impact negatively on mucosal (Tiollier et al., 2005) and 
cell-mediated immunity (Facco et al., 2005, Oliver et al., 2013, Pyne et al., 2000). However, 
it is still unclear how many aspects of immune function respond to hypoxic exercise, and 
particularly to the types of exercise and the relatively modest levels of hypoxia to which 
athletes are typically exposed during training or competition. Furthermore, it is well known 
that ?̇?O2max is reduced at altitude, with the magnitude of this reduction being proportional to 
the level of hypoxia (Ferretti et al., 1997). Hence, it is important to differentiate between the 
effects of hypoxia per se, and the influence of increased relative exercise intensity at the same 
absolute workload. Indeed, Blegen et al. (2008) found that when cycling at the same relative 
exercise intensity (60% of altitude-specific ?̇?O2max), exercising in hypoxia equivalent to an 
altitude of ~2,500 m above sea-level did not result in greater elevations in cortisol, 
adrenaline, noradrenaline or plasma cytokines compared to normoxic exercise. Hence, it is 
possible to speculate that the increased infection risk reported during altitude training may be 
due, at least in part, to inadequate control of training load while at altitude.   
1.5.2 Heat 
Similar to the effects of hypoxia, exercise in the heat is associated with an augmented stress 
hormone response compared to exercise in thermoneutral conditions (Mitchell et al., 2002, 
Laing et al., 2005a). Indeed, studies that have used a thermal clamp to maintain rectal 
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temperature at <38ºC during exercise demonstrate that a substantial portion of the 
leukocytosis and cytokinaemia associated with prolonged exercise is due to elevated core 
temperature (Cross et al., 1996, Rhind et al., 2004, Rhind et al., 1999). However, this 
augmented stress response does not appear to manifest as impairments to immune function, 
with studies showing a limited effect of exercising in the heat on neutrophil degranulation 
(Laing et al., 2005a, Laing et al., 2008), salivary S-IgA responses (Laing et al., 2005b) NK 
cell activity (McFarlin and Mitchell, 2003) or LPS-stimulated cytokine production (Starkie et 
al., 2005) compared to an equivalent exercise bout in thermoneutral conditions. Hence, it 
does not appear that exercising in the heat poses any additional threat to host defence 
compared to exercise in thermoneutral conditions. This may be partly due to the fact that 
exposure to exercise-heat stress tends to be self-limiting, with individuals typically fatiguing 
more quickly than in thermoneutral conditions (Walsh et al., 2011a). It is worth noting, 
however, that laboratory studies have generally evoked only modest increases in core 
temperature of ≤2.5°C. The effect of more severe heat stress encountered in the field, where 
core temperatures of athletes can exceed 40°C, has yet to be elucidated.  
1.5.3 Cold 
The effect of cold exposure on infection susceptibility in humans remains somewhat 
controversial. Although the popular belief is that low temperatures increase the risk of 
respiratory infections, exercising in cold (-6ºC) ambient conditions is associated with similar 
saliva flow rate and S-IgA responses in trained cyclists as exercise in temperate (20ºC) 
conditions (Walsh et al., 2002). Indeed, although there are currently only a small number of 
published studies that have examined the effect of exercising in cold environments on 
immune function, the available data do not support the idea that this poses any additional 
threat to immunity compared with exercise in thermoneutral conditions (Walsh and Whitham, 
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2006, Rhind et al., 1999).  However, it is possible that airway inflammation as a result of 
breathing large volumes of cold dry air may be mistakenly interpreted as URI by athletes 
(Walsh et al., 2011a).  
1.6 SLEEP 
Studies suggest that heavy training loads and OT are associated with reduced sleep quality 
(Hooper et al., 1995, Hausswirth et al., 2014, Killer et al. 2015). Furthermore, athletes may 
experience impaired sleep following cross meridian travel (Fullagar et al., 2015, Waterhouse 
et al., 2007) or while sleeping at altitude (Roach et al., 2013, Sargent et al., 2013). Hence, it is 
perhaps not surprising that the prevalence of poor sleep quality amongst athletes appears to 
be substantial (Samuels, 2009). Many key metabolic, immunologic and restorative 
physiological processes are adversely affected by sleep disturbance (Samuels, 2009), such 
that reductions in sleep quality can result in impaired daytime functioning (Van Dongen et 
al., 2003) and inadequate recovery between training sessions, as well as potentially 
exacerbating any immunological disturbances associated with training and competition 
(Irwin, 2002). Irwin and colleagues (1996) found that one night of partial sleep deprivation in 
healthy volunteers resulted in reduced NK cell activity and diminished IL-2 production in 
response to mitogen-stimulation, suggesting that even modest sleep disruption may 
negatively impact on host defence.  Studies have also found that sleep deprivation results in 
minor reductions in endurance exercise capacity (Oliver et al., 2009, Mougin et al., 1991, 
Plyley et al., 1987). It is possible that this, in turn, will exacerbate immune disturbances 
associated with exercise, with sleep-deprived athletes having to work at a higher relative 
intensity to sustain the same absolute workload. However, Ricardo et al. (2009) found no 
effect of a 30 h period of sleep deprivation, such as might be experienced by athletes during 
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long-haul air travel, on leukocyte trafficking, neutrophil function or S-IgA either at rest or in 
response to intense exercise.  
Overall, despite a small number of studies reporting modest changes in immune variables, it 
seems unlikely that short-term sleep disruption meaningfully increases infection 
susceptibility. However, little is known about the longer-term effects of sleep quantity and 
quality on immunity. Cohen et al. (2009) found that lower self-reported sleep quality and 
quantity during the two weeks prior to rhinovirus exposure was associated with greater risk of 
developing cold symptoms in healthy men and women. Individuals who reported less than 
seven hours of sleep per night during the two weeks prior to pathogen exposure were 
approximately three times more likely to develop a cold compared with those who slept more 
than eight hours per night. Similarly, a sleep efficiency (the percentage of time in bed spent 
asleep) of <92% was associated with more than five times greater risk of developing a cold 
compared with a sleep efficiency of >97%. Leeder et al. (2012) found that a cohort of 
Olympic athletes exhibited similar sleep duration, but significantly lower sleep efficiency 
compared to matched non-athletic controls (81% compared to 89%). It is therefore possible 
that lower sleep quality may be a contributing factor towards increased infection 
susceptibility in athletes.   
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1.7 SCOPE OF THESIS 
There is a general consensus that both acute, prolonged exercise and long-term heavy 
endurance training can negatively impact on immune function. Although athletes are not 
clinically immune deficient, it is possible that small changes to multiple aspects of immune 
function as a result of acute and chronic endurance training may make athletes more 
susceptible to opportunistic infections, particularly of the upper-respiratory tract. These 
exercise-induced immune disturbances may be exacerbated when training is undertaken in 
hypoxic conditions, with suboptimal nutritional status or inadequate sleep and recovery. 
Clearly, substantial reductions in training load are not feasible for athletes aiming to optimise 
performance and compete on the world stage. However, by exploring which modifiable 
factors influence immunity and infection risk in athletes, it is possible to provide advice to 
athletes and coaches on effective and feasible strategies to ameliorate exercise- and training-
induced immune disturbances and maintain immunocompetence. This thesis presents a series 
of studies exploring how a number of factors impact on immunity and infection incidence in 
athletes. Chapter 3 investigates illness incidence in a cohort of world-class endurance 
athletes, and examines which training-related factors predict onset of illness. Chapter 4 
investigates the effect of an intense period of repeated competition on illness incidence and 
subsequent race performance in the same cohort of athletes. Chapter 5 explores changes in 
immunological variables during short-term intensified training in cyclists, and whether CHO 
supplementation can ameliorate associated immune disturbances. Chapter 6 explores the 
effect of hydration status on immunological responses to prolonged exercise. Finally, 
chapters 7 and 8 investigate the effect of acute and longer-term hypoxic training on systemic 
and mucosal immunity.  
The following major hypotheses were tested: 
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1. Heavy training loads impair immunity and increase infection risk in endurance 
athletes (Chapters 3 and 5)  
2. Taking part in competitions increases an athlete’s risk of infection (Chapters 3 and 4) 
3. International air travel increases an athlete’s risk of infection (Chapter 3) 
4. Exposure to natural or simulated altitude exacerbates immune disturbances associated 
with prolonged exercise, and increases an athlete’s infection risk (Chapters 3, 7 and 8) 
5. Increasing CHO intake before, during and after training sessions helps prevent 
overreaching and alleviates immunological disturbances associated with intensified 
training (Chapter 5)  
6. Moderate hypohydration, due to inadequate fluid intake before and during exercise, 
exacerbates exercise-induced immune disturbances and increases an athlete’s risk of 
infection (Chapter 6) 
Hence, this thesis endeavours to provide an overview of which factors meaningfully 
influence immunity and infection risk in endurance athletes, as well as exploring some of the 
possible underlying mechanisms and potential countermeasures. The overriding aim is to 
provide a better foundation on which to prescribe effective and practicable competition- and 
training-related strategies to minimise an athlete’s risk of infection.  
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CHAPTER 2: GENERAL METHODS 
 
2.1 BLOOD SAMPLING & ANALYSES  
2.1.1 Blood sampling 
On each occasion, a venous blood sample (11 mL) was obtained by venepuncture from an 
antecubital vein. Blood was collected into two vacutainer tubes (Becton Dickinson, Oxford, 
UK) containing either lithium heparin or K3EDTA as anticoagulant. 
2.1.2 Haematological analyses 
Blood samples in the K3EDTA vacutainer (4 mL) were used for determination of red blood 
cell concentration, haematocrit, haemoglobin and total and differential leukocyte counts using 
an automated cell-counter (Ac.TTM5diff haematology analyser, Beckman Coulter, High 
Wycombe, UK). The coefficient of variation for all measured variables in our laboratory was 
<2.0%. Samples were analysed in duplicate, and the average of both values entered into 
analyses.  
2.1.3 Plasma volume changes 
Haematocrit and Haemoglobin values from haematological analyses were used to calculate 
and correct for changes in plasma volume using the equations of Dill & Costill (1974). 
2.1.4 Plasma cortisol and ACTH 
The remaining K3EDTA blood sample was centrifuged for 10 min at 1,500 g and 4 ºC. 
Plasma was aliquotted and stored at -20 °C until analysis. Plasma concentrations of cortisol 
were determined using a commercially available solid phase competitive ELISA (IBL 
International, Hamburg, Germany), with analytical sensitivity of 2.46 ng/mL and intra-assay 
coefficient of variation of <3.0%. Plasma concentrations of ACTH were determined using a 
commercially available two-site ELISA (Biomerica, California), with analytical sensitivity of 
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0.22 pg/mL and intra-assay coefficient of variation of <6.0%. Plates were read on a microtitre 
plate reader at 450 nm. All samples were assayed in duplicate.  
2.1.2 Plasma cytokine concentrations 
Plasma concentrations of IFN-𝛾, TNF-𝛼, IL-1𝛼, IL-6, IL-8, IL-10, EGF, VEGF and MCP-1 
were determined with an Evidence Investigator System using the cytokine biochip array EV 
3623 (Randox, County Antrim, UK). The intra-assay coefficient of variation was <5% for all 
measured cytokines. 
2.1.5 Antigen-stimulated cytokine production by whole blood culture 
Stimulated whole blood culture production of IFN-γ, TNF-α, IL-1α, IL-1β, IL-2, IL-4, IL-6, 
IL-8 and IL-10 was determined as follows: for each sample, 0.25 mL heparinized whole 
blood was added to 0.75 mL RPMI medium (Sigma Chemicals, Poole, UK) with no added 
stimulant (US), or stimulant at a dilution of 1:2000 (S). The stimulant used was a 
commercially available multi-antigen vaccine containing diphtheria, tetanus, acellular 
pertussis, poliomyelitis and Haemophilus influenza type b antigens (Pediacel vaccine, Sanofi 
Pasteur, Maidenhead, UK). The whole blood culture was then incubated for 24 h at 37 ºC and 
5% CO2. Following centrifugation for 4 min at 13,000 g in a microcentrifuge, supernatants 
were collected and stored frozen at -20 ºC until analysis. Cytokine concentrations were 
determined with an Evidence Investigator System using the cytokine biochip array EV 3623 
(Randox, County Antrim, UK). The intra-assay coefficient of variation was <10% for all 
measured cytokines. The US values were then subtracted from S values to isolate cytokine 
production specifically in response to the antigen-stimulation and account for plasma 
concentrations and spontaneous production during the culture period. 
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2.1.6 Lymphocyte subsets 
Fluorescent-conjugated monoclonal antibodies were used to identify specific cell surface 
markers (CD3, CD8, CD4, CD25, CD127) via four colour flow-cytometry with True 
Volumetric Absolute Counting (Partec CyFlow ML, Germany) and FloMax analysis software 
(Quantum Analysis GmbH). Briefly, either 10 μL of human regulatory T cell cocktail 
(Becton Dickinson Biosciences, Oxford, UK) or 10 μL of FITC anti-human CD3 + 10 μL 
PeCy7 CD4 + 10 μL PE CD8 (Becton Dickinson Biosciences) were added to 120 μL 
heparinized whole blood and incubated in the dark for 20 min on ice. Erythrocytes were then 
lysed by adding 1.5 mL of lyse solution (FACS lysis buffer, Becton Dickinson Biosciences). 
The sample was subsequently incubated for a further 10 min, before centrifugation at 1500 g 
for 6 min. The supernatant was aspirated and the cells re-suspended in phosphate buffered 
saline solution containing 0.1% bovine serum albumin and 2 mM EDTA. The mixture was 
centrifuged for a further 6 min at 1500 g, the supernatant aspirated and the cells re-suspended 
in 1000 μL PBS. Forward-scatter versus side-scatter plots were used to gate lymphocytes 
based on size and density, with 50,000 lymphocyte events acquired per analysis. CD4+ 
lymphocytes were further gated to identify CD25+ cells, and those that were also 
CD127low/- . This was based on the finding that CD127 expression inversely correlates with 
FoxP3 (Liu et al., 2006) and can therefore be used to identify T regulatory (Treg) cells. CD3+ 
cells were further gated to identify cells that were CD4+ (T helper) and CD8+ (T suppressor).  
2.2 SALIVA SAMPLING & ANALYSES 
2.2.1 Saliva collection 
Samples were collected in the morning immediately upon waking, following an overnight 
fast of at least 8 h. After sitting quietly for a few minutes, participants were instructed to 
swallow to empty the mouth before collecting unstimulated whole saliva into a pre-weighed 7 
mL screw-top vial. During the 5 min collection time, participants were instructed to remain 
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seated, leaning forwards with their head tilted down, allowing the saliva to dribble passively 
into the collection tube with minimal orofacial movement. Saliva volume was determined by 
weighing to the nearest milligram, with saliva density estimated to be 1.0 g/ml (Cole and 
Eastoe, 2014). Saliva flow rate was then calculated by dividing the volume by the collection 
time. Samples were centrifuged for 3 min at 14,000 g before being stored at -80ºC until 
analysis.  
2.2.2 Salivary AMPs 
Commercially available ELISA kits were used to determine salivary concentrations of S-IgA 
(Salimetrics, Philadelphia, USA), lysozyme (Biomedical Technologies, USA), lactoferrin 
(Calbiochem, Merck KGaA, Darmstadt, Germany) and LL-37 (Hycult biotech, Uden, 
Netherlands). For lysozyme and lactoferrin determination, saliva was diluted 500x prior to 
analysis. For LL-37, saliva was diluted 5x prior to analysis. Secretion rates for each salivary 
AMP was calculated by multiplying saliva flow rate by AMP concentration. All assays were 
carried out in duplicate. The intra-assay coefficients of variation for S-IgA, lysozyme, 
lactoferrin and LL-37 were 1.8%, 5.3%, 3.0% and 3.1%, respectively.  
2.2.3 Salivary cortisol and testosterone 
Saliva samples were analysed using a solid-phase competitive ELISA to determine 
concentrations of cortisol and testosterone (Salimetrics, Philadelphia, USA). All samples 
were assayed in duplicate with analytical sensitivity of 0.2 nmol/L and 3.8 pmol/L, and intra-
assay coefficient of variation of 3.5 % and 3.0 % for cortisol and testosterone, respectively.   
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2.3 DETERMINATION OF MAXIMAL OXYGEN UPTAKE 
For determination of maximal oxygen uptake (?̇?O2max) subjects completed a continuous, 
incremental exercise test to volitional exhaustion on a magnetically-braked cycle ergometer 
(IndoorTrainer, SRM International, Jülich, Germany). Subjects arrived at the laboratory at 
7:00 am following an overnight fast of at least 10 h, and having abstained from caffeine for a 
minimum of 24 h. All tests were completed at the same time of day to reduce inter- and intra-
trial effects of diurnal variations in cytokine production and plasma cortisol. The test began at 
60 W with increments of 35 W every 3 min. Rating of perceived exertion (RPE) was noted 
and heart rate measured continuously using short-range telemetry (Polar, Kempele, Finland). 
Expired gas was collected and analysed continuously using a computerized metabolic system 
with mixing chamber (Moxus, AEI Technologies, Pennsylvania, USA) for determination of 
?̇?E, ?̇?O2 and ?̇?CO2. Using this data, fat and CHO oxidation rates were calculated using 
Stoichiometric equations, assuming that protein oxidation throughout the test was negligible 
(Brouwer, 1957). The gas analysers were calibrated with certified calibration gases of known 
concentrations before every test. The flow turbine was calibrated before every test with a 
Micro Medical SM2125 series 3 L calibration syringe (CareFusion, Hoechberg, Germany). 
The same metabolic system with identical calibration routines was used for all performance 
tests. Subjects were asked to record and replicate as closely as possible their dietary intake 
during the 24 h leading up to each incremental test, and were required to abstain from alcohol 
or caffeine consumption for 24 h before. 
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2.4 TRAINING & ILLNESS DATA 
2.4.1 Heart rate zones for prescription and categorisation of endurance training 
In Chapters 3, 4, 5 and 8, all endurance training was prescribed and analysed using the heart 
rate zones presented in Table 2.1. 
 
Table 2.1. The 5-zone intensity scale used by athletes to classify endurance training 
Intensity 
Zone 
Heart rate 
(% max) 
Binary model 
5 > 94  
4 89-93 HIT 
3 84-88  
2 74-83 LIT 
1 54-73  
 
Reference values presented are derived from the average self-reported zone cut-offs of 29 
elite cross-country skiers (Tonnessen et al., 2014). LIT: low-intensity training; HIT: high-
intensity training. 
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2.4.2 Self-reported training and illness 
Athletes in Chapters 3, 4 and 8 recorded their training daily in spreadsheet training diaries 
(Microsoft Excel) designed by the Norwegian Ski Federation or, since 2012, in the web-
based version developed by the Norwegian Olympic Federation (www.olt-dagbok.net). The 
training recorded for each session included total training volume and training time distributed 
across different training forms (endurance, strength, power, sprint) as well as time spent in 
each intensity zone for all endurance training. In addition, each session included “daily 
parametrics” and a free text field where athletes recorded additional information, including 
further details about the training session, illness symptoms and whether training was 
discontinued or modified due to illness or injury, medication use, days of travel and days 
spent at altitude. 
Based on the definitions proposed by Matthews et al. (2010) self-reported illness was 
categorized as either “moderate”, where an athlete reported symptoms indicative of infectious 
illness AND training was discontinued, or “mild” where an athlete reported symptoms but 
continued to do some form of training. An illness episode was defined as a subject reporting 
“mild” symptoms on two or more consecutive days, or “moderate” symptoms on at least one 
day. Where athletes reported allergies, asthma, or gastrointestinal distress due to 
training/nutrition practices, these were not included in the analysis. Only symptoms likely to 
be due to opportunistic infection were retained for analysis. These included symptoms of 
upper respiratory infections (blocked or runny nose, sore throat, sneezing), lower respiratory 
infections (coughing, sputum, chest congestion, wheezing, fever) and gastrointestinal 
infections (nausea, vomiting, diarrhoea, abdominal pain).  
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3.1 ABSTRACT 
 
PURPOSE: To determine risk factors for illness in elite winter endurance athletes. 
METHODS: Self-reported training and illness data for 37 elite male and female cross-
country skiers from 2007 to 2015 were analysed. Multilevel logistic regression equations 
were constructed with illness incidence and symptom duration as outcome variables, and sex, 
performance level, season, training phase, competition, air travel, altitude exposure, and 
training characteristics as independent variables. RESULTS: Data for 7,016 person-weeks 
were included, comprising 464 illness events, 110,959 hours of training, 3,812 competitions, 
1,769 international flights and 4,879 days at altitude ≥1,500 masl. On average, athletes 
reported 3-4 events of respiratory and/or gastrointestinal illness per year, with symptoms 
lasting 5 ± 4 days. During the winter, illness occurred more frequently (odds ratio 2.09, 
P<0.001) and lasted longer (b=0.043, P<0.001) compared to summer. Recent competition 
and international air travel increased the risk of illness, with adjusted odds ratios of 2.93 
(95% CI: 2.24-3.83) and 4.94 (95% CI: 3.74-6.53), respectively (P<0.001). Athletes who 
scored higher for Training Monotony had significantly lower risk of illness (odds ratio 0.87 
(95% CI: 0.73-0.99), P<0.05). Other training variables were not associated with illness when 
accounting for the other significant predictor variables. When illness did occur, athletes who 
had won an individual Olympic/World Championship medal reported shorter duration of 
symptoms compared to their less successful counterparts (b=-0.019, P<0.05). 
CONCLUSION: Future research exploring effective strategies to minimise illness risk 
associated with competition and air travel is warranted. Athletes whose weekly training 
programmes incorporate large fluctuations in daily training load may be more susceptible to 
illness. A robust immune system capable of recovering quickly from infection may be 
associated with success in elite endurance sport.  
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3.2 INTRODUCTION 
 
Reaching an international level in any sport requires a huge amount of training. Depending 
on the sport, elite endurance athletes typically train between 500 h (long distance running) 
(Billat et al., 2001, Billat et al., 2003) to in excess of 1,000 h per year (rowing, cycling, 
triathlon) (Fiskerstrand and Seiler, 2004, Neal et al., 2011, Zapico et al., 2007), with elite 
cross country skiers training ~800 h per year (Tonnessen et al., 2014). Cross-sectional studies 
indicate that individuals with high training loads experience a higher number of upper-
respiratory infections (Gleeson et al., 2013a). Furthermore, longitudinal studies with athletes 
report an increased infection incidence during periods of intense training or competition 
(Nieman, 2000, Hellard et al., 2015). Malm (2006) suggested that, although high training 
loads typically suppress immunity, in order to be a successful elite athlete an individual must 
have an immune system capable of withstanding infections even during severe physiological 
and psychological stress. However, differences in infection susceptibility between the most 
successful elite athletes and their less successful counterparts, all of whom have similarly 
high training loads, has not yet been fully explored. It is possible that the ability to withstand 
and/or recover quickly from an infection, particularly during key training and competition 
periods, could be an important predictor of success within an otherwise homogenous athlete 
group.   
A recent study by Hellard et al. (2015) investigated illness incidence amongst international 
swimmers over a four-year period, and found that illness rates were highest during the winter 
months and during intensive training periods, with the odds ratio for upper-respiratory and 
pulmonary infections increasing 1.10 times with each 10% increase in high-load training. 
However, it is not clear whether the same patterns for illness incidence are present for winter 
sports athletes, who compete during the winter months but typically undertake the highest 
training loads in the period June to October (Tonnessen et al., 2014). Furthermore, other than 
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high training loads, elite athletes are exposed to a number of additional stressors, such as 
frequent international travel, hypoxic (altitude) exposure and the psychological pressure of 
competition, which may also impact on immunity and infection susceptibility (Mazzeo, 2005, 
Wilder-Smith et al., 2012, Clow and Hucklebridge, 2001).  
The purpose of the current study was therefore: 1) to describe self-reported illness incidence 
for elite cross-country skiers across a number of competitive seasons, 2) to examine risk 
factors for illness in this cohort of world-class winter endurance athletes, and 3) to determine 
whether there are differences in the number and/or duration of illness events between athletes 
that have won an individual Olympic or World Championship medal, and those athletes that 
have not. It was hypothesised that heavy training loads and competition would both 
significantly increase the risk of illness, and that athletes who had medalled at world or 
Olympic level would report a lower number of illness events.  
3.3 METHODS 
3.3.1 Participants 
Self-reported training and illness data for the period 01.05.2007 to 30.03.2015 were collected 
from 39 elite male (n=22) and female (n=17) cross-country skiers. Inclusion criteria were 1) 
selected to represent the Norwegian national senior or recruit team for cross-country skiing 
during the analysed time period, 2) over 18 years of age, and 3) had systematically and in 
detail recorded their day-to-day training from junior through to senior level. As of 
30.03.2015, 16 of these athletes (9 males and 7 females) had won at least one individual 
senior Olympic or World Championship medal (totalling 73 individual Olympic and World 
Championship medals between them). These athletes were categorised as world-leading 
(WL), while those athletes that had not won an individual Olympic or World Championship 
medal were categorised as international level (IL). All athletes provided their written, 
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informed consent for their data to be included in the study, which was approved by the 
Loughborough University Ethical Review Committee and registered with the Norwegian 
Data Protection Authority. 
3.3.2 Training and illness data 
Athletes recorded their training and illness data daily, as previously described. In total, from 
39 athletes, 143 person-years of data were collected, typically consisting of 3-4 years per 
athlete. Of these, two athletes (eight person-years) were excluded due to inadequate detail in 
the recording of either training or illness. Self-reported illness episodes were identified as 
previously described, based on the definitions proposed by Matthews et al. (2010). Each 
event was broadly categorised as either respiratory symptoms or gastrointestinal symptoms. 
The number of days of symptoms of each illness event was recorded. Rolling one, three and 
seven day averages for total training volume, the volume of high-intensity training and the 
volume of strength/power/sprint training were calculated. Training impulse (Banister and 
Calvert, 1980) (TRIMP = training duration (min) x intensity (HR zone 1-5), Training 
Monotony (mean TRIMP / SD TRIMP) and Training Stress (TRIMP x training monotony) 
scores (Foster, 1998) were also calculated. In addition, the number of competitions, number 
of international flights and number of days at altitude (≥1,500 masl) during the previous one, 
three, and seven days were calculated.  
2.3.3 Statistical analysis 
To explore which factors were associated with onset of illness, multilevel modelling was 
employed using MLwiN software (version 2.32; University of Bristol). In repeated measures 
data, measurement time points are nested within participants, which violates an assumption in 
many single-level analyses that the data are independent. Multilevel modelling overcomes 
this by creating distinct, but associated, equations at both the within- and between-person 
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levels, yielding better estimation of the parameters and statistical significance (Hox, 2010). 
Another advantage of this type of modelling is that it does not require an equal number of 
time points for every participant; therefore, missing data are not a statistical issue.  
 Multilevel logistic regression equations were constructed to predict illness incidence, which 
was treated as a binary (0=did not become ill, 1=did become ill) outcome variable. Firstly, we 
explored whether illness events occurred more frequently for males compared with females 
(0=males, 1=female), for athletes of different performance levels (0=IL, 1=WL), during 
different times of year (spring (March-May), summer (June-August), autumn (September-
November) and winter (December-February), with summer used as the reference category) 
and during different training phases (transition phase, general preparation phase, specific 
preparation phase, competition phase, regeneration phase, with the general preparation phase 
used as the reference category) by including these as categorical independent variables in 
separate multilevel models. Training variables, air travel, altitude exposure and competition 
were entered into separate models as independent variables to determine unadjusted odds 
ratios. In order to disaggregate within-person and between-person associations, each 
participant’s aggregate for each variable was centred on the grand mean and entered into the 
level 2 equation in order to determine whether an individual with higher average values for 
that independent variable had a higher incidence of illness, compared to an individual with 
lower average values (between-person relationships). Each variable was also centred on each 
participant’s unique mean and entered into the level 1 equation in order to determine whether 
fluctuations around an individual’s average levels were associated with changes in illness 
incidence (within-person relationships). Odds ratios for training variables represent the 
increase in risk of an illness event occurring as a result of a 1 h/week increase in that training 
variable, or a 10% increase in Training Monotony, Training Stress and TRIMP. As a final 
step, based on the unadjusted models described above, we then constructed an adjusted 
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logistic multilevel model with all significant independent variables from the unadjusted 
models included. Multilevel regression equations were also constructed to determine whether 
sex, performance level, type of illness, season, training phase or training load during illness 
were significantly associated with the duration of symptoms, which was treated as a 
continuous variable. Significance was accepted at the P<0.05 level. 
3.4 RESULTS 
 
In total, data for 7,016 person-weeks were analysed. These included 464 events of illness, 
110,959 h of training, 3,812 competitions, 1,769 international flights and 4,879 days at 
altitude >1,500 m above sea level. Of all the training recorded, 91% was endurance training 
and 9% was strength/power/sprint training (Table 3.1). Of endurance training, 90% was at 
low intensity (I-zone 1 and 2), and 10% was at high intensity (I-zone 3-5).  
3.4.1 Illness incidence 
Athletes reported symptoms on 2,347 (4.8%) of the 49,147 days monitored, equivalent to an 
average of 3.4 events and 17.5 days of illness per year. For the 37 athletes included in the 
current study, average individual illness rates ranged from 1-7 events per year, despite 
modest between-athlete differences in training load, travel and competition schedule or 
training environment. Of all the illness events reported, 19% were gastrointestinal symptoms 
and 81% were respiratory symptoms. The average duration of symptoms was 5 ± 4 days, with 
this being significantly longer for respiratory symptoms compared to gastrointestinal 
symptoms (5 ± 4 vs. 3 ± 2 days, b=-1.294, P<0.001).  
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Table 3.1: Training variables and illness events by sex, performance level, training phase and season during 7,016 person-weeks for 37 elite cross-
country skiers  
For endurance training in each of the five intensity zones, strength/power (Str/Pw) and sprint training values are percentages of total training volume. Daily 
training volume and daily Training Impulse (TRIMP) are presented as mean ± SD.  
IL: International level athletes; WL: World-leading athletes (minimum one individual senior Olympic/World Championship medal)
FACTOR 
ENDURANCE  
Daily training 
volume (h:min) 
Daily 
TRIMP 
Illness 
events 
(% of 
weeks) 
Weeks 
(% of factor) I-zone 1 I-zone 2 I-zone 3 I-zone 4 I-zone 5 Str/Pw Sprint 
TOTAL 79% 3% 4% 3% 2% 8% 2% 02:20 ± 01:19 192 ± 114 6.6 7016 (100%) 
SEX            
Male 78% 4% 4% 3% 2% 7% 1% 02:11 ± 01:20 181 ± 116 7.4 3402 (48%) 
Female 79% 3% 3% 3% 2% 8% 2% 02:28 ± 01:18 203 ± 111 5.9 3614 (52%) 
PERF. LEVEL            
IL 78% 4% 4% 3% 2% 7% 2% 02:14 ± 01:20 187 ± 115 7.4 3298 (47%) 
WL 80% 3% 3% 3% 2% 7% 2% 02:24 ± 01:19 197 ± 112 5.9 3718 (53%)  
PHASE            
Transition 76% 5% 4% 2% 1% 11% 1% 02:15 ± 01:16 183 ± 108 7.3 629 (9%) 
General prep. 78% 4% 4% 3% 1% 8% 2% 02:42 ± 01:24 221 ± 116 5.3 3150 (45%) 
Specific prep. 81% 2% 3% 3% 3% 7% 1% 02:16 ± 01:08 186 ± 96 6.7 1252 (18%) 
Competition 81% 2% 3% 4% 4% 5% 1% 01:53 ± 01:03 162 ± 108 8.6 1673 (24%) 
Regeneration 76% 5% 3% 4% 3% 9% 0% 01:10 ± 01:07 102 ± 116 7.7 312 (4%) 
SEASON            
Spring 77% 4% 4% 3% 3% 8% 1% 01:50 ± 01:14 155 ± 118 8.0 1404 (20%) 
Summer 79% 4% 4% 2% 1% 8% 2% 02:44 ± 01:26 222 ± 117 4.1 1887 (27%) 
Autumn 79% 3% 4% 3% 1% 8% 2% 02:34 ± 01:18 210 ± 109 6.5 1901 (27%) 
Winter 81% 2% 3% 3% 4% 6% 2% 01:06 ± 01:07 171 ± 99 8.3 1824 (26%) 
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3.4.2 Risk factors for illness 
Unadjusted and adjusted odds ratios for illness for all the candidate risk factors are presented 
in Tables 3.2 and 3.2. Analysing respiratory symptoms separately from gastrointestinal 
symptoms did not affect which variables were associated with illness.  
3.4.2.1 Sex, performance level and family situation 
Sex was not a significant risk factor for either illness incidence or symptom duration, and nor 
was living in a household with young children (Table 3.2). However, performance level was 
significantly associated with the duration of symptoms, with this being lower for WL athletes 
(b=-0.019, P=0.034). Consequently, WL athletes reported a lower total number of days of 
illness per year compared with IL athletes (15 ± 8 days/year vs. 23 ± 11 days/year), despite 
no significant between-group differences in training load, number of flights, number of 
competitions or number of days spent at altitude.  
3.4.2.2 Time of year 
Athletes experienced significantly more illness events during autumn, winter and spring 
compared with summer, with the highest probability of illness during the winter months 
(Table 3.3). However, when adjusted for other independent variables, the highest risk of 
illness was in the spring.  Regarding training phase, the highest probability of illness was 
during the Competition Phase which was from January to March (Table 3.2), but training 
phase was no longer a significant risk factor when accounting for other variables. Season was 
also significantly associated with symptom duration, with illnesses contracted during autumn 
(b=0.024, P<0.01), winter (b=0.043, P<0.001) and spring (b=0.037, P<0.001) typically 
persisting for longer than those reported during the summer.  
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Table 3.2: Unadjusted odds ratios for illness for predictor variables  
 
Data for 7016 person-weeks from 37 elite cross-country skiers. * P<0.001; # P<0.05 
Predictor variable 
Estimated odds ratio (95% CI) 
Within subject Between subject 
Sex (M=0)  0.78 (0.60-1.02) 
Age  1.01 (0.95-1.07) 1.02 (0.99-1.05) 
Team (Recruit=0)  0.87 (0.68-1.11) 
Performance level (IL=0)  0.83 (0.63-1.10) 
Family situation (No children=0)  0.98 (0.67-1.44) 
      
Summer 1.00   
Autumn 1.63 (1.23-2.16)*  
Winter 2.09 (1.59-2.73)*  
Spring 2.00 (1.50-2.65)*  
      
General Preparation Phase 1.00  
Specific Preparation Phase 1.28 (0.99-1.65)  
Competition Phase 1.68 (1.35-2.09)*  
Regeneration Phase 1.56 (1.02-2.37)#  
Transition Phase 1.40 (1.01-1.92)#  
      
International air travel 4.53 (3.49-5.88)* 1.23 (0.19-7.91) 
Altitude exposure  1.05 (1.01-1.10)# 0.81 (0.52-1.27) 
Competition 2.74 (2.18-3.45)* 0.53 (0.19-1.45) 
      
Total training volume 0.98 (0.97-1.00) 0.91 (0.85-0.98)# 
High-intensity endurance exercise  1.16 (1.03-1.31)# 0.57 (0.30-1.09) 
Strength/Power/Sprint exercise 0.83 (0.75-0.91)* 0.70 (0.48-1.02) 
Training monotony 1.01 (0.99-1.02) 0.86 (0.79-0.93)* 
   
Training impulse 1.00 (0.98-1.01) 1.06 (1.00-1.12) 
Training stress 1.00 (1.00-1.00) 0.97 (0.96-0.99)# 
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Table 3.3: Adjusted odds ratios for illness for predictor variables retained in the final 
multilevel model  
Predictor variable 
Estimated odds ratio (95% CI) 
Within subject Between subject 
FIXED EFFECTS  
Intercept -5.116* 
   
PREDICTOR VARIABLES   
Summer 1.00  
Autumn 1.65 (1.20-2.25)*  
Winter 1.91 (1.11-3.27)*  
Spring 2.09 (1.09-3.99)*  
   
General Preparation Phase 1.00  
Specific Preparation Phase 0.70 (0.46-1.04)  
Competition Phase 0.78 (0.46-1.34)  
Regeneration Phase 0.97 (0.46-2.04)  
Transition Phase 0.88 (0.44-1.75)  
   
International air travel 4.94 (3.74-6.53)* 2.65 (0.16-44.7) 
Altitude exposure 1.05 (1.00-1.10) 0.76 (0.38-1.53) 
Competition 2.93 (2.24-3.83)* 0.55 (0.16-1.92) 
   
Total training volume 1.01 (0.98-1.04) 1.06 (0.90-1.15) 
High-intensity endurance exercise 1.08 (0.95-1.24) 0.80 (0.37-1.76) 
Strength/Power/Sprint exercise 0.93 (0.83-1.05) 0.82 (0.51-1.33) 
Training monotony 1.01 (1.00-1.01) 0.87 (0.73-1.00)# 
   
RANDOM EFFECTS   
Intercept 0.066 
R2 0.347 
Data for 7016 person-weeks from 37 elite cross-country skiers.  
* P<0.001; # P<0.05 
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3.4.2.3 Competition, air travel and altitude exposure 
International air travel was associated with unadjusted odds ratios of 4.53 (3.49-5.88) of 
becoming ill within the next day, 2.73 (2.25-3.31) of becoming ill within the next three days 
and 1.78 (1.52-2.06) of becoming ill within the next seven days (all P<0.001). When 
accounting for other independent variables, air travel was associated with adjusted odds ratios 
of 4.94 (3.74-6.53), 2.66 (2.17-3.26) and 1.59 (1.36-1.85) of becoming ill within one, three 
and seven days, respectively (all P<0.001). Indeed, 35% of all recorded events were 
associated with an international flight during the preceding 72 h. Of the 1769 flights 
recorded, 53% were outbound and 47% were homebound, while 95% were continental and 
5% intercontinental. Homebound flights were more likely to be associated with the athlete 
subsequently reporting symptoms compared with outbound flights (14% vs. 5%) as were 
intercontinental flights compared with continental flights (17% vs. 9%). 
Taking part in a competition was associated with unadjusted odds ratios of 2.74 (2.18-3.45) 
of becoming ill within the next day, 1.75 (1.57-1.95) of becoming ill within the next three 
days and 1.45 (1.35-1.55) of becoming ill within the next seven days (all P<0.001). When 
accounting for other independent variables, competition was associated with adjusted odds 
ratios of 2.93 (2.24-3.83), 1.78 (1.56-2.03) and 1.51 (1.38-1.66) of becoming ill within one, 
three and seven days, respectively (all P<0.001).  
Exposure to altitude of ≥1,500 masl was associated with an unadjusted odds ratio of 1.05 
(1.01-1.10) (P<0.05) of becoming ill within the next seven days, but was no longer 
significantly associated with illness when accounting for other independent variables (Table 
3.4). 
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3.4.2.4 Training  
The only training variable that was a significant risk factor illness in both unadjusted and 
adjusted models was Training Monotony. A 10% increase in between-person Training 
Monotony was associated with an odds ratio of 0.87, remaining significant when accounting 
for other variables (Table 3.4). In unadjusted models, within-person increases in the volume 
of strength/power/sprint exercise was negatively associated with illness incidence, while 
within-person high-intensity endurance exercise was positively associated with illness 
incidence (Table 3.3). However, both became non-significant when accounting for other 
independent variables (Table 3.4). Between-person total training volume and Training Stress 
were both negatively associated with illness incidence in unadjusted models, but became non-
significant when adjusted for other independent variables. TRIMP was not a significant risk 
factor for subsequent illness, nor was TRIMP during illness significantly associated with 
symptom duration.  
The final adjusted multilevel model included season, training phase, competition, aircraft 
travel, altitude exposure, total training volume, volume of high-intensity training, volume of 
strength/power/sprint training and training monotony (Table 3.4). 
3.5 DISCUSSION 
 
Our data indicate that elite winter endurance athletes experience three to four episodes of 
respiratory and/or gastrointestinal illness per year, with symptoms typically lasting five days. 
Few other studies have examined illness rates in athletes for periods of more than a few 
weeks or months. However, Hellard et al. (2015) reported a similar frequency of infectious 
illness for elite swimmers who experienced, on average, four episodes of respiratory, 
gastrointestinal and/or urogenital infection per person-year. This suggests that elite endurance 
athletes experience broadly similar illness rates, regardless of whether their competition 
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season falls during the winter or summer months. Although we unfortunately do not have 
equivalent data for a sedentary or recreationally active control group in Norway during the 
same time period, these illness rates do not appear to differ markedly from those of adults in 
the general population, who typically experience approximately two to four respiratory 
episodes per year (Heikkinen and Jarvinen, 2003, Monto, 2002). However, it is worth noting 
that there appears to be high inter-individual variability in infection susceptibility, even 
within a homogenous group of elite athletes.  
Cross-country skiers experience the highest frequency of illness during the winter months, 
similar to elite swimmers (Hellard et al., 2015) and mirroring seasonal patterns for respiratory 
infections observed in the general population (Monto, 2002). However, when adjusting for 
other variables, such as the number of competitions, spring was associated with the highest 
risk of illness. It should be noted, however, that since these athletes typically train and 
compete on snow until mid-April, the months categorised as “spring” bear much resemblance 
to winter. Furthermore, it is during these months that vitamin D levels would be expected to 
be at their lowest (Klingberg et al., 2015), with recent research indicating that vitamin D 
deficiency is an important predictor of infection in endurance athletes (He et al., 2013). Since 
training phase was not a significant risk factor when adjusted for season, and since patterns of 
illness appear to be similar for both summer and winter sport athletes, this suggests that time 
of year is a more important in determining illness risk than which training phase the athlete is 
in.  
Of the candidate factors, the single biggest risk factor for illness was international air travel, 
making the athlete approximately five times more likely to experience illness the subsequent 
day. Athletes remained at an enhanced risk of illness for seven days after an international 
flight. This is in agreement with previous studies in non-athletes which have reported that 
approximately 20% of individuals experience symptoms of respiratory illness within one 
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week of commercial aircraft travel (Zitter et al., 2002) and that cabin staff are more 
predisposed to respiratory infections than the general population (Whelan et al., 2003). 
Schwellnus et al. (2012) found that athletes traveling to a foreign destination more than five 
time zones difference from their home country had a 2-3 fold increase in risk of illness. 
However, in contrast to the current study, homeward travel was not associated with an 
increased risk of symptoms. The majority of homebound flights included in the present 
analyses were following competition weekends, with athletes typically flying home the same 
day and often within a few hours of finishing the final competition. As such, it is possible to 
speculate that infection risk was further exacerbated because athletes were traveling home in 
an already somewhat immunocompromised state, since it is well-documented that acute bouts 
of strenuous and prolonged physical activity result in immune disturbances that persist for a 
number of hours (Walsh et al., 2011). Air travel is associated with a number of stressors 
which may increase infection risk. These include: time-zone changes, sleep disruption, 
increased pathogen exposure due to crowded conditions in airports and on aircraft, mild 
hypoxia and drying of oral and nasal mucosa, as well as psychological stress. It is therefore 
not surprising that simulated long-haul flights have been found to result in a transient 
impairment of some aspects of immune function (Wilder-Smith et al., 2012). Hence, although 
often unavoidable, athletes are advised to minimise air travel as much as possible, 
particularly immediately prior to important competitions and major championships. When 
competing in central Europe, driving between competition venues may be a preferable 
alternative to flying, provided the driving distance is feasible. Where this is not possible, 
flying out as early as possible prior to a major competition will reduce the likelihood of the 
athlete experiencing illness during the event itself, although this of course does not ameliorate 
the risk of illness disrupting the training/tapering process. Following competitions abroad, 
delaying homeward travel until the subsequent day may be preferable to flying home on the 
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same day. Further research is necessary in order to identify the mechanisms underlying the 
increased infection risk associated with air travel. Including measures of psychological stress 
in such a study would be of particular interest.  
The training distribution of the athletes followed a 90:10 distribution of low intensity: high 
intensity endurance training, similar to that previously reported for endurance athletes 
training more than 500 h per year (Seiler and Kjerland, 2006). In contrast to the findings of 
Foster (1998) neither TRIMP nor Training Stress were associated with increased illness 
incidence at the between- or within-person level, when accounting for other risk factors. 
Although within- person changes in Training Monotony was not significantly associated with 
illness, those athletes with higher average Training Monotony were somewhat less 
susceptible to illness than athletes with lower Training Monotony. This finding suggests that 
a microcycle that avoids large fluctuations in total daily training load may be preferable to 
one that alternates between very hard and very easy days, at least in terms of reducing illness 
risk.  This is an interesting finding and contrasts with current recommendations that athletes 
should add variety to limit training monotony (Walsh et al., 2011a). However, typical 
practice in cross-country skiing does traditionally incorporate “hard” and “easy” training 
days, so these findings may be indicative that it is more extreme fluctuations above this norm 
which increase infection risk. Rather than measuring only daily variation in TRIMP, a 
calculation that also accounts for differences in activity type (e.g. skiing vs. running vs. 
cycling) would give a more accurate indication of the true training monotony. It is also 
possible to question the validity of TRIMP as an accurate measure of training load, since it 
does not account for activity type and assumes that the relationship between heart rate and 
intensity is linear, rather than exponential, and may therefore somewhat underestimate the 
load associated with high-intensity training. 
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None of the other measured training variables were significantly associated with illness 
incidence when accounting for other independent variables. This is in contrast to Hellard et 
al. (2015) who found that increases in high-load and resistance training augmented the risk of 
upper-respiratory and pulmonary infections. In the current study, high-intensity endurance 
exercise was significantly associated with illness only in the unadjusted models. This can 
likely be explained by the fact that high-intensity endurance exercise was a sum of all 
recorded time spent in Intensity Zones 3-5, including interval training, intensive continuous 
training and competition. However, since competitions are associated with additional 
physiological and psychological stress above that typically encountered even during the most 
intense training sessions, competition was also treated as a separate binary variable (did the 
athlete compete? Yes/No). A high-pressure competition during which the athlete remains 
continuously in Intensity Zone 4 for 40 min likely represents a somewhat different 
physiological and psychological stimulus to an interval session composed of ten 4 min 
repetitions in the same intensity zone. Indeed, since only competition remained significant in 
the adjusted model, it appears that some other factor than merely time spent at high-intensity 
contributes to the increase in illness susceptibility following competition. Whether this is 
related to greater psychological stress, greater physiological stress, environmental factors 
such as crowd exposure, or a combination of these, is not clear. Whatever the underlying 
mechanisms, the finding that taking part in competitions increases the risk of illness is in 
agreement with previous studies (Nieman, 2007), although Hellard et al. (2015) found that 
the risk of upper respiratory tract and pulmonary infections in swimmers was higher in the 
periods of intensive training than in both competition and post-competition periods. 
However, unlike swimmers, cross-country skiers perform their most intensive training during 
the summer and primarily compete during the winter months (Tonnessen et al., 2014) which 
may account for this discrepancy.  
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In an attempt to examine whether athletes who rested completely recovered more quickly 
than those who continued to train through illness, we explored whether average daily training 
load during illness was associated with symptom duration. However, this was confounded by 
symptom severity, since athletes typically continued to do some form of training when they 
experienced light symptoms, while taking complete rest during more severe symptoms, with 
severe symptoms also being associated with more prolonged illness. Finding a valid means of 
exploring what effect training following onset of symptoms has on illness duration remains a 
challenging but important area for future research.      
It is well known that ascent to high altitude alters both physiological and metabolic function, 
and can influence immune function (Mazzeo, 2005). However, it is not clear whether the 
moderate altitudes to which elite endurance athletes are typically exposed results in clinical 
changes in immunity and infection susceptibility. Tiollier et al. (2005) found a cumulative 
negative effect of physical exercise and hypoxia on S-IgA levels in elite cross-country skiers 
during 18-days of live high, train low altitude training. Since reduced S-IgA levels have been 
consistently linked to increased risk of upper-respiratory symptoms (Gleeson et al., 1999, 
Neville et al., 2008) it is likely that such a reduction would make athletes more susceptible to 
illness. However, the current results indicate that altitude exposure does not significantly 
increase the risk of an athlete becoming ill when other factors, such as air travel to and from 
the altitude camp, are accounted for. However, it is worth noting that, in contrast to the 
majority of previous research on altitude and immune function, athletes in the current study 
regularly trained and competed at altitude, with the average athlete reporting 35-40 days per 
year at ≥1,500 masl. It is possible that this may have limited any adverse effects of hypoxia, 
either because athletes were already partially acclimatised, or as a result of athletes and 
coaches developing effective strategies to minimise infection risk at altitude through many 
years of practical experience.  
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In the current study, the athletes of the highest performance level experienced a lower total 
number of annual illness days compared to athletes of a somewhat lower performance level. 
This was principally due to significantly shorter duration of symptoms, although there was 
also a non-significant tendency for WL to report a lower number of events. Although it is not 
possible to determine cause and effect, this is in accordance with the findings of Hellard et al. 
(2015) that swimmers of a higher performance level had a lower risk of upper-respiratory 
tract infections, suggesting that a robust immune system capable of withstanding and 
recovering quickly from infection, even during periods of high physiological, psychological 
and environmental stress, may be a predictor of success in an otherwise homogenous group 
of elite endurance athletes. Although there were no significant differences between the two 
groups in terms of training load, number of flights, number of competitions or number of 
days spent at altitude, athletes in the WL group were slightly older than those in the IL group 
(25 ± 4 years vs. 23 ± 5 years). It is unlikely that such a small difference in age would have 
any meaningful effect on immune function, but it is possible to speculate that two additional 
years of experience may be associated with behavioural differences (e.g. better routines in 
terms of hygiene, nutrition and hydration) which could influence infection incidence.     
Although in the general population, men appear to be somewhat more susceptible to viral and 
bacterial infections than women (Klein, 2000) recent studies of athletes suggest a higher 
incidence of respiratory illnesses amongst females compared to males (Engebretsen et al., 
2010, Engebretsen et al., 2013, He et al., 2014, Soligard et al., 2015). However, in the current 
study, sex was not significantly associated with either illness incidence or symptom duration. 
The current dataset includes a large amount of data for some of the world’s best winter 
endurance athletes. However, a clear limitation is that both training and illness data were self-
reported. Although elite cross-country skiers have previously been found to self-report their 
training accurately (Sylta et al., 2014), only 79% of 159 respiratory illnesses reported by 
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athletes during the Sochi Olympic Games were due to infection (Soligard et al., 2015). Since 
not all symptoms in the current study were verified by a physician, or better still confirmed 
via pathological examination of nasal and throat swabs, it is likely that some of the illness 
events included in analyses were due to non-infectious causes, such as airway inflammation 
or allergen exposure. It is also possible that elite athletes may be more/less apt to self-report 
illness than the general population. However, since the current analyses are based only on 
comparisons within or between individuals from the same athlete group, a reporting bias is 
unlikely to be a major issue. 
3.6 CONCLUSION 
 
World-class cross-country skiers experience, on average, 3-4 respiratory and/or 
gastrointestinal illness events per year, with symptoms typically lasting 5 days. The highest 
illness rates for these athletes occur during the winter months (Dec-Feb). However, world-
leading athletes experience fewer illness days per year compared to athletes of a lower 
performance level. International air travel and taking part in competitions both significantly 
increase the risk of illness. Since both are inherent components of international-level sport, 
future research exploring effective strategies to minimise illness risk associated with 
competition and air travel is warranted. In terms of reducing infection susceptibility, a 
microcycle that avoids large fluctuations in total daily training load may be preferable.  
.   
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4.1 ABSTRACT 
 
PURPOSE: To determine whether participating in a cross-country skiing stage race (Tour de 
Ski) affects subsequent illness incidence, training and race performance. METHODS: Self-
reported training and illness data from 44 male and female elite cross-country skiers were 
included. In total, 125 person-years of data were collected (2-3 seasons per athlete). Illness 
incidence, training load and performance in international competitions were calculated for 
athletes who did and did not participate in Tour de Ski. RESULTS: 48% of athletes reported 
becoming ill during or in the days immediately after taking part in Tour de Ski, vs. 16% of 
athletes who did not participate. A larger proportion of the male athletes, both in the TDS 
(53% vs. 44%) and CON (21% vs. 8%) groups, became ill in this time period compared to the 
female athletes. There was no significant change in race performance in the 6 weeks 
following Tour de Ski for female athletes. However, for the male athletes, average placing in 
international races was significantly worse following participation in Tour de Ski (9th (95% 
CI: 6th-15th) vs. 18th (95% CI: 14th-23rd), p=0.003). Similarly, best placing achieved in 
international competition was significantly worse for the 6 weeks after taking part in Tour de 
Ski compared to the 6 weeks before (3rd (95% CI: 2nd-6th) vs 10th (95% CI: 14th-23rd), 
p=0.03). Furthermore, there was a significant interaction effect when examining performance 
in World Championship and Olympic Games for men and women who took part in Tour de 
Ski compared to CON (F(1,49)=4.187, p=0.046). While female athletes who took part in 
TDS typically performed relatively better in these major championships compared to CON, 
male athletes who took part in Tour de Ski typically performed worse in Olympic/World 
Championships than CON. CONCLUSION: Participating in Tour de Ski appears to result in 
~3-fold increase in risk of illness in this period. Male athletes appear more prone to illness 
and also see a drop in race performance following Tour de Ski. 
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4.2 INTRODUCTION 
 
Elite cross-country skiers typically perform approximately 800 hours of training per year, 
more than 90% of which is endurance training (Tonnessen et al., 2014). With such large 
volumes of training, these athletes frequently tread a fine line between the optimal training 
load to stimulate performance adaptation, and excessive overload leading to maladaptive 
outcomes (Meeusen et al., 2013). Previous studies suggest that intense periods of training and 
competition may result in adverse changes to a number of immune variables (Gleeson et al., 
1995, Mackinnon and Hooper, 1994). This in turn appears to lead to an increased 
susceptibility to opportunistic infections, in particular upper-respiratory tract infections such 
as colds and influenza (Nieman, 2000). However, limited data exist on the effects of 
intensified periods of competition on illness incidence in world-class endurance athletes 
already training in excess of 700 hours per year.  
The Tour de Ski is an event that has been part of the cross-country skiing calendar every year 
since its introduction by the International Ski Federation (FIS) in 2006. The race consists of 
six to nine stages during late December and early January. These stages are held in the Czech 
Republic, Germany, Italy, and Switzerland, with the competition typically running over an 
eight to eleven day period, including one or two rest days. For those athletes that take part, it 
undoubtedly represents the most intense period of competition of the season. Not only are 
competitors required to push their bodies to the physical limit on multiple consecutive days, 
but they are also exposed to the additional stressors of travel, cold temperatures (typically 
ranging from +4°C to -10°C) and moderate altitude (1000-1300 m above sea level), as well as 
the repeated psychological pressure of competition. Stage races such as this provide a unique 
opportunity to examine the impact of short-term OR in elite athletes, something that is often 
not feasible or achievable in a laboratory setting. It seems conceivable that taking part in a 
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stage race such as Tour de Ski could have an immunodepressive effect, resulting in increased 
illness incidence during both the competition period itself, and in the days that follow. 
Indeed, anecdotal reports from athletes and coaches suggest that this may well be the case, 
although no empirical evidence is currently available.  
Furthermore, a large number of elite cross-country skiers choose to take part in Tour de Ski 
in the same year that they also participate in Olympic Games or World Championships. 
Recent studies have examined the training and peaking practices of elite athletes leading up 
to major championships, and underlined the importance of an appropriate training volume 
and intensity distribution (Tonnessen et al., 2014, Tonnessen et al., 2015). These studies also 
found that competitions are a key component in an athlete’s preparation for a major 
championship, making up a substantial proportion of all high-intensity training in this period. 
However, it is not known whether a stage race such as Tour de Ski, characterized by a 
marked shift in the normal intensity distribution towards more high-intensity activity (of 
which all is performed as competitions rather than interval training) and relatively little low-
intensity training, could affect subsequent training and race performance. It is possible that 
taking part in such an event could impair an athlete’s ability to achieve peak performance in 
major championships 5-7 weeks later, or even lead to a state of non-functional OR or OT 
(Meeusen et al., 2013). On the other hand, it is equally conceivable that taking part in Tour de 
Ski might in fact play a beneficial role in the preparation process of these athletes.   
Hence, the aims of the current study were to determine, 1) whether athletes experience 
increased illness during and in the days immediately after taking part in Tour de Ski, 
compared to those athletes who do not take part in Tour de Ski, 2) whether taking part in 
Tour de Ski affects subsequent training and race performance, particularly in major 
championships (Olympic Games and FIS Nordic Ski World Championships), and 3) whether 
any of these effects are influenced by sex. 
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4.3 METHODS 
 
4.3.1 Subjects 
Self-reported training and illness data from 27 male and 17 female elite cross-country skiers 
were included in the current study. In total, 127 person-years of data were collected, typically 
consisting of 2-3 seasons per athlete from 2006-2014 (Table 4.1). Of the data collected, 10 
seasons were excluded due to inadequate detail in the recording of either training or illness, 
or due to periods of missing data. A further two seasons were excluded as outliers due to the 
athletes experiencing repeated and unusually prolonged episodes of illness, resulting in the 
annual number of illness days being far above (>3 SDs) the group mean. Of the remaining 
115 seasons, 42 included participation in Tour de Ski. In total, data for 38,525 person-days 
were collected, including 380 episodes of illness and 86,739 hours of training.  
 
Table 4.1: Characteristics of athletes included in the study at the time of the analysed 
season. 
 
Male  
n=27 (63 seasons) 
Female  
n=17 (52 seasons) 
Age (yrs) 24 ± 3 24 ± 4 
Body mass (kg) 76.0 ± 6.1 60.1 ± 4.8 
?̇?O2max (ml·kg-1·min-1) 78.2 ± 5.1 70.6 ± 5.2 
?̇?O2max (L·min-1) 5.9 ± 0.5 4.2 ± 0.4 
Annual training volume (h) 716 ± 91 816 ± 103 
Took part in Tour de Ski n=17 (27%) n=25 (48%) 
Data are presented as mean ± SD. 
Inclusion criteria were 1) currently, or during the analysed time period, selected to represent 
the Norwegian national senior or recruit team for cross country skiing, 2) over 18 years of 
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age, and 3) systematic and detailed recording of their day-to-day training from junior through 
to senior level. In total, these athletes had won 106 World Championship and Olympic 
medals (individual and relay events). The regional ethics committee of Southern Norway 
reviewed the study and concluded that, due to the nature of the investigation, it did not 
require their approval. The study was therefore submitted to and approved by the Norwegian 
Data Protection Authority (NSD), and all athletes gave their oral and written informed 
consent for their data to be included in the study. 
4.3.2 Training and illness monitoring 
Athletes included in the study recorded their day-to-day training and illness data as 
previously described. To determine whether taking part in this event might increases the risk 
of illness, the number of athletes that experienced an episode of illness either during, or 
within 10 days after completion of the Tour de Ski, was determined. The percentage of 
athletes that became ill during Tour de Ski or in the ten days immediately after taking part in 
Tour de Ski was then compared to the percentage of athletes who did not compete in Tour de 
Ski and who became ill in the same time period (control).  
4.3.4 Training load 
To determine whether taking part in Tour de Ski resulted in a significant increase in exercise 
load above “normal” and whether taking part would impact on subsequent training, average 
daily training impulse (TRIMP) (Banister and Calvert, 1980) was determined for 6 weeks 
immediately before Tour de Ski, during Tour de Ski (including races, warm-ups, cool downs 
and training on rest days), and for 6 weeks after Tour de Ski. This was calculated by 
multiplying duration in minutes by the intensity zone (1-5; Table 2.1) reported in the training 
diaries. TRIMP values, total race time and distance covered during Tour de Ski were also 
compared between the sexes. 
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4.3.5 Race performance 
In addition, to determine whether participation in Tour de Ski might have an impact on 
subsequent race performance, average FIS points and placing per race, and best placing were 
determined for the 6 weeks immediately before Tour de Ski and 6 weeks immediately after 
Tour de Ski for both males and females for the Tour de Ski group (TDS) and a matched 
control group (CON). This 6-week time-frame was chosen as it typically represents the race 
period between Tour de Ski and that season’s major championships (World 
Championships/Winter Olympic Games), while also being long enough to include a 
minimum of one World Cup race for every athlete. Where possible, a different season for the 
same athlete was used as the control. In two cases this was not possible as the athletes in 
question had competed in Tour de Ski in all available seasons, and therefore control athletes 
were matched as closely as possible based on sex, age, discipline and performance level. 
Only international competitions were included in these analyses (World Cup, World 
Championship and Olympic races), and only performance in each athlete’s own discipline 
(i.e. sprint races for sprint skiers, distance races for distance skiers). Results were taken from 
the FIS website (www.fis-ski.com/cross-country/). FIS points were calculated using the 
following formula:  
(F · Tx) / To – F 
Where: F= FIS Factor (800 for interval starts, 1200 for sprints / pursuits with a break, 1400 
for mass starts and pursuits without a break); Tx = competitor’s race time in seconds; To = 
winner’s race time in seconds.  
In addition, to determine whether taking part in Tour de Ski might adversely affect an 
athlete’s subsequent performance in Olympic Games or World Championships 1-2 months 
later, placing in these events was compared for both males and females for TDS and CON. In 
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order to account for differences in performance level and indicate whether or not the athletes 
were able to reach peak performance at this time, placing in World Championships/Olympic 
Games were normalised as a percentage of each athlete’s mean placing in international 
competition for that whole season.  For example, where an athlete’s mean result for the 
season was 9th, and they finished 6th in the Olympic Games, this was expressed as 66.7%.  
4.3.6 Statistical analyses 
Normally distributed data are presented as means ± SD. Data that were not normally 
distributed data were treated using a Box-Cox transformation (Box and Cox, 1964) to meet 
the assumption of normality prior to analysis, and are presented as back transformed 
geometric mean ± 95% CI. Data were analysed using an independent or mixed-model 
ANOVA with a Bonferroni post-hoc correction. Differences in total race time and total race 
distance between men and women were analysed using an independent samples T-test. 
Significance was accepted at the p<0.05 level.  
4.4 RESULTS 
 
4.4.1 Training and competition load 
Taking part in Tour de Ski resulted in a significant increase in average daily TRIMP 
compared to 6 weeks before Tour de Ski for both men and women (Figure 4.1). The female 
athletes had significantly higher training loads than the male athletes both 6 weeks before and 
6 weeks after Tour de Ski, but there was no sex-difference in TRIMP during the competition 
period itself (Figure 4.1). However, total Tour de Ski competition time was significantly 
higher for men than women, as was total Tour de Ski race distance (Figure 4.2).  
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4.4.2 Illness incidence 
In 20 / 42 (48%) seasons which included participation in Tour de Ski, athletes reported 
becoming ill during or in the first 10 days immediately after the competition. Only 12 / 73 
(16 %) of the athletes who did not take part in Tour de Ski reported becoming ill in the same 
time period (Figure 4.3). Out of the 20 episodes of illness reported, 85 % were symptoms 
indicative of upper respiratory infection (sore throat, blocked/runny nose, coughing, sneezing, 
headache, fever). When comparing men and women separately, a larger proportion of the 
male athletes, both in the TDS and CON groups, became ill in this time period compared to 
the female athletes (Figure 4.3).   
 
 
 
Figure 4.1: Average daily TRIMP score for 6 weeks before Tour de Ski, during Tour de 
Ski, and 6 weeks after Tour de Ski. 
#significantly different from 6 weeks before TDS for both men and women (p<0.01); * 
significantly different from men (p<0.01).  Data are Mean+SD. 
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Figure 4.2: Total race distance (A) and total competition time (B) in men’s and women’s 
Tour de Ski. * Significantly different from men (p<0.001). Data are Mean+SD. 
 
4.4.3 Race Performance  
There was no significant change in race performance in the 6 weeks following Tour de Ski 
for female athletes. However, for the male athletes, average placing in international races was 
significantly worse following participation in Tour de Ski (Figure 4.4), increasing from 9th to 
18th with no significant change in CON (Interaction effect: F(1,34)=9.884, p=0.003). 
Similarly, best placing achieved in international competition was significantly worse for the 6 
weeks after taking part in Tour de Ski compared to the 6 weeks before (Figure 4.5), going 
from 3rd to 10th, despite no significant change in CON (Interaction effect: F(1,34)=5.130, 
p=0.03). There was also a borderline significant effect for average FIS points per race 
(Interaction effect: F(1,26)=4.152, p=0.05). Despite no change in CON, pairwise 
comparisons showed that average FIS points per race went up significantly in the TDS group 
(p=0.007) from 13 (95% CI: 9.1-17.5) to 22 (95% CI: 16.1-28.9), a difference equivalent to 
skiing ~26 seconds slower in a 15 km classic style race.  
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Finally, there was a significant interaction effect when examining performance in World 
Championship and Olympic Games for men and women who took part in Tour de Ski 
compared to CON (F(1,49)=4.187, p=0.046). While female athletes who took part in Tour de 
Ski typically performed relatively better in these major championships compared to CON, 
male athletes who took part in Tour de Ski typically performed worse in Olympic/World 
Championships than CON (Figure 4.6).   
 
 
Figure 4.3: Percentage of male and female athletes who became ill during or within 10 
days after Tour de Ski, or during the same time period for the control group.  
 
TDS = took part in Tour de Ski  
CON = did not take part in Tour de Ski  
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Figure 4.4: Average placing achieved by male athletes in international competition 
(World Cup/Olympic Games/World Championships) 6 weeks before and 6 weeks after 
Tour de Ski.  
 
Data are geometric mean ± 95% CI. 
TDS = took part in Tour de Ski, CON = did not take part in Tour de Ski 
* Significantly different vs. 6 weeks before TDS (p=0.003). No change in CON. 
  
9th
18th
17th
13th
0
5
10
15
20
25
6 wks before TDS 6 wks after TDS
A
v
e
ra
g
e
 r
e
s
u
lt
TDS
CON
* 
 
 
71 
 
 
 
 
Figure 4.5: Best placing achieved by male athletes in international competition (World 
Cup / Olympic Games / World Championships) 6 weeks before and 6 weeks after Tour de 
Ski.  
 
Data are geometric mean ± 95% CI. 
TDS = took part in Tour de Ski, CON = did not take part in Tour de Ski 
* Significantly different vs. 6weeks before TDS (p<0.001). No change in CON. 
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Figure 4.6: Placing in World Championships (WC) & Olympic Games (OL) normalised 
as a percentage of each athlete’s mean placing for the season (i.e. less than 100% = better 
than average performance).  
 
 Data are mean+SD. 
TDS = took part in Tour de Ski, CON = did not take part in Tour de Ski. 
Significant interaction effect (Gender*TDS, p=0.046) 
 
4.5 DISCUSSION 
 
To the authors’ knowledge, this is the first study to investigate the effects of an intense period 
of repeated competition on subsequent illness incidence, training and race performance in a 
large cohort of world-class winter sports athletes. A main finding of this study is that athletes 
taking part in a cross-country skiing stage race resulting in a significant increase above 
normal training load, had a ~3-fold higher risk of contracting an illness during and in the days 
immediately after the competition, compared to control athletes, with male athletes in both 
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groups appearing somewhat more susceptible to illness than female athletes. Another major 
finding is that male athletes typically see a drop in race performance for at least 6 weeks 
following participation in Tour de Ski, alongside a concurrent reduction in training load. 
The finding of increased illness following participation in Tour de Ski is in accordance with 
previous studies reporting a relationship between upper respiratory illness (URI) risk and a 
high level of exercise stress (Nieman, 1994, Moreira et al., 2009, Gleeson et al., 2011a). The 
results also support earlier findings that URIs are the most common medical complaint 
affecting athletes (Reeser et al., 2003, Fricker et al., 2005), with 17 / 20 cases reported 
following Tour de Ski being symptomatic of URI. However, it is worth bearing in mind that 
the observed increase in illness could also be due to factors in addition to the physiological 
stress of the competition itself. For example, it is possible that athletes may have had a 
higher-than-normal exposure to pathogens due to increased contact with crowds and media 
during the competition period. 
Compared to female athletes, a greater proportion of male athletes reported becoming ill, in 
both the TDS and CON groups (30% of all male athletes vs. 25% of all female athletes). This 
difference does not appear to be explained by differences in absolute training load, since 
there was no significant difference in TRIMP between males and females during the race 
period. However, because the male athletes had a lower baseline training load going into the 
race, the increase in TRIMP as a result of taking part in Tour de Ski was greater (27% 
increase in TRIMP compared to 16% for the female athletes). Furthermore, evidence suggests 
that men typically have a somewhat lower immune response than women, and therefore may 
be more susceptible to opportunistic infections such as colds and influenza (Engler et al., 
2008), possibly due to an immunosuppressive effect of testosterone (Furman et al., 2014).  
On the other hand, in contrast to the general population, data from medical reports following 
major sporting events such as the Olympic Games have generally found a higher incidence of 
 
 
74 
 
illness among female compared to male athletes (Engebretsen et al., 2010, Engebretsen et al., 
2013, Soligard et al., 2015, He et al., 2014), which does not correspond with the findings of 
the current study.  
The male athletes experienced a significant drop in performance in international races in the 6 
weeks following participation in Tour de Ski, while there was no change for female athletes. 
Furthermore, male athletes typically performed relatively worse in World Championships and 
Olympic Games after taking part in Tour de Ski in the same season (~5-7 weeks earlier), 
while female athletes typically performed somewhat better following Tour de Ski 
participation. This is likely, at least in part, due to a marked (20%) reduction in training load 
for the men after compared to before Tour de Ski, while the female athletes appear better able 
to recover and maintain a similar training load in the weeks following the race. The reduction 
in TRIMP observed for the men from before to after Tour de Ski is equivalent to 3.7 hours 
less per week of low-intensity training (zone 1), or 56 minutes less per week of high-intensity 
training (zone 4). It is possible that such a reduction in training stimulus could impact 
negatively on the resulting physiological adaptation and thereby explain the drop in race 
performance. It is interesting that the male athletes had a significantly lower training load 
going into Tour de Ski, so that the increase in training load above baseline during Tour de Ski 
was greater for the male athletes than it was for the female athletes. This may have increased 
the risk of Tour de Ski participation leading to non-functional OR or even OT in the male 
athletes (Meeusen et al., 2013), and may help to explain why they were subsequently unable 
to maintain their normal training load after the competition.  
As well as differences in training load before and after the event, the observed sex differences 
in subsequent race performance may be partly explained by greater competition load in men’s 
compared to women’s Tour de Ski. The total race distance for the men is ~71% further than 
in women’s Tour de Ski, with each stage typically being substantially longer. Similarly, total 
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competition time is ~46% longer for the men. However, it is interesting that this did not result 
in a significant difference in TRIMP, due to the female athletes typically engaging in 
markedly more low-intensity physical activity around and between races (e.g. longer warm-
ups and cool-downs), and more easy training on the rest days during Tour de Ski. Another 
possible explanation for the drop in performance observed for the male, but not the female 
athletes, is that there are a greater number of male athletes competing at the very top end of 
cross-country skiing. Hence, the time differences between places is typically smaller, and a 
reduction in performance resulting in a small time decrement can mean a loss of a greater 
number of places compared to the women’s elite races where the time differences between 
competitors are typically larger. For example, for the last three Olympic Games, the average 
time difference between 1st and 20th position in the men’s 50 km event was 47 seconds, 
compared to an average time difference of 3:32min between 1st and 20th position in the 
equivalent women’s 30 km event (www.fis-ski.com).  
As a greater proportion of the male athletes reported illness during and following Tour de Ski 
this may also have affected their subsequent performance, due to loss of training days during 
this time. A final explanation could be that a greater proportion of top level female cross-
country skiers choose to take part in Tour de Ski, and that any absolute performance 
decrements are therefore not reflected in race positions or FIS points, because the majority of 
the other competitors have been similarly affected. For example, of the 19 athletes who came 
top 10 in the three women’s individual cross distance events in the 2014 Olympic Games (10 
km classical, 15 km skiathlon, 30 km freestyle), 68% had participated in Tour de Ski earlier 
in the same season. Of the men, only 38 % of the athletes who claimed the top ten places in 
the individual cross-country distance events (15 km classical, 30 km skiathlon, 50 km 
freestyle) had also competed in Tour de Ski in the same season.     
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A strength of this current study is that it includes a considerable amount of data for a large 
cohort of world-class endurance athletes. However, because the data are based on athlete self-
report, and illness episodes were therefore not verified by a medical professional, it is not 
possible to ascertain whether the symptoms reported were truly due to an infection. Indeed, 
Spence et al. (2007) found that pathogens were isolated in fewer than 30% of symptomatic 
URI cases in elite triathletes, suggesting that a large proportion may be due to non-infectious 
causes. However, it is worth noting that these findings are likely partly explained by low 
incidence of common cold during the summer months when this study was conducted. 
Similar concerns may be raised regarding the accuracy of the training data. However, Sylta et 
al. (2014) concluded that elite endurance athletes self-report their training with high accuracy. 
The same level of accuracy and validity likely holds true for this data set, as both athlete 
groups used similar reporting routines and a number of the athletes are, in fact, included in 
both papers. In addition, athletes recorded both their training and illness symptoms on a daily 
basis, which likely reduced reporting error. It should be recognised that the analysis method 
used in the current study, based on seasons rather than individuals, is susceptible to the 
influence of a small number of outliers. However, all of the individuals included in the 
current study were part of the Norwegian national team and therefore represent a highly 
homogenous group of elite athletes. During the analysed time period, cross-country skiing 
training culture in Norway has changed very little. Hence, both inter- and intra-individual 
differences between seasons in terms of training variables are small, and outliers with 
abnormal annual illness rates were excluded from the analyses.  
Taking part in an 8-11 day cross-country skiing stage race appears to result in a ~3-fold 
increase in the risk of contracting an illness, primarily URI, in this period. Whether taking 
part in the competition or not, male athletes appear somewhat more prone to illness than 
female athletes. Furthermore, unlike their female counterparts, male athletes see a drop in 
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race performance for at least 6 weeks following participation in Tour de Ski, possibly due to 
suboptimal training loads going into and coming out of the event. Male athletes also typically 
perform worse in subsequent World Championships / Olympic Games when taking part in 
Tour de Ski earlier in the season. Female athletes, on the other hand, appear to perform 
somewhat better after participating in Tour de Ski.  
4.6 CONCLUSION 
 
In accordance with previous studies linking training load and infection susceptibility, this 
study provides evidence that an intense period of competition leads to increased illness 
incidence, even in elite athlete populations who already have an extremely high training load. 
The study also provides new insight into how participation in such an event might influence 
subsequent training and race performance.  This information can aid in making an informed 
decision about whether or not an athlete should take part in a competition such as Tour de Ski 
in the same season that they are also aiming to reach peak performance for Olympic Games 
or World Championships. When making this decision, coaches and athletes should reflect 
carefully on the potential impact the race may have on the rest of the competition season. 
Male athletes, in particular, may wish to consider foregoing Tour de Ski in an Olympic year. 
However, if the decision is made to participate, careful consideration should be given 
regarding how best to train in the weeks and days before and after the race, in order to 
prevent maladaptive outcomes and instead turn the event into a beneficial component of the 
athlete’s championship preparation.   
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5.1 ABSTRACT 
 
Upper respiratory infections are particularly prevalent during intensified training (IT) or 
competition and in athletes suffering from overreaching (OR). High CHO intake may play a 
role in the prevention of OR and ameliorate associated immune disturbances. PURPOSE: To 
determine the effects of IT and CHO supplementation on markers of OR and immunity. 
METHODS: In a randomised, double-blind, crossover design, 13 male cyclists (age 25 ± 6 
years, ?̇?O2max 72 ± 5 ml/kg/min) completed two 8-day periods of IT while ingesting either high 
(6%) (H-CHO) or low (2%) (L-CHO) carbohydrate beverages before, during and after every 
training session. Blood samples were collected before and immediately after an incremental 
test to fatigue on days 1 and 9. RESULTS: IT resulted in decreased peak power in the 
incremental test (375 ± 37 vs. 391 ± 37 W, P<0.001), reduced maximal heart rate (179 ± 8 vs. 
190 ± 10 bpm, P<0.001), reduced resting haematocrit (39 ± 2 vs. 42 ± 2 %, P<0.001) and 
increased plasma volume (PV) (P<0.001), with no difference between trials. Resting plasma 
cortisol was increased while plasma ACTH was reduced following IT (P<0.05), with no 
differences between trials. Following IT, resting whole blood culture production of IL-1α in 
response to antigen-challenge was higher in L-CHO than H-CHO (0.70 (95% CI 0.52-0.95) 
pg/ml vs. 0.33 (0.24-0.45) pg/ml, P<0.01), as was production of IL-1β (9.3 (95% CI 7-10.4) 
pg/ml vs. 6.0 (5.0-7.8) pg/ml, P<0.05). Circulating total leukocytes (P<0.05) and neutrophils 
(P<0.01) at rest were increased with IT, as was neutrophil:lymphocyte ratio and percentage 
CD4+ lymphocytes (P<0.05), with no difference between trials. There were no significant 
changes in numbers of Treg cells between trials, or following IT. CONCLUSION: IT resulted 
in changes consistent with symptoms of OR, although immunological and performance 
changes were modest. Increasing CHO intake was not able to better maintain peak power, or 
alleviate physiological/immunological disturbances. 
. 
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5.2 INTRODUCTION  
 
 Overload is a key training principle used by athletes and coaches to improve physical 
performance. Periods of intensified training (IT) are therefore commonly incorporated over 
the course of a training season. However, when high training load is combined with 
insufficient recovery and/or other stressors such as lack of sleep, psychological stress, 
environmental stress or inadequate energy intake, it can lead to a state of OR and place 
athletes at risk of developing Overtraining Syndrome (OTS) (Meeusen et al., 2013). Although 
Chapter 3 did not find a significant relationship between overall training volume or intensity 
and infection risk, high day-today fluctuations in training load were associated with an 
increased risk. Furthermore, repeated competition over a number of consecutive days was 
associated with increased infection incidence, and a reduction in race performance in Chapter 
4, suggesting that this competition period induced a state of overreaching in many of the 
athletes.   
Much anecdotal evidence indicates increased URS incidence in athletes with OTS. This is not 
altogether surprising, since previous studies have also reported reduced S-IgA (Gleeson et al., 
1995, Mackinnon and Hooper, 1994), reduced numbers of natural killer (NK) cells (Gleeson 
et al., 1995, Meyer et al., 2004) and CD3+ and CD4+ cells (Baj et al., 1994b), impaired 
neutrophil function (Robson-Ansley et al., 2007, Baj et al., 1994b), reduced 
glutamine/glutamate ratio (Halson et al., 2003, Rowbottom et al., 1995, Coutts et al., 2007, 
Parrybillings et al., 1992) and elevated plasma concentrations of IL-6 and creatine kinase at 
rest (Robson-Ansley et al., 2007) following IT. In addition, studies suggest that the capacity 
of immune cells to produce cytokines in response to an immune challenge may be impaired 
(Baj et al., 1994b, Lancaster et al., 2004, Morgado et al., 2012). Cytokines play a key, 
pleiotropic role in orchestrating the responses of lymphocytes, macrophages and other 
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immune cells during an infection (Trinchieri, 1997, Biron et al., 1999, Samuel, 2001). 
Disturbances to the profile of cytokine production in response to IT may therefore increase 
infection susceptibility. Gleeson et al. (2011a) found that athletes with a high training load 
(≥11 h moderate-high intensity training per week) had more than twice as many URI 
episodes, alongside approximately three-fold higher resting IL-2, IL-4 and IL-10 production 
in response to antigen challenge compared to athletes with a low training volume (<6 h per 
week). An elevated anti-inflammatory response, and specifically increased IL-10 production, 
appears to be a risk factor for URS in athletes (Gleeson et al., 2012). IL-10 is primarily 
produced by lymphocytes and, in particular, regulatory T (Treg) cells (Gleeson et al., 2011b); 
circulating numbers of Treg cells appear to be higher in physically active compared with 
sedentary individuals (Handzlik et al., 2013) but no studies to date have investigated changes 
in this cell population during IT. 
CHO intake may play a role in the prevention of OR and alleviate associated immune 
disturbances (Achten et al., 2004, Halson et al., 2004, Costa et al., 2005), possibly via 
attenuation of the stress hormone response to exercise (Costa et al., 2005). Most competitive 
endurance athletes typically ingest some CHO during prolonged bouts of training or 
competition. However, it is not clear whether increasing CHO ingestion before, during and 
after exercise in line with American College of Sports Medicine (ACSM) guidelines 
(Rodriguez et al., 2009) can provide additional protection against OR and immune 
disturbances compared to more modest CHO intakes in and around the exercise occasion.  
The aim of the current study was therefore to determine the effects of eight days of 
intensified cycling training with a self-selected diet supplemented with beverages with either 
a low or high CHO concentration before, during and after the training, on circulating 
leukocytes and lymphocyte subsets, antigen-stimulated cytokine production, and plasma 
hormones in competitive cyclists. 
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5.3 METHODS 
 
5.3.1 Subjects  
Thirteen highly trained, competitive male cyclists provided their written, informed consent to 
participate in the study, which was approved by the Loughborough University ethical 
advisory committee. Prior to the start of the study, participants completed a health screen 
questionnaire. Subjects could be included if they were between 18 and 35 years of age, had a 
?̇?O2max of ≥ 64 mL/kg/min, had been actively competing in cycling for at least two years and 
were currently engaging in a minimum of 6 h of cycling training per week. Participants were 
also required to be currently healthy and without upper-respiratory symptoms or use of any 
medication during the past four weeks. Exclusion criteria were: smoking, suffering from, or 
with a history of, cardiac, hepatic, pulmonary, renal, neurological, haematological, 
psychiatric or gastrointestinal illness, or baseline haematological values (leukocyte and 
erythrocyte counts) outside the normal range. Baseline characteristics were as follows (mean 
± SD): age 25 ± 6 years, body mass 69.7 ± 6.3 kg, height 1.78 ± 0.03 m, body fat percentage 
13.4 ± 4.1%, and ?̇?O2max 72.2 ± 4.9 mL/kg/min, 5.0 ± 0.5 L/min.      
5.3.2 Study design 
The study was conducted using a double-blind, placebo-controlled, crossover design. Each 
participant completed two 8-day periods of intensified training in a randomized and 
counterbalanced order, separated by a 15-day washout period (Figure 1). During one trial, 
participants were provided with high concentration CHO solutions to drink before, during 
and after every training session (H-CHO). In the other trial they were given a taste-matched 
low CHO solution (L-CHO).  
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5.3.3 Baseline training 
Prior to the start of the study, participants were asked to record all of their training for a 
minimum of two weeks. Session structure and duration, type of exercise, heart rate and power 
output data (where available) were uploaded to an online training diary (TrainingPeaks, 
Peaksware LLC, Colorado). These data were analysed to give a baseline total weekly number 
of hours of cycling, and training volume at different intensities, and used to calculate and 
prescribe individual training plans for each IT period.  
 
Figure 5.1: Diagrammatical representation of the intensified training protocol.  
5.3.4 Intensified training 
During each 8-day IT period participants were prescribed an individualised training plan with 
targets for training time, heart rate and power output set for every session. HR and power 
targets were based on results from the initial ?̇?O2max test. If performance in the baseline 
?̇?O2max test of the second trial differed significantly from that of the first trial (i.e. if the 
athlete’s fitness has improved or deteriorated between the two trials), power targets were 
adjusted accordingly so that relative training intensity was identical for both trials . During 
each IT period, total training volume was doubled compared to baseline training, and time 
spent at high-intensity more than trebled, with high intensity training comprising ~35% of 
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total training time. Training was categorized into five heart rate zones as previously 
described. 
All participants were prescribed two sessions per day, with every session including a high-
intensity interval training component (Zones 3-5). In addition to maximal incremental tests, 
participants attended the laboratory for supervised training sessions on days 1, 2, 5, 6, and 8 
of both trials.  
All training was performed either out on the road or in the laboratory on the participant’s own 
bike equipped with a power meter (SRM PowerMeter Shimano DA7950 compact, SRM 
International, Jülich, Germany) and mounted on a stationary turbo trainer. Heart rate and 
power output were recorded continuously for every session with a sampling frequency of 4 
Hz and stored on the SRM PowerControl 7. All training data were subsequently uploaded to 
and analysed in an online training diary (TrainingPeaks, Peaksware LLC, Colorado). 
Participants were required to complete every session prescribed in their training plan in order 
to be included in the study. The two IT periods were separated by a 15-day washout, during 
which participants were encouraged to take time to recover before returning to normal 
training. Participants were asked to continue recording and uploading training data during the 
washout period.  
5.3.5 Nutritional intervention 
For both trials, participants were provided with a specified volume and composition of drink 
before, during and after every training session (Table 5.1). Drinks ingested before and during 
exercise were taste-matched, and participants were informed that the only difference in the 
nutritional intervention between the two trials was that in one they would be provided with 
two recovery drinks, whereas during the other, one of these drinks would be replaced with a 
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‘recovery pill’. They were informed that the purpose of the study was to investigate the 
efficacy of a new amino acid pill versus a drink, on recovery from exercise.   
For a typical 2 hour training session, this provided a CHO intake of 187.5 g in H-CHO 
compared to 52.4 g in L-CHO (an additional 17 g protein was provided after exercise in the 
H-CHO group, with no protein received in the L-CHO group). The composition of the drinks 
provided in the H-CHO trial were chosen to conform with the current ACSM guidelines on 
recommended CHO intake for endurance exercise (Rodriguez et al., 2009). Participants were 
asked to refrain from ingesting any other sports nutrition products or nutritional supplements 
for the duration of the study and were provided with a diet diary in which to record weighed 
food and fluid intake for 3 days prior to and throughout the course of each trial. 
 
Table 5.1: Volumes and compositions of drinks provided before, during and after 
training sessions in H-CHO and L-CHO trials.  
 H-CHO L-CHO 
 
Before exercise 
 
118 mL 20% CHO solution (24g)  118 mL 2% CHO solution (2.4g)  
 
 
During exercise 
 
 
1 L per hour 6% CHO solution 
(60g/h)  
 
1 L per hour 2% CHO solution 
(20g/h)  
 
After exercise 
 
 
 
 
 
1x 500 mL 6% CHO solution 
(30g)  
 
1x 500 mL 2.7% CHO / 3.3% 
PRO solution (13.5g) 
 
 
1x 500 mL 2% CHO solution (10g)  
 
1 x cellulose capsule (0g) 
 
Values in parentheses indicate CHO content in grams.  
CHO: carbohydrate; PRO: protein 
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5.3.5 Maximal incremental test  
On days 1 and 9 of each trial, subjects completed a continuous, incremental exercise test to 
volitional exhaustion on a magnetically-braked cycle ergometer (IndoorTrainer, SRM 
International, Jülich, Germany) for determination of ?̇?O2max as previously described.  
5.3.6 Blood sampling and analyses 
On days 1 and 9 of each trial, blood samples were collected at rest immediately before the 
start of the maximal exercise test (PRE), and immediately after cessation of exercise (POST). 
On each occasion, a venous blood sample (11 mL) was obtained by venepuncture from an 
antecubital vein. Blood was collected into two vacutainer tubes (Becton Dickinson, Oxford, 
UK) containing either lithium heparin or K3EDTA as anticoagulant. Haematological analysis 
was immediately performed on the K3EDTA sample, with the remaining sample used for 
determination of plasma cortisol and ACTH, as outlined previously. The heparinized sample 
was used for determination of antigen-stimulated cytokine production by whole blood culture 
and lymphocyte subsets via four colour flow-cytometry, as previously described.  
5.3.7 Statistical analysis 
Data are presented as means ± SD unless otherwise stated. All statistical analyses were 
performed using IBM SPSS Statistics 22.0. The Shapiro–Wilk test was used to determine 
whether data were normally distributed. A two-way repeated measures ANOVA was used to 
determine whether there were significant differences between L-CHO and H-CHO trials 
before and after intensified training. A post hoc test with Bonferroni correction for multiple 
comparisons was used to determine the location of variance. Variables found to be 
significantly non-normal were transformed to normality using a log transformation prior to 
analysis, and are presented as back-transformed geometric mean with 95% CI. Based on the 
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results of Mauchly’s sphericity test, Greenhouse-Geisser corrections were applied for epsilon 
<0.75 and Huynd-Feldt corrections applied for epsilon >0.75 where violations of sphericity 
were identified. Statistical significance was accepted at the P<0.05 level. Pearson product-
moment correlation analyses were used to determine whether changes in any of the measured 
immune variables correlated significantly with changes in performance, in order to determine 
whether any could be used as potential markers of overreaching.  
5.4 RESULTS 
 
During the 8-day IT period, total training volume was increased from 9.3 ± 2.4 h/wk at 
baseline, to 23.5 ± 3.4 h/wk, with high-intensity training increased from 2.6 ± 2.5 to 6.5 ± 4.0 
h/wk, with no differences between trials. Over the 8-day period, participants completed 24.3 
± 3.3 MJ of cycling, with no significant difference between the trials. Total daily energy 
intake was significantly lower in L-CHO compared to H-CHO (14.65 ± 2.68 MJ/d vs. 17.36 
± 3.21 MJ/d, P<0.001). This difference was primarily due to lower CHO intake in L-CHO 
(505 ± 107 g/d vs. 679 ± 105 g/d, P<0.001; 7.2 ± 1.6 g/kg/d vs. 9.7 ± 1.5 g/kg/d, p<0.05). 
However, in both trials participants remained weight stable with a mean body mass change of 
-0.19 ± 1.08 kg.  
There was no change in ?̇?O2max following IT. However, in both L-CHO and H-CHO trials, IT 
resulted in decreased peak power in the maximal incremental exercise test compared to 
baseline (375 ± 37 W vs. 391 ± 37 W, p=0.001) (Figure 5.2), reduced maximal HR (179 ± 8 
bpm vs. 190 ± 10 bpm, P<0.001), reduced haematocrit (39 ± 2 % vs. 42 ± 2 %, P<0.001) and 
a 14 ± 10 % increase in plasma volume (PV) at rest (P<0.001) (Table 5.2), with no 
significant differences between trials.  
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Table 5.2: Haematological variables and plasma volume changes before and after acute 
maximal exercise, and before and after the 8 day intensified training intervention. 
  PRE IT  POST IT 
  Pre-exercise Post-exercise 
8-days 
intensified 
training 
Pre-exercise Post-exercise 
RBC 
(x109/L) 
H-CHO 4.60 ± 0.22 4.87 ± 0.28 * 4.25 ± 0.19 † 4.47 ± 0.23 †* 
L-CHO 4.60 ± 0.16 4.87 ± 0.16 * 4.29 ± 0.23 † 4.52 ± 0.23 †* 
Hb (g/dL) 
H-CHO 14.3 ± 0.8 15.1 ± 0.9 * 13.2 ± 0.8 † 13.9 ± 0.9 †* 
L-CHO 14.1 ± 0.8 14.9 ± 0.9 * 13.0 ± 0.8 † 13.6 ± 0.9 †* 
HCT (%) 
H-CHO 41.9 ± 2.4 45.0 ± 2.7 * 39.0 ± 1.7 † 41.3 ± 1.8 †* 
L-CHO 42.0 ± 1.3 45.1 ± 1.7 * 39.2 ± 2.0 † 41.7 ± 2.0 †* 
PV (% of 
baseline) 
H-CHO 100 ± 0 89 ± 4 * 114 ± 11 † 104 ± 12 †* 
L-CHO 100 ± 0 90 ± 5 * 114 ± 10 † 104 ± 9 †* 
Data are mean ± SD. RBC: red blood cell count; Hb: Haemoglobin; HCT: Haematocrit; IT: 
intensified training; PV: Plasma volume. * Significant effect of acute maximal exercise 
(P<0.001), † significantly different from same time point pre-intensified training (P<0.001).  
 
 
Figure 5.2: Percentage change in peak power achieved during the incremental, maximal 
exercise test for each participant following the intensified training period with L-CHO 
and H-CHO. Dashed line indicates significant mean change (P<0.01)  
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Circulating total leukocytes and neutrophils at rest were increased after IT (Table 5.3), as 
was the percentage of lymphocytes that were CD4+ (29 ± 6 % vs. 26 ± 7 %, P<0.05), with no 
difference between trials. Seven of the 13 participants had somewhat lower than normal 
numbers of CD4+ cells (<0.5 x109 cells and <30% of total lymphocytes) at baseline. The 
exercise-induced increase in CD4+ cells was significantly reduced following IT (0.10 ± 0.14 
x109 vs. 0.19 ± 0.11 x109, P<0.01). There were no significant changes in numbers of 
CD24+CD25+CD127low/- Treg cells following intensified training in either trial (Table 5.3). 
Resting neutrophil:lymphocyte ratio was significantly increased following IT in both trials 
(Figure 5.3).  
 
Figure 5.3: Change in neutrophil: lymphocyte ratio for each participant following 
intensified training with L-CHO and H-CHO. Dashed line indicates significant mean 
change (P<0.05) 
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Table 5.3: Leukocyte counts before and after acute maximal exercise, and before and 
after 8 days intensified training in L-CHO and H-CHO trials. 
 
    PRE IT 
 
POST IT 
    Pre-exercise Post-exercise Pre-exercise Post-exercise 
WBC 
HCHO 5.30 ± 0.85 8.34 ± 1.49* 5.99 ± 1.00 † 9.14 ± 1.70 *† 
LCHO 5.43 ± 0.93 7.93 ± 1.27* 5.92 ± 0.94 † 8.31 ± 1.17 *† 
NEUT 
HCHO 2.45 ± 0.49 3.17 ± 0.75* 2.93 ± 0.78 † 3.99 ± 1.08 *† 
LCHO 2.58 ± 0.69 3.26 ± 0.77* 3.00 ± 0.78 † 3.74 ± 0.81 *† 
MONO 
HCHO 0.51 ± 0.12 0.75 ± 0.22* 0.59 ± 0.15 0.89 ± 0.33* 
LCHO 0.53 ± 0.13 0.72 ± 0.18* 0.55 ± 0.14 0.75 ± 0.21* 
LYMPH 
HCHO 2.17 ± 0.61 4.08 ± 1.07*# 2.26 ± 0.65 4.03 ± 0.98*# 
LCHO 2.12 ± 0.47 3.65 ± 0.66* 2.17 ± 0.47 3.53 ± 0.95* 
CD4+ 
HCHO 0.55 ± 0.21 0.77 ± 0.23*# 0.58 ± 0.20 0.71 ± 0.20*†# 
LCHO 0.54 ± 0.20 0.69 ± 0.23* 0.58 ± 0.20 0.65 ± 0.18*† 
CD4+CD25+ 
HCHO 0.14 ± 0.04 0.22 ± 0.07* 0.14 ± 0.05 0.19 ± 0.05* 
LCHO 0.14 ± 0.05 0.18 ± 0.06* 0.13 ± 0.04 0.16 ± 0.05* 
CD4+CD25+ 
CD127low/- 
HCHO 0.05 ± 0.02 0.06 ± 0.03* 0.05 ± 0.02 0.06 ± 0.02* 
LCHO 0.05 ± 0.02 0.06 ± 0.02* 0.05 ± 0.02 0.05 ± 0.02* 
 
Data are mean ± SD. Cell counts are corrected for changes in plasma volume.  
IT: intensified training; WBC: total white blood cells; NEUT: neutrophils; MONO: 
monocytes; LYMPH: lymphocytes; CD4+: lymphocytes expressing CD4 (T helper cells); 
CD4+CD25+: lymphocytes expressing CD4 and CD25; CD4+CD25+CD127low/-: 
Lymphocytes expressing CD4 and CD25, but not CD127 (Treg cells).  
 
* Significant effect of acute maximal exercise (P<0.01), † significant difference from same 
time point pre-intensified training (P<0.01), # significant difference from L-CHO at same 
time point (P<0.05).  
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Resting plasma ACTH was significantly lower following IT, while resting plasma cortisol 
concentration was increased (Figure 5.4). There was no significant effect of IT on the 
exercise-induced change in ACTH or cortisol. Nor were there any significant differences 
between L-CHO and H-CHO in either hormone. Following IT, production of IL-1α at rest in 
response to antigen challenge was higher in L-CHO compared to H-CHO, as was production 
of IL-1β (Figure 5.5). Production of TNFα in response to antigen challenge also tended to be 
higher in L-CHO post IT (14.7 (11.0-19.6) vs. 8.6 (5.0-14.9) pg/ml, P=0.063). Antigen-
stimulated production of IL-2 (Pre IT: LCHO 21.6 (10.9-41.8) pg/ml, HCHO 23.0 (12.1-
42.7) pg/ml; Post IT: LCHO 16.0 (6.7-36.5) pg/ml, HCHO 28.4 (13.2-59.6) pg/ml), IFN-γ 
(Pre IT: LCHO 1.9 (0.8-3.8) pg/ml, HCHO 1.9 (0.8-3.6) pg/ml; Post IT: LCHO 2.5 (1.0-5.1) 
pg/ml, HCHO 1.6 (0.6-3.3) pg/ml), IL-6 (Pre IT: LCHO 67 (34-133) pg/ml, HCHO 58 (28-
117) pg/ml; Post IT: LCHO 83 (48-144) pg/ml, HCHO 29 (14-61) pg/ml), and IL-4 (Pre IT: 
LCHO 1.9 (1.3-2.6) pg/ml, HCHO 1.9 (1.3-2.6) pg/ml; Post IT: LCHO 2.7 (2.1-3.6) pg/ml, 
HCHO 3.0 (2.2-3.8) pg/ml) were not significantly altered by the intensified training and did 
not differ between trials.  
Submaximal fat oxidation during the first five stages of the incremental test was significantly 
increased following IT in both trials, with this increase being greater in L-CHO (Figure 5.6). 
The workload at which maximal fat oxidation occurred was also increased following IT (226 
± 45 W vs. 181 ± 41 W, P<0.01) with no difference between trials.  
None of the measured variables correlated significantly with changes in performance 
following intensified training.  
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Figure 5.4: Resting plasma cortisol and ACTH following intensified training.  
Values are mean ± 95% CI. † Indicates significant difference from pre-intensified training, 
P<0.05. Corrected for change in plasma volume.  
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Figure 5.5: Resting antigen-stimulated production of IL-1α and IL-1β by whole blood 
culture before and after intensified training with L-CHO and H-CHO.  
Values are mean ± 95% CI. #significant difference between L-CHO and H-CHO (P<0.05). 
Corrected for change in plasma volume. 
  
A 
B 
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Figure 5.6: Individual changes in antigen-stimulated production of IL-1α and IL-1β by 
whole blood culture from pre- to post-intensified training in L-CHO and H-CHO trials.  
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Figure 5.7: Average fat oxidation during the first five stages (60-235 W) of the 
incremental test before and after intensified training in L-CHO and H-CHO trials.  
Values are mean + SD. *significant difference from pre-intensified training in both trials, 
P<0.01. #significant interaction effect, P<0.05. 
 
5.5 DISCUSSION 
 
The main finding of the current study is that an 8-day period of IT in highly trained cyclists 
induces some immunological, haematological, physiological and exercise-related changes 
consistent with the symptoms of OR. However, high-dose CHO supplementation in and 
around the exercise training occasion, in addition to a self-selected diet, did not reduce the 
associated maximal power output decrement or ameliorate hormonal and immunological 
disturbances compared to a more moderate CHO intake. This is in agreement with Snyder et 
al. (1995) who found that even when muscle glycogen was maintained via CHO 
supplementation, competitive cyclists still displayed symptoms of OT following 15 days of 
IT. In contrast, Achten and colleagues (2004) found that an increase in dietary CHO from 5.4 
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to 8.5 g CHO/kg bm/day better maintained physical performance in runners undergoing a 
period of IT, reducing the symptoms of OR. Similarly, Costa et al. (2005) found that 
consumption of a very high CHO diet (12 g CHO/kg bm/day) during IT attenuated cortisol 
release and increased salivary secretory immunoglobulin-A concentration compared to a self-
selected, and more moderate, CHO intake of 5.9 g/kg bm/day. Halson et al. (2004) found that 
ingestion of a high CHO beverage before, during and after training sessions over the course 
of an 8-day period of intensified cycling training better maintained performance and reduced 
symptoms of OR compared to a low CHO placebo (9.4 vs. 6.4 g/kg bm/day). However, in the 
current study, total daily CHO intake in the L-CHO trial was higher than in these studies at 
7.2 g/kg bm/day; a daily amount classed as ‘high’ in the International Olympic Committee’s 
latest consensus on sports nutrition (Burke et al., 2011). It is possible that this intake was 
already sufficient to provide some protection against immunological disturbances and other 
symptoms of OR. Another possible explanation is differences in training during the IT 
period.  Compared with the study of Halson et al. (2004) participants in the current study 
completed a greater total volume of cycling (23.5 h/wk vs. 15.3 h/wk) but less high-intensity 
training (6.5 h/wk vs. 10.5 h/wk). Since muscle glycogen utilization is related to exercise 
intensity (Saltin and Karlsson, 1971), it is possible to speculate that the lower number of 
hours of high intensity training in the current study may have resulted in lower glycogen 
depletion, and that CHO supplementation was therefore less critical in maintaining 
performance. In addition, participants in the current study were highly trained, with greater 
aerobic capacity than participants included in the above mentioned studies, and may therefore 
have been more resilient to detrimental effects of the IT period. Indeed, despite showing 
some symptoms of OR, the performance decrement in the current study was relatively modest 
(~4%), and it is possible that the training load during IT was not, in fact, sufficient to induce 
a true state of OR in these well-trained athletes.  
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The IT did, however, result in a marked reduction in resting haematocrit, haemoglobin and 
red blood cell concentration, likely primarily indicative of a pronounced plasma volume 
expansion. It is well reported that physical training stimulates an increase in plasma volume 
(Convertino, 1991) and it is likely that the changes observed in the current study are primarily 
indicative of adaptation rather than OR. However, it is also possible that these changes were 
due, at least in part, to changes in red cell destruction or production as a result of IT. Indeed, 
strenuous endurance exercise has been associated with increased intravascular haemolysis, 
due to oxidative damage to red blood cells (Smith, 1995).  
Whether or not the changes in immune variables observed in the current study following IT 
might make athletes more susceptible to URI is not clear. The ~315 nmol/L increase in 
resting plasma cortisol may have negative implications for host defence, particularly since 
mean concentration at baseline was already towards the upper end of the normal range. 
Several studies have investigated the effect of IT on plasma cortisol concentrations, with the 
majority reporting no significant change in resting plasma cortisol following IT (Urhausen et 
al., 1998, Mackinnon et al., 1997, Hooper et al., 1993). It is possible that the increase 
observed in the current study, along with elevations in circulating leukocytes, neutrophils, 
CD4+ lymphocytes and neutrophil:lymphocyte ratio, may be only a transient effect caused by 
incomplete recovery from the previous exercise bout ~13 h earlier.  
Handzlik et al. (2013) recently reported that endurance trained athletes with a high training 
load (~15 h/wk) had a significantly higher proportion of regulatory T cells as a percentage of 
total lymphocytes and higher antigen-stimulated in vitro IL-10 production compared with 
sedentary individuals. However, in the current study, there was no significant effect of IT on 
absolute or relative numbers of regulatory T cells or antigen-stimulated IL-10 production, 
suggesting that these variables are not altered by short-term increases in training load in 
individuals already training ~9 h/wk. However, antigen-stimulated production of IL-1α and 
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IL-1β were both reduced following IT in H-CHO and increased following IT in L-CHO. 
Type 1 cytokines, such as IL-1, promote cellular immunity by stimulating the functional 
activity of T cytotoxic cells, NK cells and activated macrophages (Gleeson et al., 2013b). 
Reduced production of these cytokines in response to an immune challenge may therefore 
have negative implications for host defence. Similar to the results observed for the H-CHO 
trial, (Morgado et al., 2012) reported impaired production of IL-1β from dendritic cells and 
monocytes in swimmers following IT. However, that IL-1α and IL-1 β production should be 
increased following IT in L-CHO appears counterintuitive, and further research is necessary 
to corroborate these findings. Nevertheless, it is clear that increasing CHO intake during 
exercise, from 20 to 60 g/h, does not provide any additional benefit in preserving the 
measured immune parameters during IT in this cohort of highly trained cyclists. In fact, since 
neither maximal power output nor immunity were better maintained with a high CHO intake, 
and increases in fat oxidation were lower, it could be argued that ingesting a moderate (~20 
g/hr) CHO dose during short-term IT may be more advantageous than a higher CHO dose, at 
least when athletes already have a high daily intake of dietary CHO (>7 g CHO/kg bm/day). 
This intake during exercise appears sufficient to help prevent large maximal power output 
decrements, and preserve immunity, while facilitating greater adaptation in terms of fat 
oxidation. Whether this improved capacity to oxidise fat has subsequent performance benefits 
once recovery from IT is complete is unknown.  
The mean ?̇?O2max of participants in the current study was 72.2 mL/kg/min, and to our 
knowledge, no previous study has attempted to intentionally overreach such highly endurance 
trained athletes. The current data indicate that these athletes are relatively robust to increases 
in training load and can tolerate multiple consecutive days of IT without large reductions in 
maximal power output or severe immune disturbances. However, since many of the 
participants had lower than expected numbers of CD4+ cells and higher than expected plasma 
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cortisol already at baseline, it is possible that their habitually high training loads may already 
be associated with some mild immunodepression.  
5.6 CONCLUSION 
 
Eight days of IT results in a number of changes consistent with the symptoms of short-term 
OR in highly trained cyclists, although both immunological and exercise-related changes are 
relatively modest. When ingesting an otherwise self-selected diet, increasing CHO intake 
immediately before, during and after training sessions did not better maintain maximal power 
output, or alleviate physiological/immunological disturbances compared to a more moderate 
CHO intake. The results also highlight the importance of considering plasma volume changes 
when interpreting results from training studies, since even highly trained individuals appear 
to demonstrate a pronounced plasma volume expansion following just eight days of IT.  
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6.1 ABSTRACT 
 
PURPOSE: There is some evidence that performing acute exercise in a hypohydrated state 
can exacerbate immune disturbances compared to when euhydration is maintained before and 
during exercise. The purpose of this study was therefore to determine the effects of prolonged 
exercise and hydration status on plasma cortisol and antigen-stimulated cytokine production. 
METHODS: Twelve healthy males cycled for 120 min at 60% V̇O2max on two occasions, 
either euhydrated or moderately hypohydrated (induced by fluid restriction for 24h). Blood 
samples were collected before and after exercise and following 2 h recovery for 
determination of cell counts, plasma cortisol and in vitro antigen-stimulated cytokine 
production by whole blood culture. RESULTS: Fluid restriction resulted in mean body mass 
loss of 1.3% and 3.9% before and after exercise, respectively. Exercise elicited a significant 
leukocytosis and elevated plasma cortisol (623 ± 101 nmol/L pre-exercise vs. 729 ± 127 
nmol/L post-exercise, p<0.05), with no differences between trials. IL-6 production was 
significantly reduced 2 h post-exercise (4.1 (1.5-10.0) pg/ml 2h post-sexercise vs. 9.0 (3.7-
22.4) pg/ml pre-exercise, p<0.05), while IL-10 production was elevated post-exercise (0.68 
(0.43-0.94) pg/ml post-exercise vs. 0.42 (0.10-0.82) pre-exercise, p<0.05). IFN-γ and IL-2 
production tended to decrease post-exercise, although this did not reach statistical 
significance. No significant effect of hydration status was observed for any of the measured 
variables. CONCLUSION: Prolonged exercise appears to result in augmented anti-
inflammatory cytokine release in response to antigen challenge, possibly coupled with acute 
suppression of pro-inflammatory cytokine production, corresponding with studies using 
mitogen or endotoxin as stimulant. Moderate hypohydration does not appear to influence 
these changes.  
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6.2 INTRODUCTION 
 
Studies suggest that athletes frequently commence training or competition in a mildly or 
moderately hypohydrated state (Da Silva et al., 2012, Fernando Aragon-Vargas et al., 2009, 
Maughan et al., 2005, Volpe et al., 2009), and that they typically fail to ingest sufficient fluid 
to offset losses through sweating during exercise (Da Silva et al., 2012, Maughan et al., 2004, 
Maughan et al., 2005, Beis et al., 2012). Compared with exercise in a euhydrated state, 
moderate dehydration would be expected to result in an augmented stress response and thus 
likely greater disturbances to immune function. For example, Maresh et al. (2006) found that 
athletes hypohydrated to ∼5% body mass loss had significantly higher plasma cortisol 
concentrations prior to and 20 min following acute submaximal exercise. The aims of the 
current study were therefore to determine, 1) the acute effects of a single bout of prolonged 
exercise on plasma cortisol and antigen-stimulated cytokine production by whole blood 
culture, and 2) how these effects differ depending on whether exercise is undertaken in a 
euhydrated or moderately hypohydrated state. It was hypothesised that immediately 
following 2 h of cycling exercise at 60 %V̇O2max, there would be no significant change in 
antigen-stimulated production of type 2/anti-inflammatory cytokines, but that there would be 
a transient suppression of type 1/pro-inflammatory cytokine production relative to baseline, 
with values returning towards resting levels within 2 h of recovery. In addition, it was 
hypothesised that exercise in a moderately hypohydrated state would lead to a somewhat 
augmented cortisol response, and greater disturbances of cytokine production compared to 
exercise in a euhydrated state.  
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6.3 METHODS 
 
6.3.1 Subjects 
Twelve healthy, male university students provided their written, informed consent to 
participate in the study, which was approved by the Loughborough University ethical 
advisory committee. Prior to the start of the study, participants completed a health screening 
questionnaire. Subjects could be included if they were between 18 and 35 years of age, 
currently healthy and without URS or use of any medication during the past four weeks. 
Exclusion criteria were: smoking, suffering from, or with a history of, cardiac, hepatic, 
pulmonary, renal, neurological, haematological, psychiatric or gastrointestinal illness, or 
haematological values (leukocyte and erythrocyte counts) outside the normal range. Baseline 
characteristics were as follows (mean ± SD): age 21 ± 1 years, body mass 73.6 ± 7.7 kg, 
height 1.77 ± 0.07 m, ?̇?O2max 57.6 ± 6.1 ml/kg/min.      
6.3.2 Laboratory visits 
On the first laboratory visit, 1-2 weeks prior to the first experimental trial, subjects completed 
a continuous, incremental exercise test to volitional exhaustion for determination of V̇O2max, 
as previously described. The work rate corresponding to 60% V̇O2maxwas then calculated 
from the V̇O2– work rate relationship using a linear equation. After a 15-minute recovery, 
participants cycled for 20 min at a steady-state work rate equivalent to 60% V̇O2max with 
expired gas samples collected after 5, 15 and 20 min in order to familiarize the subjects with 
the exercise protocol for subsequent trials, and to ensure that the calculated work rate elicited 
the desired relative exercise intensity. The final three days prior to commencing the first 
experimental trial, participants attended the laboratory in the morning following an overnight 
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fast. On each occasion nude body mass was measured, and the average of these taken as 
baseline euhydrated body mass.    
For each experimental trial, subjects arrived at the laboratory at 08:00 following an overnight 
fast of at least 10 h. All trials were completed at the same time of day to reduce inter-trial 
effects of diurnal variations in cytokine production and plasma cortisol (Kanaley et al., 2001, 
Petrovsky et al., 1998). Subjects were requested to refrain from strenuous exercise and, in an 
effort to standardize their nutritional status, asked to record and replicate as closely as 
possible their dietary intake during the 24 h leading up to each trial, and instructed to refrain 
from foods with a high water-content. The two trials were conducted in a randomized and 
counterbalanced order, and separated by six or seven days. For the dehydrated trial (DH), 
fluid intake was restricted to 500 mL of water during the 24-h period prior to the start of the 
trial, and no fluid was ingested in the morning before or during the exercise test. In the 
euhydrated trial (EU), subjects were asked to drink normally in the 24 h leading up to the trial 
and to consume 500 mL of water in the morning 1-2 h before the start of exercise test to 
ensure adequate hydration. In the EU trial subjects were also provided with 250 mL of water 
every 20 min during exercise to offset fluid losses through sweating. Before each trial, 
subjects provided a first pass morning urine sample. The exercise protocol was identical for 
both trials. 
Prior to the start of exercise, subjects voided and nude body mass was recorded. After sitting 
quietly for 10 min, an initial resting blood sample was obtained. Subjects then cycled for 120 
min at 60 % V̇O2max on a stationary cycle ergometer in a laboratory maintained at 21 ± 1ºC. 
Expired gas was collected after 15, 45, 75 and 105 min of exercise to determine V̇O2. Heart 
rate was measured using short-range telemetry (Polar, Finland) at 15-minute intervals. 
Immediately after completion of exercise, blood and urine samples were collected, and body 
mass measured before participants were provided with 500 mL of water. Subjects then sat 
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quietly for 120 min, before providing a final blood sample. Urine osmolality before and after 
exercise was determined via freezing-point depression using a single-sample osmometer 
(Osmomat 030, Gonotec, Berlin, Germany). 
6.3.3 Blood sampling and analyses 
Blood samples were collected at rest immediately before the start of exercise (t0), 
immediately after cessation of exercise (t120), and after a 2-hour recovery period (t240). 
Haematological variables, plasma concentrations of cortisol and antigen-stimulated cytokine 
production were determined as previously outlined. Haematocrit and Haemoglobin values 
were used to calculate changes in plasma volume using the equations of Dill & Costill 
(1974). 
6.3.4 Statistical Analysis 
Data are presented as Mean ± SD. Statistical analyses were performed using IBM SPSS 
Statistics 19. Changes in total and differential leukocyte counts, plasma cortisol and antigen-
stimulated cytokine production were analysed using a 2-way repeated measures ANOVA with 
trial (DH and EU) and time (pre-exercise, post-exercise and 2 h post-exercise) as factors. 
Although ANOVA are generally considered robust to minor violations of normality (Maxwell 
and Delaney, 2004), cytokine data that were found to be significantly non-normal were 
transformed to normality using a log transformation prior to analysis. The statistical analysis 
and calculation of summary statistics was subsequently carried out on the transformed data 
with summary statistics transformed back to the original scale for presentation as geometric 
means with 95% CIs. A Bonferroni adjustment was used to correct for multiple comparisons. 
Between-trial differences in mean heart rate, RPE and % ?̇? O2max during exercise were 
determined using a paired samples t-test. Significance was accepted at the p<0.05 level. 
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6.4 RESULTS 
 
Compared to baseline euhydrated body mass, fluid restriction in the DH trial resulted in body 
mass loss of 1.3 ± 0.7% and 3.9 ± 1.0% before and after exercise, respectively, compared to 
+0.2% ± 0.6% and -1.1 ± 0.5% before and after exercise in EU. Urine osmolality decreased 
following exercise and was significantly (P<0.01) higher in DH compared to EU at both time 
points (972 ± 134 vs. 707 ± 229 mOsm/kg, and 933 ± 138 vs. 555 ± 254 mOsm/kg at pre- and 
post-exercise, respectively). Subjects cycled at an average power output of 175 ± 22 W for the 
2-h exercise period. This elicited an exercise V̇O2 of 60 ± 4 % V̇O2max, which did not differ 
significantly between trials. Mean heart rate was significantly (P<0.001) lower during exercise 
in EU than DH (154 ± 10 bpm vs. 161 ± 10 bpm). Similarly, RPE was significantly lower for 
EU than DH (13 ± 2 vs. 14 ± 3, P<0.01).  
Red blood cell concentration, haematocrit and haemoglobin concentration were all 
significantly higher post-exercise and at 2 h post-exercise (Table 6.1). The post-exercise 
increase in haemoglobin was significantly higher in DH than EU. Plasma volume was 
significantly reduced both immediately post and 2 h post-exercise, but did not significantly 
differ between trials. Nor did adjusting for plasma volume change the outcomes of statistical 
tests, and hence the data presented are uncorrected values. Analyses of leukocyte counts 
demonstrated a significant main effect of time for total and differential leukocytes, with no 
significant difference between trials. Under both conditions, exercise resulted in a significant 
increase in total leukocytes, neutrophils and monocytes above baseline, which persisted during 
the 2-h period of recovery (Figure 6.1). Lymphocytes also increased significantly immediately 
following exercise, before dropping below baseline after 2 h. Plasma cortisol was significantly 
elevated by approximately 22 % post-exercise in both trials, with no difference between trials. 
Figure 6.2 shows plasma cortisol concentration pre-, post- and 2 h post-exercise. 
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Table 6.1: Haematological variables pre-, post- and 2 h post-exercise in euhydrated and 
dehydrated trials 
 
Data are Mean (SD) * Indicates significant difference from pre-exercise (P<0.001); † 
Indicates significant interaction effect (Trial*Time) (P<0.05).  
RBC: Red blood cells; Hct: Haematocrit; Hb: Haemoglobin.  
 
Stimulation with antigens resulted in significantly higher levels of all measured cytokines 
compared to unstimulated samples. Cytokine concentrations following stimulation are 
presented in Table 6.2. IL-6 production was significantly (P=0.010) reduced 2 h post-
exercise (Figure 6.3). IL-10 production also showed a main effect of time (P=0.023) with 
higher production immediately post-exercise. Although not quite reaching statistical 
significance, antigen-stimulated IFN-γ and IL-2 release tended (0.05<P<0.10) to decrease 
following exercise (Table 6.2). IL-1β and IL-1α production were not significantly altered by 
exercise. No significant effect of hydration status was observed for any of the measured 
cytokines.  
 
 
    Pre-exercise Post-exercise 2h post-exercise 
RBC (x 1012/L) 
EU 4.76 (0.35) 4.95 (0.36) * 4.96 (0.44) * 
DH 4.83 (0.40) 5.10  (0.40) * 4.95 (0.48) * 
Hct (%) 
EU 45.9 (3.2) 47.8 (3.6) * 47.4 (4.4) * 
DH 46.8 (3.0) 49.6 (4.1) * 47.9 (3.5) * 
Hb (g/dL) 
EU 15.7 (0.7) 16.4 (0.7) * 16.3 (1.1) * 
DH 15.9 (1.0) 16.9 (1.2) *† 16.3 (1.1) * 
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Figure 6.1: Total leukocyte, neutrophil, lymphocyte and monocyte counts before, 
immediately after and after 2 h recovery following 2 h cycling exercise in euhydrated 
(EU; filled circles) and dehydrated (DH; open circles) trials.  
Data are Mean ± SD. * Indicates significant difference for both trials from pre-exercise 
(P<0.05).  
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Figure 6.2: Plasma cortisol concentration before, after and after 2 h recovery following 
2 h cycling exercise in euhydrated (EU; filled circles) and dehydrated (DH; open circles) 
trials. Data are presented as Mean ± SD. * Indicates significant difference for both trials 
from pre-exercise (P<0.001).  
 
 
Figure 6.3: IL-6 production by antigen-stimulated whole blood culture pre-, post- and 2 
h post-exercise in euhydrated (EU; filled bars) and dehydrated (DH; open bars).  
Data are geometric mean with 95% CI. * Indicates significant difference for both trials from 
pre -exercise (P=0.01).  
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Table 6.2: 24-h cytokine production in response to in vitro antigen stimulation of whole blood collected pre-, post- and 2 h post-exercise 
in euhydrated and dehydrated trials.  
Data are presented as geometric means (95% CI).  
 
Euhydrated Trial Dehydrated Trial 
Statistics 
 
Pre-exercise Post-exercise 2h Post-exercise Pre-exercise Post-exercise 2h Post-exercise 
IL-1α 
(pg/ml) 
0.40 (0.11-0.76) 0.22 (0.07-0.38) 0.25 (0.01-0.56) 0.27 (0.02-0.56) 0.22 (0.08-0.38) 0.19 (0.07-0.32) 
 
IL-1β 
(pg/ml) 
1.80 (0.78-3.42) 2.50 (1.35-4.21) 1.81 (1.12-2.71) 1.95 (0.74-4.02) 1.73 (0.63-3.59) 1.38 (0.53-2.69) 
 
IL-2 
(pg/ml) 
8.01 (2.45-22.5) 6.93 (2.44-17.3) 4.80 (1.82-10.9) 5.56 (1.37-17.2) 4.31 (1.19-11.9) 3.23 (1.16-7.30) 
 
IL-4 
(pg/ml) 
0.65 (0.16-1.14) 0.73 (0.34-1.11) 0.86 (0.27-1.44) 0.58 (0.25-0.92) 0.68 (0.32-1.04) 0.55 (0.31-0.79) 
 
IL6 
(pg/ml) 
9.45 (3.47-23.5) 10.8 (4.80-22.8) 4.24 (1.70-9.16) 8.54 (3.04-21.5) 8.81 (3.13-22.3) 4.05 (1.22-10.47) 
Main effect of time F(1.93)=5.840, p=0.010 
Observed power= 0.801 
IL-10 
(pg/ml) 
0.43 (0.09-0.88) 0.77 (0.57-1.01) 0.42 (0.16-0.73) 0.40 (0.11-0.78) 0.59 (0.34-0.90) 0.38 (0.15-0.66) 
Main effect of time F(2)=4.495,  p=0.023 
Observed power= 0.707 
IFN-γ 
(pg/ml) 
0.76 (0.18-1.63) 0.58 (0.17-1.14) 0.48 (0.02-1.13) 0.87 (0.26-1.79) 0.45 (0.05-1.00) 0.52 (0.16-1.00) 
 
TNF-α 
(pg/ml) 
2.68 (1.04-5.62) 2.24 (1.38-3.43) 2.40 (1.17-4.32) 2.36 (0.77-5.36) 2.12 (0.78-4.49) 1.95 (0.80-3.83) 
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6.5 DISCUSSION 
 
The main findings of the current study are that moderate hypohydration equivalent to ≤4% 
body mass loss does not appear to influence resting or exercise-induced changes in plasma 
cortisol, total and differential leukocyte counts or antigen-stimulated cytokine production. 
However, they do provide evidence that prolonged exercise may up-regulate the production 
of IL-10 in response to antigen challenge, while inhibiting the production of IL-6 during 
recovery from a single bout of endurance exercise. Although there was also a consistent trend 
for suppressed type 1 cytokine production following exercise, due to large individual 
variations these changes did not quite reach statistical significance.  
An enhanced anti-inflammatory response to antigen challenge, as evidenced by potentiated 
IL-10 production post- exercise, indicates a shift in the type 1/type 2 cytokine balance 
towards type 2.  This corresponds with previous studies that have reported exercise-induced 
changes in T cell number and function resulting in a relatively type 2 dominant cytokine 
profile (Ibfelt et al., 2002, Lancaster et al., 2005b, Steensberg et al., 2001, Lancaster et al., 
2004). However, contrary to the current findings, these studies observed that this shift was 
primarily due to a reduction in type 1 cytokine production, with no significant change in the 
production of type 2 cytokines. Although evidence indicates that intracellular expression of 
IL-4 in both unstimulated and stimulated cultures is increased in certain cell subsets 
following exercise (LaVoy et al., 2013, Zaldivar et al., 2006) other studies have found that 
acute endurance exercise has little or no effect on IL-4 release in response to mitogen 
stimulation (Lancaster et al., 2004, Lancaster et al., 2005b), while inducing a temporal 
suppression of type 1 cytokine production, specifically IFN-γ (Lancaster et al., 2004, Baum et 
al., 1997, Starkie et al., 2001, Weinstock et al., 1997), IL-2 (Weinstock et al., 1997, Starkie et 
al., 2001, Lewicki et al., 1988), and TNF-α (Baum et al., 1997, Weinstock et al., 1997, 
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Drenth et al., 1995, Kvernmo et al., 1992, Smits et al., 1998, Starkie et al., 2000). To the 
authors’ knowledge, only two previous studies have investigated the acute exercise effects on 
IL-10 release in humans in response to stimulation. In line with our results, a recent study by 
LaVoy and colleagues (2013) reported significantly increased intracellular expression of IL-
10 in CD27-CD8+ T-cells in response to phytohemaglutinin 1 h after a 40-km cycling time-
trial. Conversely, Smits et al. (Smits et al., 1998) reported suppressed in vitro IL-10 
production in response to LPS following 15-20 min of rowing to volitional exhaustion in 
competitive oarsmen. Although these results appear contrary to those of the current study, it 
is difficult to draw direct comparisons due to dissimilarities in the training status of 
participants, exercise mode, intensity and duration. Furthermore, the primary cellular source 
of IL-10 is the lymphocyte, particularly the Treg cell subset. LPS-stimulation primarily 
activates monocytes, with any lymphocyte response being highly monocyte dependent. The 
pattern of IL-10 release elicited by LPS will therefore likely differ somewhat from that 
induced by antigen-stimulation. Van der Poll et al. (van der Poll et al., 1996) found that prior 
exposure to adrenaline potentiates LPS-induced IL-10 production in humans, both in vivo and 
in vitro, and, alongside the anti-inflammatory effects of elevations in plasma cortisol, may 
provide a plausible mechanism through which acute exercise augments IL-10 release.  
Type 1 cytokines promote cellular immunity by stimulating the functional activity of T 
cytotoxic cells, NK cells and activated macrophages (Gleeson et al., 2013b). A shift towards 
a more type 2 dominant cytokine response as seen in the current study will likely compromise 
cellular immunity while temporarily enhancing humoral immunity, particularly because the 
two are mutually inhibitory. Dysregulation of the type 1/type 2 cytokine balance has been 
associated with susceptibility to infectious disease (Lucey et al., 1996). Viral infection 
generally leads to a predominantly type 1 cytokine response (Mosmann and Coffman, 1989). 
Pitkaranta et al. (1999) found that lower virus-induced IFN-γ production in vitro was 
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associated with frequently recurring respiratory infections in children, whereas blocking of 
Type 2 cytokine expression via prior administration of antibodies to IL-10 and IL-4 reduces 
symptom severity following respiratory syncytial virus infection (Connors et al., 1994, Tang 
and Graham, 1994). Similarly, URS risk in athletes is associated with increased antigen-
stimulated IL-10 production at rest (Gleeson et al., 2012). Hence, a lower type 1/type 2 
cytokine ratio in response to immune challenge may compromise host defence against 
respiratory infections.   
Another interesting finding of the current study is that antigen-stimulated IL-6 production 
was inhibited 2 h post-exercise. It is well recognised that IL-6 is released from contracting 
skeletal muscle resulting in elevated plasma concentrations following exercise (Ostrowski et 
al., 1998, Steensberg et al., 2000). However, the results of the current study indicate that the 
capacity of immune cells to produce IL-6 in response to antigen challenge is inhibited 
following prolonged exercise.  The results of previous studies investigating changes in 
stimulated IL-6 release following endurance exercise are inconsistent. Smits et al. (1998) 
reported suppressed post-exercise IL-6 production in response to in vitro stimulation with 
LPS. Weinstock et al. (1997) found that although total LPS-induced IL-6 release appeared 
unchanged by exercise, when corrected for the number of monocytes in the culture, IL-6 
production per cell was significantly lower compared with pre-exercise. However, Baum et 
al. (1997) found no significant changes in IL-6 production from whole blood cultured with 
LPS, and Starkie et al. (2000) reported no exercise-induced changes in IL-6 production from 
monocytes, although it is worth noting that the exercise protocol used in that study was not of 
sufficient intensity to stimulate an increase in plasma cortisol. Haahr et al. (1991) reported an 
increase in IL-6 production 2 h post-exercise in response to incubation of PBMCs with LPS. 
These inconsistencies can likely be explained by variations in exercise protocols and training 
status of participants, as well as the immunological stimulant, duration of cell culture (Reddy 
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et al., 2004) and culture technique used (e.g. PBMCs vs. whole blood culture).  Well-
regulated cytokine responses are critical for host defence (Cross et al., 1995), and IL-6 plays 
a key multifunctional role in orchestrating the acute phase reaction and various immune 
responses (Kopf et al., 1994), eliciting both pro- and anti-inflammatory effects (Xing et al., 
1998). The observed exercise-induced inhibition of IL-6, coupled with an enhanced anti-
inflammatory cytokine response, may therefore be indicative of somewhat compromised 
host-defence to viral infection.  
It is well-documented that prolonged exercise results in changes in the total and differential 
numbers of circulating leukocytes along with changes in lymphocyte subsets (Ricken et al., 
1990, Shek et al., 1995). Depending on the cytokine and its principal cellular source, shifts in 
cell numbers will have clear implications for total cytokine production. However, a weakness 
of the current study was that, since the principal cellular source of IL-10 and IL-6 in antigen-
stimulated culture is not known, it was not possible to correct absolute production for such 
changes. As well as major cell types, shifts in circulating cell (e.g. lymphocyte) subsets with 
exercise (Ricken et al., 1990) may also have contributed towards changes in total cytokine 
production, as it is well-established that different subsets also vary in their proclivity to 
secrete different cytokines (Street and Mosmann, 1991). 
The observed changes in cytokine production can likely in part be explained by the exercise-
induced elevation in plasma cortisol. A glucocorticoid released from the adrenal cortex in 
response to stress, cortisol has immunosuppressive and anti-inflammatory effects (Auphan et 
al., 1995), acting to mediate the recovery from immune activation early in the stress response, 
thus preventing an “overshoot” of the immune reaction (Sorrells and Sapolsky, 2007). 
Cortisol acts to suppress the production of pro-inflammatory cytokines (Petrovsky et al., 
1998), as well as up-regulate the expression of certain anti-inflammatory cytokines (Elenkov 
and Chrousos, 2002), thus functioning as a negative feedback mechanism protecting against 
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excessive inflammation. Studies on the effect of elevated plasma cortisol on stimulated 
cytokine production are somewhat inconsistent. However, elevations in plasma cortisol 
within the physiological range, such as achieved during strenuous exercise, appear to 
suppress LPS-induced TNF-α, IL-1β and IFN-γ production, but interestingly not IL-6 
production (Petrovsky et al., 1998, DeRijk et al., 1997). In the current study there was no 
effect of fluid restriction on plasma cortisol. This is somewhat unexpected as heart rate and 
RPE data suggest that exercise in DH was more physiologically stressful than in the EU 
condition. Bishop et al. (2004) found that fluid ingestion during prolonged exercise 
attenuated the cortisol response. Mitchell et al. (2002), on the other hand, found that although 
hypohydration resulted in elevated plasma cortisol when exercise was performed in the heat, 
there was no effect of hydration status on cortisol concentration, total or differential 
leukocyte numbers or lymphocyte function when exercising in temperate ambient conditions. 
The relatively modest level of hypohydration induced in the current study appeared 
insufficient to influence the plasma cortisol response to exercise at 21ºC, and subsequently 
had no significant effect on the measured immune variables. Although it was beyond the 
scope of the current study to measure multiple hormones, it is worth noting that, in addition 
to cortisol, several other hormones known to increase with exercise also have 
immunomodulatory effects, notably adrenaline, noradrenaline, growth hormone and prolactin 
(Pedersen and Hoffman-Goetz, 2000).  
Induction of cytokine production by antigen challenge proceeds with a slower kinetic than 
that associated with powerful T-cell mitogens used in a number of previous studies, and 
induces lymphocyte responses more directly than LPS challenge. A strength of the current 
study is that the cytokine response to the multi-antigen vaccine used as stimulant can be 
considered closer to the natural response to such opportunistic infections as may be 
encountered during the recovery from exercise. It is acknowledged that measuring cytokine 
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production from whole blood culture rather than a known number of PBMCs may be 
confounded by changes in numbers and proportions of circulating lymphocytes and 
monocytes with exercise. However, a disadvantage of isolating PBMCs is that this insulates 
the cells from the influence of other cells, hormones and cytokines, while whole blood culture 
more closely replicates the natural milieu. Although changes in leukocyte subsets with 
exercise will alter the number of cells in whole blood culture and thereby influence total 
cytokine production, changes in absolute cytokine production in response to an immune 
challenge are likely to have implications for disease susceptibility, regardless of the 
underlying mechanism. A weakness of the current study is that very large individual 
variations in cytokine responses, although perhaps an interesting finding in itself, somewhat 
limit the interpretation of results. Future studies examining cytokine responses to antigen-
challenge may benefit from larger sample sizes in order to improve statistical power. 
6.6 CONCLUSION 
 
Contrary to our hypothesis, moderate hypohydration elicited by a 24-h fluid restriction 
protocol does not appear to influence plasma cortisol levels, or exacerbate exercise-induced 
immune disturbances. However, the effects of more severe levels of hypohydration on such 
immune markers remain unclear. The current study does, however, provide further evidence 
of a temporal shift towards a more type 2 dominant cytokine response to immune challenge, 
perhaps indicative of compromised host-defence to viral infection following prolonged 
exercise. Although the clinical significance of the magnitude of changes observed are not 
clear, these results may further contribute towards explaining the apparent “open-window” of 
infection that is evident during short-term recovery from endurance exercise.   
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7.1 ABSTRACT 
 
PURPOSE: To determine how immune markers are affected by acute exercise in normoxia 
and hypobaric hypoxia equivalent to 2000 m above sea-level (masl). METHODS: twelve 
males (28 ± 4 years, ?̇?O2max 63.7 ± 5.3 mL/kg/min) cycled for 75 min at 70% altitude-
specific ?̇?O2max, once in normoxia (N) and once in hypoxia (H). Blood and saliva samples 
were collected pre-, post- and 2h post-exercise. RESULTS: Participants cycled at 10.5% 
lower power output in H vs. N, with no differences in heart rate, blood lactate or RPE. Post-
exercise plasma cortisol was higher in H vs. N (683 (95% CI 576-810) nmol/l vs. 549 (469-
643) nmol/l, P<0.05), with no differences 2 hr post-exercise. There were no between-trial 
differences for ACTH, plasma cytokines or antigen-stimulated cytokine production. The 
exercise-induced decrease in CD4:CD8 ratio was greater in H vs. N (-0.5 ± 0.2 vs. -0.3 ± 0.2, 
P<0.05). There were no between-trial differences for salivary IgA or lactoferrin. However, 
there was a main trial effect for concentration (F(11)=5.99, P<0.05) and secretion 
(F(11)=5.01, P<0.05) of salivary lysozyme, with this being higher in N at every time-point. 
CONCLUSION: The observed differences are unlikely of sufficient magnitude to 
meaningfully impair host defence, particularly as they are transient in nature and since the 
other measured immune markers are unaffected by hypoxia when exercising at the same 
relative intensity.  
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7.2 INTRODUCTION 
 
Hypoxic training is routinely used by competitive endurance athletes, both to improve 
exercise performance at sea level (Levine and StrayGundersen, 1997, Stray-Gundersen et al., 
2001) and to acclimatise prior to competition at altitude (Fulco et al., 2000). However, both 
anecdotal evidence from athletes and coaches, and scientific literature point towards an 
increased incidence of opportunistic infectious illness during and immediately following a 
period of altitude training (Bailey et al., 1998). Exercise in hypoxic conditions typically 
causes greater physiological stress than exercise at sea level (Bailey and Davies, 1997). 
Taking into account this augmented stress response to exercise, coupled with reports of 
increased resting levels of adrenaline, cortisol and interleukin-6 at high altitude (Mazzeo et 
al., 2001) it is not altogether surprising that both acute and chronic hypoxic training have 
been found to impact negatively on mucosal (Tiollier et al., 2005) and cell-mediated 
immunity (Facco et al., 2005, Oliver et al., 2013, Pyne et al., 2000). However, it is still 
unclear how many aspects of immune function respond to hypoxic exercise, and particularly 
to the types of exercise and levels of hypoxia that athletes are typically exposed to during 
training or competition at altitude. Furthermore, it is well known that ?̇?O2max is reduced at 
altitude, with the magnitude of this reduction being proportional to the level of hypoxia 
(Ferretti et al., 1997). Some previous studies that have investigated differences in immune 
responses to an acute bout of exercise performed in normoxic and hypoxic conditions have 
matched trials based on absolute workload, such as a specific running speed or power output 
(Mazzeo et al., 2001, Klokker et al., 1995). However, because of the reduction in ?̇?O2max, the 
same absolute workload performed in hypoxic conditions will result in higher relative 
exercise intensity (%?̇?O2max). To determine whether the differences in responses observed are 
due to hypoxia per se, rather than this increase in relative exercise intensity, it is useful to 
instead match trials based on a fraction of altitude-specific ?̇?O2max. This is also of greater 
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relevance to endurance athlete populations, since they will typically train and compete at a 
similar relative exercise intensity at altitude as when they are at sea level. The aim of this 
study was therefore to determine how markers of systemic and mucosal immunity are 
affected by an acute bout of endurance exercise in hypoxic conditions equivalent to 2000 
masl, compared to exercising at the same relative intensity in normoxia. 
7.3 METHODS 
 
7.3.1 Participants 
Twelve healthy, physically active males volunteered their written, informed consent to take 
part in the study (mean (±SD) age: 28 ± 4 years, body mass 79.1 ± 5.9 kg, ?̇?O2max 63.7 ± 5.3 
mL/kg/min, 5.06 ± 0.45 L/min), which was approved by the regional ethics committee of 
southern Norway. All participants were engaged in regular endurance training at least three 
times per week. Prior to the start of the study, participants completed a health-screening 
questionnaire. Participants could be included if they were between 18 and 40 years of age, 
participating in regular endurance exercise and currently healthy and without URS or use of 
any medication during the past four weeks. Exclusion criteria were smoking, suffering from, 
or with a history of, cardiac, hepatic, pulmonary, renal, neurological, haematological, 
psychiatric, or gastrointestinal illness, or exposure to natural or simulated altitude (equivalent 
to ≥1,000 m above sea level) during the past eight weeks.  
7.3.2 Laboratory visits 
On the first laboratory visit, 1-2 weeks prior to the first experimental trial, participants 
completed a continuous, incremental exercise test to volitional exhaustion at sea level for 
determination of   ?̇?O2max as previously described.. The work rate corresponding to 70% 
?̇?O2max was then calculated from the ?̇?O2-work rate relationship using a linear equation. The 
same relative workload for the hypoxic trial was calculated using the same linear equation 
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and based on previous tests in the recompression chamber showing that ?̇?O2max decreases by, 
on average, 10.4 % in hypobaric hypoxia equivalent to 2000 masl (unpublished data).  For 
both main experimental trials, participants arrived at the laboratory at 07:45 am following an 
overnight fast of at least 10 h, and having abstained from caffeine for a minimum of 12 h. 
Participants were also required to abstain from alcohol or strenuous exercise for at least 24 h 
before each trial and, in an effort to standardize nutritional status, asked to record and 
replicate as closely as possible their dietary intake the day before. For both trials, participants 
completed a standardised 10 minute warm-up at 55% of altitude specific ?̇?O2max, followed by 
75 min at 70% altitude specific ?̇?O2max, on an electromagnetically braked cycle ergometer 
(Lode Excalibur Sport, Groningen, Netherlands) inside a recompression chamber (Norsk 
undervannsteknikk A/S, Haugesund, Norway). Following the exercise bout, participants 
remained inside the recompression chamber for a 2 h resting recovery. During the normoxic 
trial (N), the recompression chamber was switched off, and the doors remained open. During 
the hypoxic trial (H), the pressure was adjusted to 800 mbar (equivalent to 2000 masl at 
17ºC). Oxygen and carbon dioxide levels inside the chamber were continuously monitored 
throughout the trials. Carbon dioxide build up was controlled via three CO2 scrubbers 
containing soda lime, and oxygen was supplied continuously at a rate sufficient to maintain 
normal ambient composition (~20.9% O2, ~0.04% CO2).  To confirm that the same relative 
exercise was achieved in both trials, heart rate was measured continuously via short range 
telemetry (RCX3, Polar, Kempele, Finland), RPE was recorded every 10 min, and blood 
lactate concentration was measured from a finger prick blood sample using a portable blood 
lactate analyser (Lactate Pro LT-1710, Arkray, Kyoto, Japan) every 20 min during exercise.   
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7.3.3 Saliva sampling and analyses 
Saliva samples were collected at rest immediately before entry into the recompression 
chamber, immediately after cessation of exercise, and after a 2 h recovery period and 
analysed to determine concentrations and secretion rates of S-IgA, lysozyme and lactoferrin, 
as previously described.  
7.3.4 Blood sampling & analyses 
Blood samples were collected at the same time points as saliva, and analysed to determine 
plasma concentrations of cortisol, ACTH and cytokines (IFN-𝛾, TNF-𝛼, IL-1𝛼, IL-1𝛽, IL-2, 
IL-4, and IL-10) as well as antigen-stimulated cytokine production by whole-blood culture, as 
previously described.   For a subset of 8 participants, fluorescent-conjugated monoclonal 
antibodies were used to identify CD4+ CD25+ CD127low/- (Treg), CD3+CD4+ (T helper) 
and CD3+CD8+ (T suppressor) cells via four colour flow-cytometry as previously described.  
7.3.5 Statistical analyses 
Data are presented as means ± SD unless otherwise stated. All statistical analyses were 
performed using IBM SPSS Statistics 22.0. The Shapiro–Wilk test was used to determine 
whether data were normally distributed. A two-way repeated measures ANOVA was used to 
determine whether there were significant differences between H and N pre-, post- and 2h 
post-exercise. A post hoc test with Bonferroni correction for multiple comparisons was used 
to determine the location of variance. Variables found to be significantly non-normal were 
log transformed to normality prior to analysis (Box & Cox, 1964), and are presented as back-
transformed geometric mean with 95% CI. Based on the results of Mauchly’s sphericity test, 
Greenhouse-Geisser corrections were applied for epsilon <0.75 and Huynd-Feldt corrections 
applied for epsilon >0.75 where violations of sphericity were identified. Statistical 
significance was accepted at the P<0.05 level.  
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7.4 RESULTS 
 
On average, participants cycled at 10.5% lower power output in H compared to N (191 ± 26 
W vs. 213 ± 30 W). There were no significant differences in heart rate (N: 157 ± 11 vs. H: 
156 ± 12 bpm), blood lactate concentration (N: 3.1 ± 1.5 vs. H: 3.2 ± 1.7 mmol/L) or RPE 
(N: 15 ± 1 vs. H: 15 ± 1) between trials.  
7.4.1 Plasma cytokines, ACTH and cortisol  
In both trials, plasma cortisol and ACTH concentrations were significantly lower 2 h post 
exercise compared to pre-exercise and immediately post-exercise (Figure 7.1). Plasma 
cortisol immediately post-exercise was significantly higher in H compared to N. There were 
no significant differences between trials at any time point for plasma ACTH.  Table 7.1 
shows plasma cytokine concentrations before, immediately after and 2 h after exercise in 
normoxic and hypoxic conditions. There were no significant differences between trials at any 
time point for any of the measured cytokines. However, plasma IL-6, IL-8 and MCP1 
concentrations were significantly elevated post and 2 h post exercise in both H and N, with 
only IL-6 remaining elevated at 2 h post-exercise. Plasma VEGF was significantly reduced 
immediately post exercise in both conditions, before returning to baseline 2 h post exercise. 
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Figure 7.1: Plasma cortisol and ACTH before, immediately after, and 2 h after 
cycling exercise in normoxia and hypoxia.  
Data are geometric mean ± 95% CI. *significantly different from normoxia, (P<0.05). 
#Both trials significantly different from pre-exercise and post-exercise (P<0.01) 
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Table 7.1: Plasma cytokine concentrations before, immediately after and 2 h after 
exercise in normoxic and hypoxic conditions. 
 PRE POST 2 h POST 
IL-1a (pg/ml) 
Normoxia 0.30 (0.17-0.42) 0.25 (0.15-0.36) 0.26 (0.17-0.36) 
Hypoxia 0.29 (0.21-0.37) 0.31 (0.22-0.41) 0.37 (0.17-0.36) 
IL-6 (pg/ml) 
Normoxia 0.70 (0.58-0.85) 2.71 (2.11-3.49)# 1.10 (0.85-1.44)#† 
Hypoxia 0.70 (0.55-0.88) 2.53 (2.00-3.20)# 1.09 (0.83-1.41)#† 
IL-8 (pg/ml) 
Normoxia 2.26 (1.90-2.62) 3.47 (2.90-4.04)# 2.71 (2.10-3.33)† 
Hypoxia 2.19 (1.84-2.55) 3.31 (2.53-4.09)# 2.71 (2.01-3.40)† 
IL-10 (pg/ml) 
Normoxia 1.10 (0.84-1.44) 1.50 (1.10-2.11) 1.10 (0.89-1.35)† 
Hypoxia 0.69 (0.39-1.16) 1.55 (1.12-2.21) 1.10 (0.82-1.49)† 
TNFα (pg/ml) 
Normoxia 2.44 (1.99-2.88) 2.44 (2.09-2.80) 2.24 (1.86-2.62) 
Hypoxia 2.18 (1.88-2.48) 2.27 (1.99-2.55) 2.48 (1.98-2.48) 
 EGF (pg/ml) 
Normoxia 11.3 (8.9-14.0) 17.4 (12.1-23.8) 17.9 (13.5-22.9) 
Hypoxia 12.7 (8.9-17.2) 16.3 (10.1-23.9) 11.6 (7.2-16.9) 
 VEGF (pg/ml) 
Normoxia 14.7 (12.2-17.8) 11.5 (8.8-15.0)# 14.9 (11.5-19.3)† 
Hypoxia 13.3 (10.3-17.3) 12.0 (9.0-16.0)# 14.1 (11.4-17.4)† 
MCP1 (pg/ml) 
Normoxia 107 (93-120) 124 (111-137)# 105 (93-117)† 
Hypoxia 103 (92-113) 121 (108-135)# 111 (94-127)† 
 
Values are mean (95% CI). #significantly different from pre-exercise (P<0.01). †significantly 
different from post-exercise (P<0.01).  
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Figure 7.2: Pro-inflammatory cytokine production by whole blood culture in 
response to a multi-antigen challenge.  
IL-2: interleukin 2; IL-1: interleukin 1 (α+β); IFNγ: Interferon gamma; TNFα: Tumour 
necrosis factor alpha. Data are mean ±SD. # significant main effect of time for TNFα and 
IL-1 (P<0.05).  
 
NB: ANOVA were run for each cytokine separately, and for total pro-inflammatory 
cytokine production (IL-2+IL-1+IFNγ+TNFα) 
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Figure 7.3: Anti-inflammatory cytokine production by whole blood culture in 
response to a multi-antigen challenge. IL-10: interleukin 10; IL-4: interleukin 4. 
Data are mean ±SD. # significant main effect of time for IL-4 (P<0.01).  
 
NB: ANOVA were run for each cytokine separately, and for total anti-inflammatory 
cytokine production (IL-10+IL-4) 
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7.4.2 Antigen-stimulated cytokine production 
Figure 7.2 and Figure 7.3 show in vivo pro-inflammatory and anti-inflammatory cytokine 
production in whole blood culture in response to a multi-antigen challenge. Production of 
TNFα, IL-1 and IL-4 were significantly reduced 2 h post-exercise. There were no significant 
differences between the two trials.  
 
7.4.3 Salivary AMPs 
There were no significant differences in S-IgA concentration or secretion rate (Table 7.2). 
Both concentration and secretion rates of salivary lysozyme and lactoferrin were significantly 
increased post-exercise, with lactoferrin remaining significantly elevated 2 h post-exercise. 
There was a significant main effect of trial for both concentration (F(11)=5.99, P=0.032) and 
secretion rate (F(11)=5.01, P=0.047) of salivary lysozyme, with this being higher in N at 
every time-point.   
 
7.4.4 Lymphocyte subsets 
Total numbers of circulating lymphocytes, T cells (CD3+), T helper cells (CD3+CD4+) and 
T suppressor cells (CD3+CD8+)  were significantly reduced 2 h Post exercise (Table 7.3). 
The relative number of lymphocytes as a percentage of total leukocytes was also significantly 
reduced post and 2 h post exercise in both trials. There was no change in the absolute or 
relative number of Treg cells. The exercise-induced decrease in CD4:CD8 ratio was 
significantly greater in H compared to N (Figure 7.4) but, in both trials, this returned to 
baseline by 2 h post exercise. There were no significant differences between conditions for 
any of the other variables.  
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Table 7.2 Concentrations and secretion rates of salivary AMPs before, immediately after and 2 h after exercise in normoxia and 
hypobaric hypoxia. 
 
Salivary IgA 
  Concentration (mg/L) 
 
Secretion rate (µg/min)  
 PRE POST 2h POST PRE POST 2h POST  
Normoxia 328 ± 187 290 ± 99 257 ± 82 108 ± 68 96 ± 42 100 ± 52  
Hypoxia 334 ± 212 335 ± 135 228 ± 58 91 ± 51 105 ± 45 88 ± 42   
Salivary Lysozyme 
  Concentration (mg/L) 
Sig. main 
effect of trial 
(P=0.032) 
Secretion rate (µg/min) 
Sig. main 
effect of trial 
(P=0.047) 
 PRE POST 2h POST PRE POST 2h POST 
Normoxia 2.3 ± 1.7 3.2 ± 1.4# 2.3 ± 1.7 0.7 ± 0.5  1.1 ± 0.6# 0.8 ± 0.5 
Hypoxia 1.6 ± 1.4 3.1 ± 1.5# 1.9 ± 1.1 0.4 ± 0.1 1.0 ± 0.6# 0.6 ± 0.3 
Salivary Lactoferrin 
  Concentration (mg/L) 
 
Secretion rate (µg/min)  
 PRE POST 2h POST PRE POST 2h POST  
Normoxia 3.0 ± 1.2 9.5 ± 3.2# 5.5 ± 1.6#† 1.1  ± 1.0 3.5 ± 2.6# 2.2 ± 1.1# 
 
Hypoxia 2.9 ± 1.5 9.5 ± 3.4# 5.3 ± 1.9#† 1.0 ± 1.0 3.0 ± 1.4# 2.2 ± 1.3# 
  
Data are mean ± SD. #significantly different from pre-exercise (P<0.01). †significantly different from post-exercise (P<0.01). 
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Table 7.3: Lymphocyte subsets before, immediately after and 2 h after exercise in normoxic (N) and hypoxic (H) conditions.  
 
Data are mean ± SD. #significantly different from pre-exercise (P<0.05). †significantly different from post-exercise (P<0.05). n=8. *Relative 
numbers of lymphocytes are presented as percentage of total leukocytes, while lymphocyte subsets are presented as percentage of total 
lymphocytes. 
  
Absolute 
(x109 cells/L) 
 Relative* 
(% total leukocytes / lymphocytes) 
  PRE POST 2h POST  PRE POST 2h POST 
Lymphocytes 
N 1.54 ± 0.53 1.59 ± 0.51 1.30 ± 0.46 † 
 32 ± 9 23 ± 6 # 15 ± 7 #† 
H 1.49 ± 0.47 1.75 ± 0.35 1.02 ± 0.27 † 
 32 ± 9 23 ± 6 # 12 ± 7 #† 
T  N 0.79 ± 0.28 0.74 ± 0.24 0.53 ± 0.16 † 
 52 ± 10 48 ± 13 43 ± 15 
(CD3+) H 0.75 ± 0.31 0.81 ± 0.31 0.52 ± 0.12 † 
 50 ± 13 46 ± 12 52 ± 14 
T helper  N 0.46 ± 0.12 0.39 ± 0.10 0.32 ± 0.10 #†  30 ± 5 26 ± 6 27± 11 
(CD3+CD4+) H 0.43 ± 0.15 0.39 ± 0.11 0.31± 0.06 #† 
 29 ± 8 23 ± 7 32 ± 9 
T suppressor  N 0.32 ± 0.18 0.32 ± 0.14 0.20 ± 0.08 † 
 20 ± 8 20 ± 8 16 ± 4 
(CD3+CD8+) H 0.30 ± 0.18 0.38 ± 0.22 0.20 ± 0.08 † 
 19 ± 8 21 ± 9 19 ± 7 
T regulatory  N 0.03 ± 0.02 0.03 ± 0.02 0.02 ± 0.01 
 2.0 ± 0.6 1.7 ± 0.7 1.2 ± 0.5 
(CD4+CD25+CD127-) H 0.03 ± 0.01 0.03 ± 0.01 0.02 ± 0.01 
 2.0 ± 0.5 1.6 ± 0.8 1.8 ± 1.1 
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Figure 7.4: Change in CD4/CD8 ratio from pre- to post-exercise. Bars represent 
group mean, lines represent individual changes. *significant difference from normoxia 
(P<0.05).  
7.5 DISCUSSION 
 
The main finding of the current study is that, despite a somewhat augmented stress response 
as indicated by higher post-exercise plasma cortisol, an acute exercise bout in hypoxic 
conditions equivalent to 2000 masl does not appear to pose any meaningful additional threat 
to immune function compared to exercising at the same relative intensity in normoxia.  
However, previous studies have found that hypoxic exercise at the same absolute exercise 
intensity can exacerbate immune disturbances, highlighting the importance of accurately 
controlling exercise intensity at altitude. Lundby & Steensberg  (2004) found that there was 
no difference in post-exercise plasma IL-6 concentration with either acute or chronic hypoxic 
exposure when participants cycled at the same relative exercise intensity, whilst IL-6 release 
was augmented when exercising at the same absolute intensity. This is in agreement with the 
current study where there was no effect of hypoxia on post-exercise plasma concentrations of 
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IL-6, or any of the other measured cytokines when cycling at 70% of altitude specific ?̇?O2max. 
The comparatively modest difference in post-exercise cortisol of 134 nmol/L may not be of 
sufficient magnitude to influence cytokine production or meaningfully impair host defence, 
particularly since this difference was no longer present following 2 h recovery.  
It is well established that exercise causes changes in circulating lymphocytes subsets, 
including a transient decrease in CD4:CD8 ratio (Fry et al., 1992, Nieman et al., 1991). The 
results of the current study suggest that this exercise-induced decrease is more pronounced 
when exercising in hypoxic conditions, even when relative exercise intensity is the same. 
Although changes in CD4+ and CD8+ T lymphocytes did not reach statistical significance 
when analysed separately, it appears that both hypoxic and normoxic exercise may similarly 
decrease CD4+ cell counts, while only in the hypoxic trial was there also a concurrent 
increase in CD8+ cells. Although plasma catecholamine concentrations were not measured in 
the current study, it is possible to speculate that the greater reduction in CD4:CD8 ratio 
observed in the hypoxic trial may have been due to higher levels of circulating adrenaline. 
Compared to CD4+ cells, CD8+ lymphocytes have more β-adrenergic receptors (Landmann 
et al., 1984, Van Tits et al., 1990) which likely explains the greater mobilization of CD8+ 
cells observed with exercise. Although only speculation, it has been previously shown that 
the catecholamine response in trained individuals is augmented when exercising in hypoxic 
conditions at the same absolute intensity, and to a lesser degree also at the same relative 
intensity (Kjaer et al., 1988). This is supported by the higher post-exercise cortisol observed 
in the hypoxic trial in the current study, since the magnitude of the cortisol response typically 
reflects the magnitude of the catecholamine response. Whatever the underlying mechanism, 
the greater reduction in CD4:CD8 ratio in the hypoxic trial is unlikely to have meaningful 
negative implications for host defence since it appears to be primarily driven by a greater 
increase in circulating CD8+ cells rather than a reduction in CD4+ cells.   
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The observed reductions in TNF-α and IL-1 release in response to antigen challenge 2 h post-
exercise in both trials correspond with previous studies reporting a temporal suppression of 
mitogen- or LPS-stimulated production of type 1 cytokines following prolonged exercise 
(Baum et al., 1997, Drenth et al., 1995, Lewicki et al., 1988, Starkie et al., 2001). Conversely, 
while IL-4 production was also significantly reduced in the current study, previous research 
has found that acute endurance exercise has little or no effect on IL-4 release in response to 
mitogen stimulation (Lancaster et al., 2004, Lancaster et al., 2005b). However, in the current 
study these changes likely primarily reflect changes in the number of responder cells in the 
culture (i.e. changes in circulating leukocyte subsets). This is a weakness of the method used, 
since it does not allow identification of which cells in the culture are producing specific 
cytokines. On the other hand, using viral and/or bacterial antigens to stimulate cytokine 
production in whole blood culture probably most closely represents the natural environment, 
avoiding artefacts from cell isolation and preparation and enabling normal interactions 
between antigens and immune components within the natural hormonal milieu. Furthermore, 
it gives a measure of the total capacity to respond to an immune challenge at that specific 
time-point. The results of the current study indicate that the post-exercise reduction in 
cytokine production is not exacerbated when exercise of the same relative intensity is 
performed in hypoxic conditions.  
Previous research has found that a period of “live high, train low” altitude training impairs 
mucosal immunity (Tiollier et al., 2005). Pilardeau and colleagues (1990) found that saliva 
flow rate was significantly increased when exercising at 4350 masl compared to at sea level, 
while alpha-amylase concentration was unaffected. However, we are not aware of any 
previous studies that have investigated the effects of acute exercise and hypoxia on salivary 
IgA, lysozyme and lactoferrin, which are postulated to play an important role in mucosal 
immunity and first-line defence against invading microbials (Durr et al., 2006, Fahlman and 
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Engels, 2005, Neville et al., 2008, Tenovuo, 1989). Exercise-induced changes in salivary S-
IgA and lactoferrin do not appear to be affected by moderate hypoxia when relative exercise 
intensity is the same. The significant trial effect observed for salivary lysozyme can likely be 
largely explained by higher lysozyme concentration and secretion rate already at baseline in 
the normoxic trial, rather than an effect of hypoxia.  Hence, it does not appear that cycling for 
75 min at 70% ?̇?O2max negatively influences mucosal immunity, regardless of whether 
exercise is performed in normoxic or hypoxic conditions. Indeed, both concentration and 
secretion rates of lysozyme and lactoferrin were increased post exercise in both conditions. 
This corresponds with previous studies which have reported similarly elevated concentrations 
of salivary lysozyme and lactoferrin following intense endurance exercise at sea-level 
(Allgrove et al., 2008, West et al., 2010).  
7.6 CONCLUSION 
 
Despite somewhat higher plasma cortisol and lower CD4:CD8 ratio immediately post-
exercise in the hypoxic trial, these differences are unlikely to be of sufficient magnitude to 
meaningfully impair host defence, particularly since they appear transient in nature and since 
the other measured markers of immunity were unaffected by hypoxia. Hence, exercising at 
the same relative intensity in moderate hypoxia does not appear to exacerbate the exercise-
induced immune disturbances typically seen with endurance exercise at sea level. Since 
previous studies have, however, shown that exercising in hypoxia at the same absolute 
intensity can augment immune disturbances and potentially increase the risk of opportunistic 
infection post exercise, this highlights the importance of athletes adjusting and accurately 
monitoring exercise intensity when training and competing at altitude.  
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8.1 ABSTRACT 
 
PURPOSE: To describe changes in mucosal immunity and sleep in nine world-class male 
cross-country skiers during a 10-day altitude training camp compared to sea-level (SL). 
METHODS: Unstimulated morning saliva samples were collected at SL and on day 1, 3 and 
10 at 2000 m above sea-level for determination of salivary AMPs, cortisol, testosterone and 
osmolality. Sleep was analysed via wristwatch actigraphy. RESULTS: Low-intensity 
endurance training increased by 87% at altitude compared to SL, while high-intensity training 
and resistance training were reduced. Salivary cortisol concentration significantly (P<0.05) 
decreased on day 1 at altitude compared to SL (11 (95% CI 8-13) vs. 18 (13-23) nmol/l. 
Salivary immunoglobulin-A (S-IgA) secretion increased on day 3 compared to SL (157 (92-
238) µg/min vs. 81 (52-118) µg/min) as did LL-37 (cathelicidin) secretion (5.6 (2.5-8.6) vs. 
2.2 (1.2-3.2) ng/min. While at altitude, two athletes experienced upper-respiratory illness 
(URI). These were the only two participants to have a reduction in S-IgA concentration on 
days 1 and 3 at altitude compared to SL. Assumed sleep time was significantly reduced by 
9% at altitude compared to SL, as was sleep efficiency (79.9 ± 4.9% vs. 83.7 ± 7.0%). Day-
to-day changes in sleep variables did not correlate with training load. CONCLUSION: A 10-
day camp at moderate altitude with a high training load does not result in depression of 
mucosal immunity in elite endurance athletes, although both sleep quantity and quality are 
reduced. Monitoring individual changes in S-IgA concentration during the first 3 days at 
altitude could be a useful predictor of URI during altitude training.   
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8.2 INTRODUCTION 
 
Altitude training is a key component of the training process of many of today’s elite 
endurance athletes, used to acclimatise athletes prior to competition at altitude (Fulco et al., 
2000) or to augment red blood cell volume and enhance oxygen transport capacity in an 
attempt to improve endurance performance at sea level (Stray-Gundersen et al., 2001). For 
winter sports athletes, natural altitude also provides the opportunity to train on snow at times 
of year when this is not possible at sea level. Consequently, these athletes typically spend 
between 60 and 100 training days per year at moderate altitude (2000-3000 masl) (Tonnessen 
et al., 2014).  
Although the results of Chapter 7 suggest that a single, acute bout of exercise in hypobaric 
hypoxia equivalent to 2000 masl has limited negative effect on immune function when 
relative exercise intensity is matched, the consequences of a prolonged training camp at 
moderate altitude on immunity are still not fully understood. Some previous evidence 
suggests that altitude training can compromise immunity in well-trained endurance athletes, 
including inhibition of cytokine production and lymphocyte proliferative responses (Pyne et 
al., 2000), and reduced levels of S-IgA (Tiollier et al., 2005). However, no study to date has 
examined the effect of altitude training on other salivary AMPs such as lysozyme and LL-37 
(cathelicidin), which have also been postulated to play an important role in mucosal 
immunity (Bosch et al., 2002, Doss et al., 2010). Furthermore, rather than a “live high, train 
low” protocol, winter sports athletes typically use a “live high, train high, train low” model 
(Saunders et al., 2009), both sleeping and training at elevations of ≥2000 masl. It is possible 
that this might further compound immune disturbances.  
As well as compromised immunity, sleep is adversely affected at altitude (Reite et al., 1975). 
With many key metabolic, immunologic and restorative physiological processes adversely 
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affected by sleep disturbance (Samuels, 2009), reduced sleep quality in athletes while at 
altitude could result in impaired daytime functioning (Van Dongen et al., 2003) and 
inadequate recovery between training sessions, as well as potentially exacerbating 
immunological disturbances (Irwin, 2002). Previous studies have found that the sleep of 
young, elite footballers is disrupted at 3600 masl (Roach et al., 2013, Sargent et al., 2013). 
However, this elevation is more extreme than endurance athletes are exposed to during 
training camps. The effect of a training camp at moderate altitude on the sleep of elite 
endurance athletes has not been fully elucidated, and it is not known whether changes in 
immune variables at altitude might be related to reduced sleep quality.   
While it is seldom feasible to conduct intervention studies with elite athletes, whose careers 
depend on marginal performance gains, descriptive studies provide a viable alternative by 
which to further our understanding of this population. The aims of the current study were 
therefore to describe changes in sleep and mucosal immunity in a cohort of world-class cross-
country skiers during an altitude training camp with a high training load. We also wished to 
determine whether any of these variables might be useful in predicting which athletes 
contract an upper respiratory illness (URI) while at altitude.    
8.3 METHODS 
 
8.3.1 Participants 
Nine elite male cross-country skiers (age: 23 ± 3 years, ?̇?O2max: 82.7 ± 3.9 ml/kg/min, body 
mass: 74.1 ± 3.6 kg, annual training volume: 781 ± 97 h) volunteered their written, informed 
consent to participate in the study, which was approved by the Loughborough University 
ethical review committee. All of the athletes were members of the Norwegian senior or U23 
team for cross-country skiing. All athletes were sea level natives. Two athletes had spent 14 
days at 2000 masl seven weeks prior to the start of the study. None of the other athletes had 
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been exposed to natural or simulated altitude for at least three months prior to the start of the 
study.  
8.3.2 Training at altitude 
All of the athletes attended an 11-day altitude training camp. Athletes resided at 2000 masl 
while typically training two sessions per day; the first session as skiing on the glacier at 2800-
3000 masl, and the second session as dry-land training (roller-skiing or running) at 1000–
2000 masl. Subsequently, each day athletes spent approximately 4 h at 2800-3000 masl, 1-3 h 
at 1000-2000 masl and the remaining 17-19 h at 2000 masl. Athletes wore heart-rate monitors 
during every training session and blood lactate concentration was monitored 2-3 times per 
session during approximately half of the training sessions. Athletes recorded all of their 
training daily in an online training diary, as previously described. Training Impulse (TRIMP) 
(Banister and Calvert, 1980) was calculated using the following formula: TRIMP = Training 
time (min)*Intensity zone. Living and sleeping conditions at altitude were as similar as 
possible to sea level, with all athletes housed in single or twin rooms. 
8.3.3 Illness incidence 
Any illness before, during or after the altitude training camp was also recorded in training 
diaries. Athletes were instructed that even minor symptoms experienced while at altitude 
should be reported to the team physician, to verify whether these were due to infection. 
 8.3.4 Mucosal immunity 
Saliva samples were collected from each athlete at sea level four days prior to departure (SL), 
and on day 1 (following the first night at 2000 masl; A1), day 3 (A3) and day 10 (A10) of the 
altitude training camp for determination of saliva flow rate, osmolality, salivary 
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concentrations of cortisol and testosterone and salivary concentrations and secretion rates of 
S-IgA, Lysozyme and LL-37 (Cathelicidin) as previously described.  
8.3.5 Sleep 
Sleep quantity and quality were assessed via wristwatch actigraphy. Each athlete wore a 
wrist-mounted digital tri-axial accelerometer (Motionwatch 8, CamNtech) for 5 nights prior 
to departure (SL) and every night while at altitude. The actigraphs were configured to sum 
and store data in 1-min epochs with high sensitivity (0.01 g) and a sampling rate of 60 Hz. 
Sleep measurements included: assumed sleep, sleep efficiency (SE) defined as actual sleep 
time as a percentage of time in bed, sleep onset latency and Fragmentation Index defined as 
the sum of the mobile time (%) and the immobile bouts <=1min (%). In addition, each athlete 
completed a sleep diary each morning and evening where they recorded lights out and wake 
up time, nap times and subjective sleep quality on a scale of 1-10. Averaging data over 
several nights provides a better representation of typical sleep patterns (Ancoli-Israel, 2005). 
Hence, sleep data were averaged for the 5 nights at sea level and for the 10 nights at altitude. 
The final night at sea level and the final night at altitude were not included in analyses, due to 
early morning departure. Sleep variables were also examined day-to-day to determine 
whether there were differences during the initial days at altitude compared to later in the 
training camp and whether sleep quality/quantity was related to daily training load. 
8.3.6 Statistical analysis 
Data are presented as mean ± SD unless otherwise stated. All statistical analyses were 
performed using IBM SPSS Statistics 22.0. The Shapiro–Wilk test was used to determine if 
data were normally distributed. A one-way repeated measures ANOVA was used to 
determine if there were changes in markers of mucosal immunity at altitude (A1, A3 and 
A10) compared to SL, with a post hoc test with Bonferroni stepwise correction for multiple 
 141 
 
comparisons used to determine the location of variance. A paired T-Test was used to 
determine whether there were significant differences in sleep variables between SL and 
altitude. Variables that were found to be significantly non-normal were transformed to a 
normal distribution using a log transformation prior to analysis and are presented as back-
transformed mean with 95% CIs. Statistical significance was accepted as P<0.05. To examine 
the magnitude of differences, effect sizes (ES) were computed using Cohen’s d, where 0.2 
was considered a small effect, 0.5 a medium effect, and 0.8 a large effect. 
8.4 RESULTS 
 
8.4.1 Training load  
Table 8.1 shows training load variables at sea level and at altitude. Total training volume was 
significantly increased by 43% at altitude compared to SL. This was driven by an increase in 
low-intensity endurance training (I-zone 1), while resistance training and moderate- and high-
intensity endurance training were significantly reduced. Only 4 ± 2% of endurance training at 
altitude was performed at moderate-high intensity (I-zone 3-5), compared to 13 ± 3% at SL. 
However, due to the increase in low-intensity training, TRIMP was significantly higher at 
altitude compared to SL.  
8.4.2 Salivary cortisol and testosterone  
Table 8.2 presents salivary concentrations of testosterone and cortisol and 
testosterone/cortisol ratio at sea level and at altitude. There was no significant change in 
salivary testosterone at any time point. However, salivary cortisol concentration was 
significantly decreased on day 1 at altitude compared to SL (Figure 8.1). 
Testosterone/cortisol ratio was significantly increased on day 1 and day 3 at altitude 
compared to SL. 
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Table 8.1: Training load variables for two weeks at sea level and 10 days at altitude.  
 SEA LEVEL ALTITUDE 
Total training volume 
(min/day) 
128 ± 18 182 ±  34* 
Resistance training (min/day) 13 ± 6 7 ± 3# 
I-zone 1 (min/day) 92 ± 12 172 ± 33* 
I-zone 2 (min/day) 4 ± 6 4 ± 3 
I-zone 3 (min/day) 8 ± 2 8 ± 4 
I-zone 4 (min/day) 3 ± 2 0 ± 0# 
I-zone 5 (min/day) 3 ± 2 0 ± 0# 
% HIT 13 ± 3 4 ± 2# 
TRIMP 177 ± 22 217 ± 42* 
 
Data are presented as mean ± SD. *significantly different from sea level (P<0.001). 
#significantly different from sea level (P<0.01). %HIT = percentage of endurance training 
performed in I-zone 3-5; TRIMP = Training Impulse 
 
Table 8.2: Resting salivary cortisol and testosterone for nine elite cross-country skiers at 
sea level and at altitude 
 SEA LEVEL 
ALTITUDE 
Day 1 
ALTITUDE 
Day 3 
ALTITUDE 
Day 10 
Testosterone (pmol/l) 540 (404-676) 485 (340-630) 593 (439-746) 511 (370-653) 
Cortisol (nmol/l) 18 (13-23) 11 (8-13)* 13 (10-17) 13 (9-17) 
Testosterone/cortisol 31 (23-40) 47 (33-68)* 47 (31-69)* 41 (29-59) 
 
Data are presented as mean (95% CI). *indicates significant difference from sea level 
(P<0.05). 
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8.4.3 Salivary AMPs 
Table 4 presents salivary concentrations and secretion rates of AMPs at sea level and at 
altitude. Salivary S-IgA secretion rate was significantly increased on day 3 at altitude (Figure 
8.2). There were no significant changes in S-IgA concentration. Saliva LL-37 secretion was 
significantly increased on day 3 and day 10 at altitude. There were no significant changes in 
lysozyme concentration or secretion rate. 
8.4.4 Hydration and energy balance 
There was no significant change in body mass, saliva osmolality or saliva flow rate during the 
altitude training camp (Table 8.3). 
8.4.5 Illness incidence 
During the 10-day period at altitude, two of the athletes experienced symptoms of URI. The 
first athlete on day 5 at altitude, and the second on day 10. In both cases, duration of 
symptoms was three days. These two paticipants were also the only athletes that had a 
reduction from sea level in S-IgA concentration on day 1 and day 3 day at altitude, with 
reductions of -30 ± 27% on day 1 and -15 ± 14% on day 3 observed for these two athletes. 
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Figure 8.1: Percentage change from sea level (SL) in salivary cortisol and testosterone 
concentration for nine elite cross-country skiers on day 1, 3 and 10 at altitude.     
Bars= group mean; Markers= individual values; Line= sea level result (100%)  
*indicates significant difference from SL (P<0.05) 
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Figure 8.2: Percentage change from sea level (SL) in salivary S-IgA, lysozyme and LL-
37 secretion for nine elite cross-country skiers on day 1, 3 and 10 at altitude.        
Bars= group mean; Markers= individual values; Line= sea level result (100%)                                                                                      
*indicates significant difference from SL (P<0.05) 
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Table 8.3: Salivary AMPs, flow rate and osmolality for nine elite cross-country skiers at sea level and at altitude  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data are presented as mean (95% CI). *indicates significant difference from sea level (P<0.05).   
 SEA LEVEL  
ALTITUDE 
Day 1 
ALTITUDE 
Day 3 
ALTITUDE 
Day 10 
S-IgA     
Concentration (mg/l) 346 (157-536) 329 (227-432) 554 (298-810) 376 (173-580) 
Secretion rate (µg/min) 81 (52-118) 90 (69-115) 157 (92-238)* 96 (65-133) 
LL-37     
Concentration (µg/l) 7.6 (4.7-10.5) 11.1 (5.8-16.4) 13.5 (8.6-18.4) 10.7 (6.5-14.9) 
Secretion rate (ng/min) 2.2 (1.2-3.2) 3.4 (2.1-6.2) 5.6 (2.5-8.6)* 3.8 (1.9-5.7)* 
Lysozyme     
Concentration (µg/l) 793 (551-1080) 815 (509-1192) 1629 (807-2736) 1195 (610-1974) 
Secretion rate (ng/min) 208 (144-301) 219 (143-335) 448 (268-749) 322 (191-542) 
Saliva flow rate and 
osmolality 
    
Flow rate (ml/min) 0.30 (0.24-0.36) 0.33 (0.23-0.42) 0.37 (0.27-0.47) 0.36 (0.24-0.47) 
Osmolality (mosm/kg) 51 (42-59) 50 (42-58) 59 (50-68) 52 (42-63) 
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8.4.6 Sleep 
Table 8.4 presents sleep variables at sea level and at altitude. Assumed sleep time was 
significantly reduced by 9% at altitude compared to SL. This was primarily due to athletes 
waking earlier to train, and was to some degree compensated for by increased nap time 
during the day. SE was significantly reduced at altitude compared to SL. Figure 8.3 shows 
mean SE and training load for each day at sea level and at altitude. Followng arival at 
altitude, SE fell progressively reaching its lowest point on the sixth night, after which it 
recovered somewhat. Changes in SE did not correlate with changes in training load. There 
were no significant changes in subjective sleep quality, sleep onset latency or Fragmentation 
Index. 
Table 8.4: Sleep variables for nine elite cross-country skiers at sea level and at altitude. 
 SEA LEVEL  ALTITUDE 
Assumed nighttime sleep (min) 506 ± 29 459 ± 14* 
Sleep efficiency (%) 83.7 ± 7.0 79.9 ± 4.9# 
Fragmentation index 31.2 ± 8.5 31.8 ± 4.4 
Sleep latency (min) 11 ± 5 17 ± 7 
Subjective sleep quality (1-10) 7 ± 1 6 ± 1 
Nap time (min/day) 21 ± 26 60 ± 22* 
 
Data are presented as mean ± SD. *indicates significant difference from sea level (P<0.01)  
#indicates significant difference from sea level (P<0.05).  
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Figure 8.3: Sleep efficiency (line) and training load (bars) for five days at sea level (-5 to 
-1) and 10 days at altitude (1-10).        
 
Values are mean ± 95% CI.  
------ mean for sea level/altitude.   
S = small effect size vs. mean sleep efficiency at sea level.  
M = medium effect size vs. mean sleep efficiency at sea level. 
L = large effect size vs. mean sleep efficiency at sea level. 
 
 
  
 2 
 
8.5 DISCUSSION 
 
The main findings of the current study are that a 10-day altitude training camp with a high 
training load does not compromise mucosal immunity in a cohort of world-class endurance 
athletes, despite modest reductions in sleep quality and quantity. However, the two athletes 
who did experience URI during the altitude training camp were the only two participants that 
had a reduction from sea level in salivary S-IgA concentration on day 1 and day 3 at altitude.  
8.5.1 Mucosal Immunity 
A 10-day altitude training camp resulted in elevated salivary AMP (S-IgA and LL-37) 
secretion rates. S-IgA secretion has been postulated to be one of the most useful clinical 
biomarkers to predict URI incidence in athletes (Fahlman and Engels, 2005), and a number of 
previous studies on athletes emphasize the importance of S-IgA in the protection from 
infections of the upper respiratory tract (Fahlman and Engels, 2005, Neville et al., 2008). 
This is supported by the finding that the two athletes in the current study who subsequently 
experienced URI were also the only two participants to have a reduction in S-IgA 
concentration during the first three days at altitude. LL-37 is also secreted at the mucosal 
surfaces and exhibits a broad range of antimicrobial activity (Durr et al., 2006). Increased 
secretion rates of these two salivary AMPs may therefore provide enhanced protection 
against invading microbes. These results are not in agreement with the findings of Tiollier et 
al. (2005) who reported reduced S-IgA concentrations in elite cross-country skiers during 
altitude training. In this study, athletes spent 11 h/day at 2500-3500 masl, with the remainder 
of the day and all training at 1200 masl. In contrast, athletes in the current study spent a 
minimum of 21 h/day at ≥2000 masl. Furthermore, Tiollier and colleagues did not report 
training load at sea level, and since the control group, living and training at 1200 masl, 
 3 
 
showed similar reductions in S-IgA after 6 and 12 days, it is possible that some of these 
changes may be attributable to alterations in training load as well as to hypoxia.  
It is well documented that heavy training loads can reduce S-IgA levels (Tharp and Barnes, 
1990, Gleeson et al., 1999), and reduced relative training intensity is one possible explanation 
for the positive changes observed in the current study. In accordance with typical practice, the 
volume of high-intensity training was reduced while at altitude. Despite an increase in 
training volume and hence TRIMP, athletes only performed two moderate-intensity interval 
sessions in I-zone 3 while at altitude, with the remainder composed of low-intensity training 
in I-zone 1. Furthermore, due to lower partial pressure of oxygen and consequent reduction in 
?̇?O2max, skiing/running speed is lower at altitude even when training at the same heart rate 
and/or blood lactate concentration. Hence, the muscular load is also reduced, which may 
influence hormonal and immunological responses, although this was not supported by the 
findings in Chapter 7 which found that plasma cortisol was higher post-exercise in hypoxia, 
even at a lower absolute workload.  
As well as changes in training, it is likely that changes in AMP secretion were also driven 
directly by hypoxia. Acute, intense exercise has been found to transiently increase secretion 
rates of salivary AMPs (Allgrove et al., 2008), likely via increased sympathetic nervous 
system activity and circulating catecholamines up-regulating the expression and/or 
mobilisation of the polymeric Ig receptor, thereby increasing transcytosis of S-IgA (Walsh et 
al., 2011b). Since hypoxia similarly increases sympathetic activity (Mazzeo et al., 1998) via 
both chemoreceptor- and baroreceptor-mediated excitation (Hainsworth et al., 2007), this 
may stimulate AMP secretion and temporarily enhance mucosal immunity. However, the 
altitude training period in the current study was relatively short, and we cannot eliminate the 
possibility that negative changes in these immune markers might occur with a more 
prolonged altitude sojourn, or upon return to sea level.  
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It appears that negative changes in S-IgA concentration during the initial days at altitude 
could be a useful predictor of subsequent illness. Since all of the athletes in the current study 
lived and trained together during the altitude training camp, exposure to pathogens is likely to 
have been similar between individuals, but the reduction in S-IgA observed in these two 
athletes may have made them somewhat more susceptible to URI. However, the reason why 
these athletes had reduced concentrations of S-IgA is not clear, since there were no marked 
differences in the other measured variables compared to the athletes who did not become ill.  
The maintenance of body mass, saliva osmolality and saliva flow rate suggests that fluid and 
energy intake during the altitude training camp were sufficient to prevent severe 
hypohydration or weight loss, despite both fluid loss and energy expenditure being elevated 
at altitude (Meyer et al., 2011). 
8.5.2 Sleep 
The results of the current investigation add to previous studies which have reported reduced 
sleep quality in non-elite athletes sleeping at simulated moderate altitude (Hoshikawa et al., 
2007) and young elite football players during a training camp at 3600 masl (Roach et al., 
2013, Sargent et al., 2013). However, contrary to previous findings, the current study found 
that SE progressively declined following arrival at altitude, with the most severe disturbances 
observed on the 5th and 6th night, before recovering somewhat towards the end of the training 
camp. Intuitively, sleep disturbances would be expected to be greatest before the athletes 
begin to acclimatise. Indeed, Roach and colleagues (2013) found that sleep disturbances were 
most severe during the initial days at altitude. However, these athletes underwent a 10 h time 
zone shift prior to the start of the study, and it is possible that improvements were due to 
acclimatization to the new time zone, as well as to the altitude itself. However, why 
meaningful reductions in SE in the current study should arise only after the first two nights at 
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altitude is not easily explainable. Although sleep variables did not directly correlate with 
training load, it is possible to speculate that maintained SE during the first two nights at 
altitude might be related to athletes being well rested on arrival, following 2-3 easy training 
days. The accumulated effect of consecutive high-volume training days and hypoxia might 
then lead to a progressive reduction in sleep quality, until the athletes begin to acclimatise to 
the altitude, at which point SE begins to recover. However, further study is necessary to 
corroborate these findings. It is worth noting that the athletes in the current study had low SE, 
even at baseline. These values are similar to those reported by Leeder et al. (2012), who 
found poorer sleep quality in elite athletes compared to age and sex-matched controls, 
suggesting that heavy training loads may detrimentally influence sleep.  
Sleep is important for both cognitive and physical functioning (Reite et al., 1975, Samuels, 
2009). Deep sleep is believed to be particularly important since this is the time when growth 
hormone is predominantly released (Takahashi et al., 1968), with sleep deprivation 
diminishing this release (Sassin et al., 1969). Since growth hormone is involved in muscle 
growth, repair and recovery (Kraemer, 1988) disrupted or insufficient sleep may have 
implications for subsequent exercise performance and training adaptation. However, whether 
the modest reductions observed in the current study are of clinical relevance is not clear. 
Strenuous exercise combined with sleep deprivation and calorie deficit has been found to 
suppress immunity and decrease plasma immunoglobulin levels (Boyum et al., 1996). 
However, despite high training loads, athletes in the current study remained weight-stable and 
the observed sleep disturbances do not appear to be of sufficient magnitude to negatively 
influence the measured immune variables. 
The athletes in the current study were world-class cross-country skiers with exceptionally 
high aerobic capacity, in the setting of a typical training camp. Consequently, the 
applicability and generalizability of these results to elite endurance athlete populations is 
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high. However, the results would undeniably have been strengthened by the inclusion of a 
control group training at sea level, and/or non-exercising controls at altitude. Because these 
were professional athletes during an important preparation phase for the upcoming season, it 
was unfortunately not feasible for any of the athletes to forgo the training camp to act as 
controls.  
Since there were significant differences in training variables, it is not clear whether altitude, 
changes in training, or both, contributed to the observed changes in mucosal immunity and 
sleep. However, elite athletes do not typically implement the same intensity and volume of 
training at altitude as they do at sea level. The training of elite cross-country skiers is 
characterized by high training volumes of ~800 h/year, with a large proportion of endurance 
training performed at low intensity (91% in zone 1 and 2) (Tonnessen et al., 2014). When 
athletes are at altitude, this high volume, low intensity model is exaggerated, with 96% of 
endurance training performed in I-zone 1 and 2. Matching training between the two 
conditions would therefore make the results less relevant to this population. While tightly 
controlled laboratory studies are crucial in elucidating mechanistic connections, they may not 
always accurately reflect the real-world practices of elite athletes. Applied field studies can 
therefore play an important part in bridging the gap between science and practice.  
8.6 CONCLUSION  
 
Despite previous evidence indicating a negative effect of hypoxic training on immunity, it 
appears that it is possible for elite endurance athletes to sleep and train at moderate altitude 
without compromising mucosal immunity. Reducing high-intensity training while at altitude, 
as well as maintaining hydration and energy balance, may have a role to play in ameliorating 
immunological disturbances. Monitoring individual changes in S-IgA levels upon arrival at 
altitude could provide coaches and practitioners with a useful predictor of URI. While both 
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sleep quality and quantity are reduced at altitude, these reductions do not appear to be severe 
and could likely be compensated for via, for example, making provision for daytime naps and 
modest adjustments in training and meal times to allow athletes more time in bed.  
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CHAPTER 9: GENERAL DISCUSSION 
9.1 OVERVIEW OF EXPERIMENTAL STUDIES 
 
CHAPTER 2: Risk factors for illness in elite endurance athletes 
 Season, air travel, competition and large fluctuations in training load = risk factors 
 Frequency: 3-4 episodes per year. Duration of symptoms: ~5 days  
 Higher performance level = fewer days of illness 
 
CHAPTER 3: Influence of repeated competition on illness and performance 
 Participating in a stage race = 3x greater risk of illness 
 Male athletes more prone to illness and see a drop in subsequent race performance       
 Due to lower training load before and after the event? 
 
CHAPTER 4: Influence of overreaching & CHO supplementation on immunity 
 8-days intensified training = symptoms of OR in highly trained cyclists.  
 Immunological and performance changes relatively modest.  
 Increasing CHO from 20 g/h to 60 g/h during training does not better maintain 
performance, or alleviate physiological/immunological disturbances. 
 
CHAPTER 5: Influence of hydration status & endurance exercise on immunity 
 No effect of moderate hypohydration (~4% body mass loss) on cortisol or immune 
responses to exercise 
 Prolonged exercise = augmented anti-inflammatory cytokine response to antigen 
challenge 
 
CHAPTER 6: Influence of acute hypoxia & endurance exercise on immunity 
 Plasma cortisol and exercise-induced decrease in CD4:CD8 ratio greater when 
exercising at same relative intensity in hypoxia vs. normoxia  
 Other immune markers unaffected 
 Differences unlikely to meaningfully impair host defence, particularly as they are 
transient in nature. 
 
CHAPTER 7: Influence of altitude training on mucosal immunity & sleep 
 10-days at moderate altitude does not result in depression of mucosal immunity in 
elite endurance athletes  
 Sleep quantity and quality reduced 
 Changes in S-IgA during initial days at altitude = useful predictor of URI? 
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HYPOTHESIS 1: Heavy training loads impair immunity and increase infection risk in 
endurance athletes  
This hypothesis was not supported by our findings in Chapter 3. Neither between-person nor 
within-person differences in training load were found to be significant predictors of illness 
risk. In Chapter 4, an intensified period of training did result in some immunological 
disturbances. However, these immune changes were relatively modest, and whether such 
changes translate into meaningful increases in infection risk is not clear. 
HYPOTHESIS 2: Taking part in competitions increases an athlete’s risk of infection  
This hypothesis was supported by the findings of Chapter 3 and 4, which indicate that 
competing, both in single events and multi-day stage races, approximately triples an athlete’s 
risk of illness.  
HYPOTHESIS 3: International air travel increases an athlete’s risk of infection  
This hypothesis was supported by the results of Chapter 3, which found that aircraft travel 
makes an athlete five times more likely to experience illness within the next three days.   
HYPOTHESIS 4: Exposure to natural or simulated altitude exacerbates immune 
disturbances associated with prolonged exercise, and increases an athlete’s infection 
risk  
This hypothesis was not supported by the findings in this thesis. In Chapter 3 we found that, 
when accounting for air travel to and from the training camp, altitude was not a significant 
predictor of illness. Although Chapter 7 found that there was an augmented cortisol response 
to exercise at a simulated altitude of 2,000 masl, this did not appear to translate to greater 
immune disturbances when exercise was performed at the same relative intensity. Similarly, 
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mucosal immunity was not impaired in cross-country skiers during a 10-day altitude training 
camp in Chapter 8.  
HYPOTHESIS 5: Increasing CHO intake before, during and after training sessions 
helps prevent OR and alleviates immunological disturbances associated with intensified 
training  
This hypothesis was not supported by the findings in Chapter 5. In terms of preventing 
immune disturbances associated with intensified training, a high CHO intake (60g/h) during 
exercise provided no additional benefit compared to a lower CHO dose (20g/h) in cyclists 
consuming an otherwise self-selected diet.  
HYPOTHESIS 5: Moderate hypohydration, due to inadequate fluid intake before and 
during exercise, exacerbates exercise-induced immune disturbances and increases an 
athlete’s risk of infection 
This hypothesis was not supported by the findings in Chapter 6. Twenty-four hour fluid 
restriction, resulting in hypohydration equivalent to ~4 % body mass loss, did not influence 
plasma cortisol concentrations or exacerbate immune disturbances associated with prolonged 
cycling exercise in temperate conditions.   
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9.2 HOW FREQUENTLY DO ATHLETES BECOME ILL? 
 
Despite a perception amongst athletes and coaches that endurance athletes experience more 
URS episodes than the general population, no scientific studies to date have been able to 
conclusively verify this. The findings in Chapter 3 indicate that elite winter endurance 
athletes experience three to four episodes of respiratory and/or gastrointestinal illness per 
year, with symptoms typically lasting five days. Only a small number of previous studies 
have examined illness rates in athletes for periods of more than a few weeks or months. 
Hellard and colleagues (2015) reported a similar frequency of infectious illness for elite 
swimmers who experienced, on average, four episodes of respiratory, gastrointestinal and/or 
urogenital infection per person-year. This suggests that elite endurance athletes have broadly 
similar illness rates, regardless of whether their competition season falls during the winter or 
summer months. Although we unfortunately do not have equivalent data for a sedentary or 
recreationally active control group in Norway during the same time period, these illness rates 
do not appear to differ markedly from those of adults in the general population, who typically 
experience approximately two to four episodes of respiratory infection per year (Monto, 
2002, Heikkinen and Jarvinen, 2003).  
Spence and colleagues (2007) reported that elite triathletes experienced, on average, one URS 
episodes over a 5 month period, significantly more than sedentary controls or recreational 
athletes. However, there was no significant difference in the number of URS episodes with an 
identified pathogen. Hence, the difference may not be due to higher infection rates in athletes 
but, rather, down to more frequent reporting of non-infectious URS. Although the 
mechanisms underlying symptomatic but non-infectious URS are not clear, they may be due 
to inflammation from mechanical damage to airways caused by breathing large volumes of 
air during strenuous exercise, or migration of inflammatory cytokines released during 
exercise and as a result of muscle damage. Another possibility is that elite athletes over-
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report URS compared to the general population. This is perhaps not surprising, since minor 
symptoms which do not noticeably impair daily function in a sedentary individual may 
become much more apparent when attempting to perform strenuous physical activity.  
Although total illness rates appear to be broadly similar between summer and winter 
endurance athletes, it is important to note that there appears to be high inter-individual 
variability in infection susceptibility. Even within a homogenous group of elite athletes, the 
frequency and duration of URS and other minor infectious illness appears to vary 
considerably. Amongst 37 male and female athletes on the Norwegian national cross-country 
skiing team, mean annual illness rates varied from 1-7 events per year between athletes, 
despite little difference in training load, travel and competition schedule or training 
environment. Indeed, since these were athletes from the same team, many would have spent 
substantial portions of the year traveling, competing and training together in the same 
locations. These between-person variations can likely be explained, at least in part, by genetic 
differences. For example, Cox et al. (2010) found that cytokine gene polymorphisms may 
partly account for differences in URS risk in highly-trained athletes. Correspondingly, in 
Chapters 4, 5 and 6 we observed high inter-individual differences in cytokine production. 
However, behavioural and lifestyle differences outside of training, such as diet, sleep 
behaviours, hygiene and domestic circumstances, almost certainly also contribute. 
Higher performance level appears to be associated with a lower number of annual illness 
days. In Chapter 3 we found that having won at least one Olympic or World Championship 
medal was a negative predictor of illness duration compared with athletes that had not 
medalled in a major championship. This is in accordance with Hellard et al. (2015) who 
found that international level swimmers experienced fewer episodes of illness than national 
level swimmers. It also lends some support to the theory of Malm (2006) that the relationship 
between infection and training load follows an S-curve, where high training loads may 
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negatively influence host defence, but successful elite athletes must have a robust immune 
system capable of withstanding and recovering quickly from infection, even during periods of 
high physiological stress. However, personal communications with support staff and coaches 
suggests that the most successful athletes are often also those who are the most meticulous in 
terms of hygiene, sleep, nutrition and hydration. It is possible that, as well as potential 
genetic/physiological differences, such behaviours may contribute towards disparities in 
infection rates.  
9.3 WHEN DO ENDURANCE ATHLETES BECOME ILL? 
 
9.3.1 Season 
As previously mentioned, URS episodes in endurance athletes appear to cluster around 
periods of intense training and competition. As such, it might be expected that athletes from 
winter and summer sports experience different annual patterns of illness, since they compete 
and undertake heavy training periods at different times of the year. However, Chapter 3 
shows that peak illness rates for cross-country skiers occur during the winter months, similar 
to patterns of illness observed for athletes  from summer sports (Hellard et al., 2015) and 
mirroring normal seasonal trends for respiratory infections in the general population (Monto, 
2002). Cross-country skiers are twice as likely to experience illness during the winter and 
spring compared to summer, even when correcting for other factors such as differences in the 
number of competitions and flights.  
9.3.2 Periods of competition 
Previous studies have found that athletes have an increased risk of URS following 
competition (Nieman et al., 1990, Nieman et al., 2006a). This is supported by the findings in 
Chapter 3, which show that competition is a potent risk factor for illness, making an athlete 
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three times more likely to experience URS or gastrointestinal illness within the subsequent 
three days. Not surprisingly, therefore, Chapter 4 found that taking part in a stage race, where 
athletes compete on multiple consecutive days, similarly increases the risk of illness. 
Additionally, and perhaps most importantly, such an event can impact detrimentally on 
performance for at least six weeks, particularly in male athletes for whom the competition 
load is greater. Competitions are characterised by extreme physical exertion, but may also be 
associated with psychological stress and environmental extremes of temperature and altitude, 
as well as typically exposing athletes to crowds of spectators and media. All of the above 
factors may contribute to the observed increase in illness risk.  
9.3.3 Periods of heavy training 
Similar to competing, previous studies suggest that heavy training negatively impacts on 
immunity and makes athletes more susceptible to infection (Gleeson et al., 1995, Gleeson et 
al., 1999, Gleeson et al., 2011a, Heath et al., 1991, Spence et al., 2007). This was not 
supported by our data in Chapter 3, which failed to find a significant relationship between 
illness incidence and training load. However, we did find that athletes whose training 
incorporated more extreme day-to-day fluctuations in training load were somewhat more 
susceptible to illness. Interestingly, Hellard and colleagues (2015) found that the risk of 
illness in swimmers was 50% lower during competition periods compared with intensive 
training periods, whereas our data show that risk of illness in cross-country skiers is 
significantly increased following competition, but not significantly related to intensive 
training. Unlike swimmers, however, cross-country skiers undertake their most intensive 
training periods during the summer (Tonnessen et al., 2014). Perhaps, then, both competition 
and intensive training can negatively influence host defence, but this only manifests as 
significantly higher infection rates during the winter months when URS frequency in the 
general population peak, and pathogen exposure is therefore higher. Training and/or 
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competing in the winter may also be associated with increased airway irritation due to 
breathing high volumes of very cold air, which may mimic the sore throat symptoms of an 
upper-respiratory infection and result in athletes reporting more frequent URS at this time.  
High training loads are an inevitable part of elite sport. However, when high training loads 
are combined with insufficient recovery, a state of non-functional OR or OT may occur, and 
this appears to be coupled with an increased frequency of infection (Meeusen et al., 2013, 
McKenzie, 1999). Chapter 5 shows that eight days of intensified training results in a number 
of changes consistent with the symptoms of short-term overreaching in highly trained 
cyclists, but that the immunological changes are relatively modest. Although determining the 
clinical relevance of such changes is difficult, they are unlikely to be of sufficient magnitude 
to have any profound influence on host defence. Small, transient immune impairments are 
likely outweighed by the longer-term performance benefits that an athlete would expect to 
reap as a consequence of such a training period. As such, these data do not provide grounds 
on which to advise highly trained athletes against incorporating short-term periods (≤8 days) 
of intensified training into their training programmes. However, athletes and coaches should 
be aware that there may be a small increase in infection risk as a result of functional OR 
during these periods. Non-functional OR and OT can, on the other hand, result in long-term 
detriments to immunity and performance which can persist for up to several years (Meeusen 
et al., 2013). It is therefore of critical importance that athletes respect the balance between 
training and recovery. Since the effects of more prolonged periods of intensified training have 
not been investigated, and since the potential negative consequences can be substantial, 
intensified training periods lasting much in excess of one week are not advised, and such 
training should not be completed without adequate nutritional support, or in the presence of 
other life stressors.  
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Although the prevalence of OT in elite athlete populations is high (Morgan et al., 1987, 
Matos et al., 2011), its aetiology remains poorly understood.  A number of explanations have 
been proposed, including elevations in circulating pro-inflammatory cytokines (Smith, 2000), 
glycogen depletion (Snyder, 1998) and endocrine disturbances (Meeusen et al., 2013). The 
most effective marker to diagnose OT remains a negative change in performance, despite 
maintained or increased training load, combined with mood disturbances (Meeusen et al., 
2013). A number of studies have attempted to identify novel markers of OR, in order to 
facilitate earlier detection of an athlete who is at risk of becoming overtrained, before any 
long-term detriment to health and/or performance occurs. However, the majority of 
biochemistry measures investigated to date likely only provide a general indication of 
training stress, and are not able to consistently distinguish between overreached and non-
overreached athletes (Coutts et al., 2007). Given that an increase in infection susceptibility is 
cited as a common symptom of OT, investigating immune system changes presents an 
attractive starting point in the search for novel markers. Although a number of variables in 
Chapter 5 were significantly altered by the intensified training period, none correlated 
significantly with performance changes. As such, it is unlikely that any of these markers can 
be used to accurately differentiate between overreached and non-overreached athletes. 
Indeed, many of the changes observed, particularly in circulating leukocyte numbers, are 
likely primarily a reflection of incomplete recovery from the previous exercise bout. 
Furthermore, the immune changes observed are unlikely to be of sufficient magnitude to 
explain the increase in infection incidence commonly reported in overtrained athletes. The 
changes in resting and post-exercise plasma cortisol and ACTH following the intensified 
training period do, however, provide some support for the theory that changes in the 
sensitivity of the Hypothalamic-Pituitary-Adrenal axis may play a role in the aetiology of OT 
(Meeusen et al., 2013).  
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Clearly, it is not ethical to intentionally induce a true state of OT in study participants, and it 
is possible that some of the modest changes observed in Chapter 5 may manifest as more 
severe immune disturbances if intensified training was sustained for a longer period resulting 
in non-functional OR or OT. Indeed, some of the participants in the current study showed 
very little impairment in performance, suggesting that we were not successful in inducing a 
state of OR in these individuals. This is interesting, since previous studies report successfully 
OR their participants using a similar, or even slightly shorter, period of intensified training 
(Halson et al., 2003, Achten et al., 2004, Halson et al., 2002). However, our participants had a 
substantially higher aerobic capacity than athletes in these studies, and it is possible to 
speculate that they may therefore also have had a higher tolerance for the intensified training.  
9.3.4 Periods of travel  
Chapter 3 indicates that air travel is a potent risk factor for illness amongst athletes. This 
corresponds with data from non-athletes which has found that individuals are more likely to 
experience URS following a flight (Zitter et al., 2002) and that cabin staff are at a greater risk 
of URS compared to the general population (Whelan et al., 2003). Since elite athletes have to 
travel frequently between competition venues and training camps, exploring strategies to 
effectively minimise infection risk during air travel is a worthwhile area for future research.  
9.3.5 Exposure to environmental extremes 
Previous studies examining the effects of high altitude (>3,000 masl) on immune function 
indicate that exposure to hypoxia can result in immune disturbances and potentially increase 
infection risk (Mazzeo, 2005, Oliver et al., 2013, Pyne et al., 2000, Facco et al., 2005, 
Hartmann et al., 2000). However, the results of Chapter 7 and 8 suggest that, when absolute 
workload is reduced so that relative exercise intensity is the same as at sea-level, acute or 
short-term (up to 10 days) training at moderate altitude (≤3,000 masl) does not appear to 
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result in any meaningful impairment to the measured immune markers, despite a somewhat 
augmented stress hormone response to acute exercise. However, correctly adjusting exercise 
intensity when training at altitude can be challenging, particularly during the initial days of 
exposure, and an athlete’s perception of effort may require “recalibrating”. The use of blood 
lactate and heart rate measures can be a useful tool to provide objective feedback to athletes 
to ensure that they exercise at the desired workload.  
In accordance with previous studies with recreational athletes and at more extreme elevations 
(Roach et al., 2013, Hoshikawa et al., 2007), both sleep quality and quantity are reduced in 
elite endurance athletes while training at moderate altitude. These reductions do not appear to 
negatively influence immunity, but may have implications for recovery and adaptation, 
particularly since training volume during such training camps is typically high. Changes in 
mealtime and training schedules to allow athletes more time in bed, and making provision for 
daytime napping can likely offset these relatively modest reductions in nocturnal sleep 
quality. Indeed, a recent study by Faraut and colleagues (2015) found that two 30 min 
daytime naps normalized the catecholamine and immune perturbations associated with sleep 
restriction.  
9.3.6 Summary 
Elite endurance athletes typically experience three to four episodes of URS and/or 
gastrointestinal illness per year, with the highest illness rates observed during the winter 
months. As such, annual illness rates in these athletes do not appear to differ markedly from 
those of adults in the general population, and these data do not support the theory that 
endurance athletes are more prone to opportunistic infections. Furthermore, the timing of 
these episodes does not appear to deviate markedly from normal seasonal trends, although 
illness events do typically cluster around periods of competition and travel.  However, even 
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within a homogenous athlete population, large individual differences exist in illness 
susceptibility that cannot be explained by differences in training, competition, travel or 
environmental conditions. Since fewer annual illness days appears to be associated with 
success in elite endurance sport, exploring novel strategies to minimise illness risk in athletes 
remains an important area of research.  
9.4 POSSIBLE MECHANISMS FOR INCREASED INFECTION RISK 
 
It is clear that both acute and chronic endurance exercise influences a number of aspects of 
immune function. However, the immune system is characterised by a large amount of 
redundancy, so that it is not easy to determine what magnitude of change is necessary to 
meaningfully impact on host disease susceptibility.   
Chapter 6 provides further evidence of a temporal shift towards a more type 2 dominant 
cytokine response to antigen challenge following prolonged exercise, perhaps indicative of 
compromised host-defence to viral infection. This is in accordance with a number of previous 
studies that have used mitogen as stimulant (Lancaster et al., 2004, Lancaster et al., 2005b, 
Steensberg et al., 2001). The ability of cells to produce cytokines in response to an immune 
challenge has consequences for the functional capacity of the immune system as a whole, and 
is likely reflective of an individual’s ability to defend against invading pathogens. As such, 
these changes may contribute towards explaining the “open-window” of infection observed 
during the short-term recovery from endurance exercise.  
A number of previous studies have shown an association between salivary S-IgA and 
infection susceptibility in athletes (Gleeson et al., 1999, Gleeson et al., 2012), and Chapter 7 
provides further support for this relationship since the two athletes who contracted a URS 
were also the only two participants to have a drop in salivary S-IgA concentration upon 
ascent to altitude. To date, S-IgA concentrations and secretion rates remain the only immune 
 20 
 
markers to show a consistent relationship with URS risk in athletes (Walsh et al., 2011b). 
Furthermore, the collection of saliva is simple and non-invasive, making it an attractive and 
viable tool for measuring immune status of athletes in the field. However, since S-IgA 
secretion rates are highly variable both within and between individuals (Neville et al., 2008), 
defining a normal range is difficult. It is therefore important that individualised 
baseline/healthy values be established for each athlete.  
9.5 WHAT CAN BE DONE TO MINIMISE INFECTION RISK? 
 
9.5.1 Training 
It is generally accepted that there exists a dose-response relationship between training and 
performance. Asking athletes to reduce their total training load is therefore not a feasible 
means of lowering infection risk. However, it is possible that the same total training dose can 
be organised and administered in a slightly different way in order to minimise immune 
disturbances. Current guidance suggests that, in order to maintain immune health, athletes 
should employ gradual and periodised increases in training loads, avoid excessively high 
training loads, included non-specific cross-training, ensure sufficient rest and recovery and 
add variety to limit training monotony (Foster, 1998, Walsh et al., 2011a). However, our data 
in Chapter 3 indicate that Training Monotony (mean daily training load divided by the 
standard deviation) was actually inversely related to illness incidence, while none of the other 
measures of training were significantly related to illness incidence. It is possible to question 
whether the calculation originally proposed by Foster (1998), and used in Chapter 3, is a true 
measure of training monotony. Since it reflects only day-to-day fluctuations in total training 
load, the expression “Training Monotony” would perhaps be better replaced with a term such 
as “Training Load Volatility”. In order to truly measure training monotony, a formula that 
also accounts for activity type is necessary; however, this was unfortunately beyond the scope 
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of the current thesis.  It is somewhat unexpected that none of the other training variables 
significantly predicted illness. However, descriptive studies suggest that the training of elite 
cross-country skiers typically already conforms to the above-mentioned guidelines 
(Tonnessen et al., 2014) and, in terms of reducing immune disturbances, there may therefore 
be limited scope to further optimise training practices of most elite endurance athletes.  
9.5.2 Nutrition 
Much research has been dedicated to finding effective strategies to ameliorate exercise and 
training-induced immune disturbances. However, the majority appear to have only a limited 
effect on post-exercise immune function.  Regardless of whether an athlete is in energy 
balance, euhydrated, nutritionally supplemented and well-rested, prolonged and/or intense 
physical exercise will inevitably result in some magnitude of immune disturbances. However, 
some strategies do appear to be beneficial in ameliorating these perturbations. In terms of 
nutritional strategies, consuming a high CHO diet and supplementing with CHO during 
exercise appear to be the most effective strategies to alleviate exercise-related 
immunodepression. Studies have found that ingesting a high dose of CHO is beneficial in 
reducing immune disturbances following acute, prolonged exercise (Nieman et al., 2003, 
Henson et al., 1998, Nieman et al., 2006b, Bishop et al., 2003) and consuming a high CHO 
diet appears to better maintain some aspects of immunity during periods of intensified 
training (Costa et al., 2005). Indeed, a review by Gunzer et al. (2012) suggested that, in terms 
of macronutrients, the single most effective strategy for maintaining immune function in 
athletes is to consume a ≥6% CHO beverage during prolonged exercise.  
However, the effect of acute CHO supplementation immediately before, during and after 
exercise during intensified training while consuming an otherwise self-selected diet had not 
been previously explored. Many athletes do not meet the current ACSM and IOC guidelines 
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of 30-60 g CHO per hour during endurance training, but nor do they typically perform 
prolonged exercise while ingesting zero CHO. In Chapter 5 we therefore wished to determine 
whether ingesting the upper end of the ACSM recommended dose of CHO during an 
intensified training period akin to a training camp, has any additional benefit for performance 
and/or immunity above that of a more modest CHO intake (20 g per hour). Supplementation 
with the low CHO dose was found to be equally effective in maintaining performance and 
immunocompetence during short-term intensified training. This may be particularly relevant 
for individuals who experience gastrointestinal distress when ingesting higher CHO doses, or 
for athletes who wish to moderate their calorie intake. However, it should be noted that both 
the low and high CHO supplemented groups had a high total dietary CHO intake outside of 
training sessions. As such, even if only a modest dose is ingested in and around the exercise 
sessions themselves, based on previous studies and the findings in Chapter 5, total daily CHO 
intake during intensified training should not be less than ~7 g/kg bm.  
9.5.3 Hydration 
Chapter 6 indicates that moderate hypohydration (≤4% body mass loss post-exercise) does 
not influence plasma cortisol or systemic immunological responses to exercise performed in 
temperate conditions. Nor does this level of hypohydration appear to detrimentally effect 
mucosal immunity (Killer et al., 2015). However, the effect of more severe hypohydration on 
such immune markers remains unclear, and for performance and health general 
recommendations are that athletes should aim to drink enough to maintain euhydration, 
limiting body mass loss to <2% (Rodriguez et al., 2009). Maintaining euhydration becomes a 
particular concern when athletes are exercising in the heat or at altitude, when fluid losses, 
both during and outside of exercise, are exacerbated. Indeed, Mitchell et al. (2002) found that 
hypohydration resulted in an augmented cortisol response when exercise was performed in 
the heat, but had no effect when exercising in temperate ambient conditions.  
 23 
 
9.5.4 Competition and travel schedule 
Based on the findings from Chapters 3 and 4, it is clear that athletes and coaches should 
carefully consider competition and travel schedules. This becomes particularly key in the lead 
up to important events, due to the potential negative consequences for both health and 
performance. Competitions are an important part of the training process and can be an 
important source of motivation, as well as often providing financial and sponsorship 
incentives. Athletes may therefore feel pressure to, or wish to, take part in as many 
competitions as possible. However, it is clear that an excessive competition schedule can 
markedly increase infection risk and potentially impair performance for a number of weeks. 
The number of competitions in which an athlete participates will to a large degree, be 
influenced by the characteristics and structure of the sport in which they partake. For 
example, cross-country skiers will compete most weekends during the winter, while a 
marathon runner may only take part in a handful of races each year. In some sports, most 
notably road cycling, many athletes compete in stage races requiring heavy exertion over 
multiple consecutive days. When deciding whether or not an athlete should take part in such a 
competition in the same season that they are also aiming to attain peak performance for 
Olympic Games or World Championships, coaches and athletes should reflect carefully on 
the potential impact this may have on the rest of the competition season. If the decision is 
made to participate, careful consideration should be given regarding how to optimise training 
in the weeks and days before and after the race, in order to prevent maladaptive outcomes and 
instead turn the event into a beneficial component of the athlete’s championship preparation.   
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9.6 LIMITATIONS AND FUTURE DIRECTIONS 
 
As with any body of work, there are a number of limitations to this thesis which should be 
acknowledged. Firstly, Chapters 3 and 4 are based on self-reported training and illness data. 
Although elite endurance athletes appear to self-report their training with high fidelity (Sylta 
et al., 2014), the same level of accuracy has not been confirmed for illness. The results of 
these studies would undoubtedly have been strengthened had every episode of illness been 
verified by a physician and/or pathology analyses. However, achieving this with a cohort of 
38 elite athletes over a period of many years would not only have required a huge amount of 
resources, but also that athletes committed to reporting to the laboratory and providing a 
sample whenever they experienced symptoms. This was not feasible with this particular 
population. For similar reasons, Chapter 8 is descriptive in nature as it was not viable for any 
of the athletes to forgo the altitude training camp to act as controls. It is possible to question 
how much can really be learned from such descriptive studies, since the lack of a control 
group limits interpretation of the data. However, this type of design often provides one of the 
only means by which to study elite athlete populations, who are rarely willing to participate 
in intervention studies. Applied field studies are characterised by high external validity, and 
the results are likely of more relevance to elite athlete populations than many tightly 
controlled laboratory studies conducted with recreational athletes or university student 
populations. As such, although Chapter 8 provides little new information about the 
underlying mechanisms of how altitude trainings influences immune function, it does deliver 
an important take-home message that current altitude training practice allows elite athletes to 
train at moderate altitude without compromising mucosal immunity. However, there is 
certainly a need for future well-controlled studies exploring the mechanisms and effects of 
altitude training on other aspects of immunity, and to determine whether strategies related to 
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training, nutrition and recovery can be effective in abolishing immune perturbations 
associated with hypoxic training.  
Host defence is the end product of a very large number of cells and responses, with the 
immune system displaying a large amount of redundancy. Hence, determining the clinical 
relevance of changes in a single immune marker is difficult. The question therefore remains 
as to how to measure immune function in a meaningful way. In this thesis, we chose to look 
at a number or immune variables in combination, in an effort to determine the effects of the 
interventions on a number of aspects of host defence. Since previous research has shown that 
an elevated anti-inflammatory cytokine production is associated with both training load and 
increased infection risk in athletes (Gleeson et al., 2012, Gleeson et al., 2013a) this was 
chosen as a primary outcome measure in Chapters 5, 6 and 7. Compared to mitogen-
stimulation, the cytokine response to the multi-antigen vaccine used in these chapters is 
closer to the natural response to the types of opportunistic infections that might typically be 
encountered during recovery from exercise. However, measuring cytokine production from 
whole blood culture may be confounded by increased cell death in cell culture (Green and 
Rowbottom, 2003) and, more critically, by changes in numbers of circulating lymphocytes 
and monocytes with exercise. As such, although measuring resting antigen-stimulated 
cytokine production by whole-blood culture is a promising method of exploring cellular 
immune responses and changes in infection susceptibility with long-term training, it is 
perhaps less useful when attempting to determine changes to host defence with acute 
exercise. On the other hand, changes in absolute cytokine production are likely to have 
implications for infection susceptibility, regardless of the underlying mechanism. Measuring 
cytokine production from isolated peripheral blood mononuclear cells overcomes the issue of 
exercise-induced shifts in leukocyte populations, but removes the cells from the normal 
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hormonal milieu. This presents a limitation, given the interactive and context-dependent 
nature of cytokines.  
In chapters 5, 6 and 7 we observed large inter-individual variability in cytokine responses. 
This somewhat limited our ability to detect significant effects as a result of the interventions, 
since differences between individuals were often greater than the magnitudes of change 
observed following exercise/training. This large inter-individual variability in cytokine 
production is an interesting finding in itself, and may contribute towards explaining why 
some individuals are more illness-prone than others. Indeed, data from Cox et al. (2010) 
suggests that cytokine gene polymorphisms may partly account for differences in infection 
risk in highly-trained athletes. However, as a result, future studies examining changes in 
antigen-stimulated cytokine production following exercise/training may benefit from larger 
sample sizes in order to improve statistical power. Given that we observed large inter-
individual differences, and that results are heavily influenced by exercise-induced changes in 
the circulating number of responder cells, the value of antigen-stimulated cytokine production 
by whole blood culture as an immune measure may primarily lie in cross-sectional studies, 
where resting samples can be collected from a larger cohort of individuals. Other markers of 
immune function may be more appropriate for acute exercise intervention studies, which are 
typically also characterized by more modest sample sizes.   
Although in vitro and ex vivo measures, such as those used in the current study, offer a 
valuable insight into the effect of an intervention on immunity, they often lack clinical 
relevance since the extent to which such changes translates to increased infection risk is 
unclear. A small number of recent studies within the field of exercise immunology have 
therefore utilized cutaneous measures of in vivo immunity, such as delayed-type 
hypersensitivity responses to intradermal injection of antigens, or contact hypersensitivity 
responses to epicutaneous application of antigens (e.g. Davison et al., 2015, Diment et al., 
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2015, Harper Smith et al., 2011). Assessing responses to a whole-body immune challenge has 
advantages over ex vivo and in vitro immune measures, since these methods avoid isolating 
immune cells from the integrated neural and hormonal influences within the normal tissue 
environment. Being relatively non-invasive, these cutaneous measures of in vivo immunity 
provide an attractive avenue by which to further explore the effects of exercise stress on 
immunity in humans. There is also a need for a greater number of longitudinal studies that 
include measures of both immune function AND infection incidence in athletes. This can 
assist in determining the clinical relevance of training-induced changes in commonly 
measured immune markers.  
Chapters 3 and 4 included no measures of immune function, and purely examined illness 
incidence. Ultimately, whether or not an athlete contracts an infection might be regarded as 
the gold-standard outcome measure. However, determining whether or not infection 
susceptibility is increased requires follow-up over a more prolonged period of time because, 
although a factor may impact negatively on host defence, this will not manifest as an 
infection unless the individual is in fact exposed to a pathogen. Furthermore, a large 
proportion of symptomatic URS are not caused by an infectious agent, and it is possible that 
differences in illness rates between non-athletes and athletes may be primarily due to athletes 
experiencing a greater number of unidentified/non-infectious URS episodes (Spence et al., 
2007). If this is the case, then mechanisms other than impaired host defence might underlie 
the increased illness incidence associated with heavy training, although it should be noted 
that the study by Spence and colleagues was conducted during the summer months, a time 
period when low incidence of infectious URI would be expected. Since URS appear to be 
associated with reduced athletic performance regardless of whether or not they are associated 
with an identifiable pathogen (Walsh et al., 2011b), a better understanding of the aetiology of 
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symptomatic but non-infectious URS in athletes would improve our ability to prevent and 
treat them. 
Even within a homogenous athlete group there are large inter-individual variations in illness 
susceptibility which cannot be explained by competition- or training-related factors. Much of 
this difference is likely to be genetic. However, cross-sectional studies exploring behavioural 
or lifestyle differences between illness-prone and less illness-prone athletes, could be useful 
in determining whether there are feasible changes that athletes can implement in order to 
reduce their risk of illness. This is particularly important since there appears to be an 
association between athletic success and predisposition to illness, although the causality of 
this relationship remains unclear. The results from Chapter 3, and from previous studies of 
swimmers, provide typical annual illness rates for elite athletes, and allow practitioners and 
researchers to identify athletes who deviate markedly from the norm.  
Research pertaining to infection risk associated with prolonged, strenuous exercise and high 
training loads is primarily of relevance to highly trained and elite athlete populations. 
Although recreational athletes may also undertake strenuous exercise and relatively large 
volumes of training, the repercussions of minor illnesses such as upper-respiratory tract 
infections for these individuals are small compared to an elite athlete whose career depends 
upon being in optimal physical condition. Despite this, the vast majority of studies in the area 
of exercise immunology have been conducted with moderately trained individuals. The extent 
to which these findings are generalizable to elite athletes is questionable, and prescribing 
accurate guidelines for this population based on results from moderately trained or untrained 
individuals is problematic. As such, although conducting studies with elite athletes is 
challenging, there is a need for more research in this population.  
  
 29 
 
9.7 PRACTICAL GUIDELINES AND APPLICATION IN THE FIELD  
 
1. FINDING:  Illness risk amongst athletes is particularly high in winter months and during 
periods of competition, intensified training periods and international travel. 
GUIDELINE:  Additional precautions should be taken at these times (e.g. minimising 
exposure to crowds and infected individuals and optimising nutrition, recovery and 
hygiene).   
 
2. FINDING: There is high inter-individual variation in illness incidence. While the average 
elite endurance athlete experiences 3-4 upper-respiratory and/or gastrointestinal illnesses 
per year, 16% of athletes experience 6 or more episodes per year and can be categorised as 
“illness prone”.   
GUIDELINE: Coaches/support staff should identify illness prone athletes, as they may 
benefit from additional support (e.g. to correct potential nutrient or energy deficiencies or 
implement lifestyle changes) in order to normalise illness rates. 
 
3. FINDING: Highly-trained endurance athletes (?̇?O2max >65 ml/kg/min) are reasonably 
robust to short-term periods of intensified training (≤8 days)  
GUIDELINE: Intensified training periods can be incorporated into the training of these 
athletes without substantial impairments to immunity or performance, but these should not 
be so prolonged or severe as to induce a state of non-functional OR.  
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4. FINDING: In athletes undertaking intensified training and consuming an otherwise self-
selected diet, ingesting 60 g of CHO per hour during exercise is no better than 20 g of 
CHO per hour in terms of maintaining immunity and performance.  
GUIDELINE: A moderate CHO intake (~20 g/hour) during exercise is sufficient to 
maintain immunity and performance during intensified training, provided total daily CHO 
intake is not less than 7 g/kg bm.  
 
5. FINDING: Changes in immune markers do not correlate with the magnitude of 
performance decrement following intensified training, and are therefore not able to 
differentiate between overreached and non-overreached athletes.  
GUIDELINE: To-date, no biochemical marker is able to consistently diagnose OT, and 
regular and standardised performance testing of athletes is therefore important in order to 
monitor for OR. 
 
6. FINDING: Moderate hypoxia equivalent to 2,000 masl does not meaningfully exacerbate 
immune disturbances when exercise is performed at the same relative intensity. 
GUIDELINE: Training load should be carefully monitored and controlled while at 
altitude. Absolute workload should be reduced so that relative exercise intensity is not 
higher than at sea-level. For this, heart rate and blood lactate measures may be useful to 
help athletes “recalibrate” their perception of effort at altitude.  
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7. FINDING: Athletes who subsequently contract a URS have a reduction in salivary S-IgA 
concentration on day 1 and 3 at altitude.  
GUIDELINE: Monitoring individual changes in salivary S-IgA upon ascent to altitude 
can be a useful and non-invasive predictor of infection risk in athletes.  
 
8. FINDING: Athletes experience reduced sleep quality and quantity while residing and 
training at altitude.  
GUIDELINE: Training and mealtime schedules during altitude training should allow 
athletes adequate time in bed. Daytime naps can help athletes compensate for reductions in 
nocturnal sleep quality.  
 
9. FINDING: Traveling on aircraft makes an athlete five times more likely to contract an 
illness.  
GUIDELINE: In the final days and weeks leading up to a major championship, air travel 
should be minimised where possible. When traveling on aircraft, limit unnecessary stress 
and take precautions to minimise pathogen exposure.  
 
10. FINDING: Taking part in a competition triples an athlete’s risk of illness.   
 GUIDELINE: Although competitions are an important part of the training and peaking 
process, it is advised that the competition schedule be moderated leading up to important 
events in order to reduce the risk of illness. 
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11. FINDING: Taking part in periods of repeated competition not only increases 
infection risk, but can also impair race performance for many weeks.  
 GUIDELINE: Participation in multi-day stage races is not advised in the lead up to major 
championships.  
 
12. FINDING: Elite endurance athletes with greater training load volatility have higher 
illness rates.  
GUIDELINE: Large day-to-day fluctuations in training/competition load should be 
avoided.  
 
13. FINDING: Male cross-country skiers have lower training loads but higher 
competition loads than their female counterparts, and also experience greater illness rates 
and performance decrements following a stage-race. 
GUIDELINE: Higher habitual training loads, achieved via a gradual, periodised increase, 
can allow athletes to better tolerate and recover from the physical demands associated with 
an intense period of competition or training. 
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9.8 CONCLUSION 
 
Although athletes are not clinically immune deficient, multiple small changes to immune 
function as a result of endurance exercise and training have been suggested to compromise 
resistance to URS and other minor infections.  
The results of this thesis, however, indicate that elite endurance athletes typically experience 
3-4 upper-respiratory and/or gastrointestinal illnesses per year. As such, this does not support 
the assertion that endurance athletes have abnormally high infection rates compared to the 
general population. That being said, illness incidence varies considerably between 
individuals, with 16% of athletes experiencing ≥6 episodes (≥30 days) of illness per year. The 
loss of thirty training days every season can clearly have significant negative implications for 
performance and for an athlete’s career, particularly if they fall during critical periods of 
training or competition. Indeed, we have found that ultimate athletic success (medalling at 
Olympic Games or World Championships) is associated with significantly fewer annual 
illness days. Understanding the factors that influence an athlete’s infection risk therefore 
remains an important line of enquiry.  
The results of the present thesis indicate that two of the most potent risk factors for infection 
in endurance athletes are air travel and competition; respectively tripling and quintupling an 
athlete’s risk of illness. Other factors, such as inadequate CHO intake, hypohydration, and 
hypoxic exposure, may influence infection risk at the extremes. However, the majority of 
endurance athletes are unlikely to severely restrict CHO or fluid intake, or be exposed to 
extremes of altitude (>3,000 masl). Within the moderate ranges that elite athletes would 
expect to encounter them, and which were consequently explored in this thesis, these factors 
appear to have negligible influence on immunity and infection risk.  
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